var title_f11_63_12272="Conversion of supraventricular tachycardia with adenosine";
var content_f11_63_12272=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F70842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F70842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 570px\">",
"   <div class=\"ttl\">",
"    Conversion of supraventricular tachycardia with adenosine administration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 550px; height: 98px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram during conversion of supraventricular tachycardia to sinus rhythm with administration of adenosine. During tachycardia at a rate of 230 beats/min, there is a normal-appearing QRS complex without a delta wave (no ventricular preexcitation), and there is no distinct P wave. After conversion to sinus rhythm, there is a short PR interval (80 milliseconds) and wide up-sloping QRS complex (90 milliseconds) representing ventricular preexcitation, indicative of the Wolff-Parkinson-White syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: MacDonald MG, Mullett MD, Seshia MMK. Avery's Neonatology Pathophysiology &amp; Management of the Newborn, 6th Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12272=[""].join("\n");
var outline_f11_63_12272=null;
var title_f11_63_12273="Ileus";
var content_f11_63_12273=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plain abdominal radiograph demonstrating ileus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 491px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain film of the abdomen in a child with malrotation illustrates a nonspecific ileus pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Carlo Buonomo, MD, Children's Hospital-Boston. Copyright &copy; Carlo Buonomo, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12273=[""].join("\n");
var outline_f11_63_12273=null;
var title_f11_63_12274="Construction of an ileostomy - transection proximal limb";
var content_f11_63_12274=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F61779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F61779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Construction of an ileostomy - transection proximal limb",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts opening the proximal limb of the ileum in preparation for constructing an ileostomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12274=[""].join("\n");
var outline_f11_63_12274=null;
var title_f11_63_12275="Globin bands Hb H disease";
var content_f11_63_12275=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F53915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F53915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Globin bands attached to the red cell cytoskeleton in hemoglobin H disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 452px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    SDS-PAGE analysis of ghosts and cytoskeletons of red cells from two patients with hemoglobin H (HbH) disease and a normal control. A prominent globin band is seen in both the ghosts and cytoskeletons of the cells from patients with HbH disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Advani, S, et al. Blood 1992; 79:1058. Copyright &copy; 1992 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12275=[""].join("\n");
var outline_f11_63_12275=null;
var title_f11_63_12276="Early menopause (primary ovarian insufficiency)";
var content_f11_63_12276=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/63/12276/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12276/contributors\" id=\"au6039\">",
"       Lawrence M Nelson, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/63/12276/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12276/contributors\" id=\"se3550\">",
"       William F Crowley, Jr, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12276/contributors\" id=\"se4464\">",
"       Robert L Barbieri, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?11/63/12276/contributors\">",
"       Deputy Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12276/contributors\" id=\"de5123\">",
"       Kathryn A Martin, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12276/contributors\" id=\"de2799\">",
"       Constanza Villalba, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?11/63/12276?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      PRIMARY OVARIAN INSUFFICIENCY OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Primary ovarian insufficiency (POI) is a condition in which the ovaries stop functioning normally in women who are younger than 40. The condition used to be called &ldquo;premature ovarian failure&rdquo; and \"premature menopause,\" but these terms are misleading, because women with primary ovarian insufficiency do not always stop menstruating, and their ovaries do not always completely shut down [",
"     <a class=\"abstract\" href=\"UTD.htm?11/63/12276/abstract/1\">",
"      1",
"     </a>",
"     ]. That's important to keep in mind, because the diagnosis of primary ovarian insufficiency does not always mean that pregnancy is impossible. What's more, the condition does not imply that a woman is aging prematurely. It simply means that her ovaries are faltering.",
"    </p>",
"    <p>",
"     In women with primary ovarian insufficiency, the ovaries:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Stop releasing eggs, or release them only intermittently, and",
"      </li>",
"      <li>",
"       Stop producing the hormones estrogen, progesterone, and testosterone, or produce them only intermittently",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Given these effects, primary ovarian insufficiency makes pregnancy unlikely. Learning of this can be emotionally devastating to some women, especially if they have not had children or want more children. For them, the diagnosis squelches dreams of motherhood. If that is true for you, take some time to heal emotionally and to learn about your options.",
"    </p>",
"    <p>",
"     Take time to honor your feelings of grief and loss. Being diagnosed with primary ovarian insufficiency can be a life-changing experience [",
"     <a class=\"abstract\" href=\"UTD.htm?11/63/12276/abstract/2\">",
"      2",
"     </a>",
"     ]. It is natural to feel down, but be mindful of depression. You may even want to seek out counseling or to participate in a professionally-monitored support group for women with primary ovarian insufficiency. If you have a partner, remember that he or she may also be affected by your diagnosis, so it might be useful to find help in processing related emotions for the two of you.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      PRIMARY OVARIAN INSUFFICIENCY CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     In the vast majority of cases, healthcare providers do not know why primary ovarian insufficiency occurs. Some cases of the condition can be explained by genetic abnormalities, exposure to toxins, or autoimmune disorders, but most cases are \"idiopathic,\" meaning they have no known cause [",
"     <a class=\"abstract\" href=\"UTD.htm?11/63/12276/abstract/1\">",
"      1",
"     </a>",
"     ]. Even so, it is important for women to be tested for the known causes of primary ovarian insufficiency. Some of the known causes may be associated with other effects on your health or the health of your family members.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Genetic causes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Genetic causes of primary ovarian insufficiency may be due to abnormal chromosomes or abnormal individual genes. Chromosomes are structures that house thousands of genes. Chromosomal abnormalities that lead to primary ovarian insufficiency include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Turner syndrome &mdash; The sex of a person is determined by their complement of X and Y chromosomes. Women normally have two X chromosomes, while men have one X chromosome and one Y chromosome. In Turner syndrome, women have only one X chromosome; the other one is missing. The lack of a second X chromosome (Turner syndrome) is the most common chromosomal defect in humans. It causes abnormalities throughout the reproductive system and can cause primary ovarian insufficiency. Missing just a portion of one X chromosome (a critical portion) can also cause primary ovarian insufficiency.",
"      </li>",
"      <li>",
"       Fragile X syndrome &mdash; Fragile X syndrome is the most common cause of intellectual disability (mental retardation) worldwide. People who have fragile X have a defective gene on the X chromosome. Those who have the defective gene do not always have mental retardation, but the genetic abnormality can worsen with each successive generation; hence, a woman whose primary ovarian insufficiency is caused by a change in the fragile X gene is at risk of having an intellectually disabled baby, if she is able to conceive and give birth. For this reason, women who are carriers for the abnormality in the fragile X gene are advised to undergo genetic counseling before trying to get pregnant.",
"      </li>",
"      <li>",
"       Other chromosomal and genetic causes &mdash; Several other chromosomal and genetic abnormalities can lead to primary ovarian insufficiency. For example, some women have Y chromosome material, even though the Y chromosome should exist only in men. Although this condition is rare, women who have Y chromosome material need to have their ovaries removed because the abnormality can cause ovarian tumors. Other genetic abnormalities that can cause primary ovarian insufficiency include those that impair normal hormonal function.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Toxic causes",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common causes of toxin-induced ovarian insufficiency are chemotherapy drugs and radiation therapy, both of which are used to treat cancer (see",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=see_link\">",
"      \"Ovarian failure due to anticancer drugs and radiation\"",
"     </a>",
"     ). Other toxic causes of ovarian insufficiency may include certain viruses.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Autoimmune causes",
"     </span>",
"     &nbsp;&mdash;&nbsp;The job of the immune system is to identify and destroy foreign or abnormal cells that can cause infection, cancer, or other problems. Unfortunately, the immune system sometimes misdirects its efforts and begins attacking the body's normal, healthy cells. In some cases of primary ovarian insufficiency, the immune system mistakenly attacks hormone-producing (endocrine) organs, including not only the ovaries but also the adrenal glands, the thyroid glands, and other structures.",
"    </p>",
"    <p>",
"     Women whose ovarian insufficiency is caused by an autoimmune disorder should have their adrenal and thyroid function evaluated. If the adrenal glands are affected, it can cause a very serious and potentially life-threatening condition called primary adrenal insufficiency (Addison's disease). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/0/9220?source=see_link\">",
"      \"Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      PRIMARY OVARIAN INSUFFICIENCY SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Most women with primary ovarian insufficiency undergo a normal puberty and have regular periods before developing ovarian insufficiency. The most common symptom that prompts them to seek medical care is missed or infrequent periods.",
"    </p>",
"    <p>",
"     Some women first notice that their periods are infrequent or absent when they stop taking birth control pills, but that does not mean that the pills caused primary ovarian insufficiency. While taking the pill may mask the condition, it cannot cause it.",
"    </p>",
"    <p>",
"     Other primary ovarian insufficiency symptoms include hot flashes or vaginal dryness, because women eventually produce little or no estrogen. As the condition progresses, some women may also develop vaginal inflammation and thinning of the vaginal walls, which can make intercourse painful.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Family planning",
"     </span>",
"     &nbsp;&mdash;&nbsp;Primary ovarian insufficiency often interferes with a woman's ability to get pregnant. Even so, between 5 and 10 percent of women with the condition are able to conceive and give birth normally. Others become pregnant through in vitro fertilization using donor eggs. (See",
"     <a class=\"local\" href=\"#H14\">",
"      'Infertility treatment'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      PRIMARY OVARIAN INSUFFICIENCY DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     If you are younger than 40 and have not had a regular period for three months or longer, see a healthcare provider for a full evaluation.",
"    </p>",
"    <p>",
"     Even if you do not want to get pregnant, the condition can have broad-reaching implications for your overall health. Women with primary ovarian insufficiency are at increased risk for osteoporosis and possibly even heart disease, so it's important that the condition be detected early and managed appropriately.",
"    </p>",
"    <p>",
"     To determine the cause of your irregular, absent, or unusually light periods, your healthcare provider should ask whether:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       You have symptoms besides light, irregular, or absent periods. Some women with primary ovarian insufficiency have hot flashes or vaginal dryness, and these symptoms hold clues about how the ovaries are working.",
"      </li>",
"      <li>",
"       You have had surgery on your ovaries, or received chemotherapy or radiation therapy, as these all damage ovarian tissue. (See",
"       <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=see_link\">",
"        \"Ovarian failure due to anticancer drugs and radiation\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       You or any of your family members have any autoimmune diseases, such as polyglandular failure, hypothyroidism, Addison disease, vitiligo, myasthenia gravis, Graves' disease, Sj&ouml;gren syndrome, lupus, hypoparathyroidism, recurrent mucocutaneous candidiasis, celiac disease, type 1 diabetes, or rheumatoid arthritis. A personal or family history of these conditions can point to autoimmune ovarian insufficiency. (See",
"       <a class=\"medical medical_review\" href=\"UTD.htm?23/26/23976?source=see_link\">",
"        \"Pathogenesis, diagnosis, and treatment of autoimmune ovarian failure\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       You have any symptoms of adrenal insufficiency, such as decreased appetite, weight loss, vague abdominal pain, weakness, fatigue, salt craving, or darkening of the skin. These symptoms are important, because roughly 3 percent of women with primary ovarian insufficiency develop adrenal insufficiency (see",
"       <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33800?source=see_link\">",
"        \"Clinical manifestations of adrenal insufficiency in adults\"",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Any of your family members have primary ovarian insufficiency. Approximately 10 percent of cases of ovarian insufficiency run in families.",
"      </li>",
"      <li>",
"       You have a family history of fragile X syndrome, mental retardation, or developmental delay. A family history of these conditions suggests that fragile X syndrome could be involved in your diagnosis.",
"      </li>",
"      <li>",
"       You have any hearing loss, because some genetic causes of primary ovarian insufficiency can cause deafness.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Important tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;In addition to asking you detailed questions about your personal and family history, and performing a physical examination, your healthcare provider should order a blood test to measure various hormone levels.",
"    </p>",
"    <p>",
"     To be diagnosed with primary ovarian insufficiency, you must have elevated levels of a hormone called follicle stimulating hormone (FSH). High levels of FSH indicate that your brain is trying to stimulate the ovaries but the ovaries are not responding. That's important because the ovaries sometimes fail not because they are dysfunctional, but because the brain or the body's master gland, the pituitary, has stopped properly regulating ovarian function.",
"    </p>",
"    <p>",
"     If blood tests confirm that you have primary ovarian insufficiency, your healthcare provider should then look for a potential cause. Tests used to determine the cause of the disorder include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Karyotyping, which determines whether any chromosomal abnormalities exist",
"      </li>",
"      <li>",
"       Antibody measurements, which can point to autoimmune causes of ovarian insufficiency",
"      </li>",
"      <li>",
"       Various types of genetic testing",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      PRIMARY OVARIAN INSUFFICIENCY TREATMENT",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H444454\">",
"     <span class=\"h2\">",
"      Taking care of you",
"     </span>",
"     &nbsp;&mdash;&nbsp;The diagnosis is more than infertility and affects a woman's physical and emotional well-being. Management of the condition must address both [",
"     <a class=\"abstract\" href=\"UTD.htm?11/63/12276/abstract/3\">",
"      3",
"     </a>",
"     ]. Before deciding about your plans for a family, it is first important to be healthy yourself. There are multiple choices available to you if you decide you want to become a parent.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Estrogen replacement",
"     </span>",
"     &nbsp;&mdash;&nbsp;One of the main goals of primary ovarian insufficiency treatment is replacing the estrogen that the ovaries have stopped producing. That's important, because estrogen is vital to certain normal processes. The bones, for example, need estrogen stimulation to stay strong and resistant to fracture. Without estrogen, women with primary ovarian insufficiency are at risk of developing the bone-thinning disease osteoporosis.",
"    </p>",
"    <p>",
"     There is also some controversial evidence that a lack of estrogen, particularly before the age of 50, can increase the risk of heart disease. What's more, without estrogen, women often develop symptoms of menopause, namely hot flashes, night sweats, sleep disturbance, and vaginal dryness. Estrogen therapy aims to prevent or alleviate all of these consequences of estrogen deficiency. However most women cannot take estrogen alone; they must combine it with a progestin (a form of progesterone) to prevent a condition that could lead to cancer of the uterus.",
"    </p>",
"    <p>",
"     Most experts currently recommend that women with primary ovarian insufficiency should take estrogen until age 50 years, the average age of menopause. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/63/37880?source=see_link\">",
"      \"Management of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Type of estrogen therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;The main form of estrogen that the ovaries normally produce is called estradiol. Some experts believe that giving women this type of estrogen best mimics the \"natural condition,\" but other forms of estrogen are available and are also effective.",
"    </p>",
"    <p>",
"     Women who opt for estradiol can get it in pill form, in a patch that is worn on the skin, or in a ring that is inserted into the vagina. The estradiol patch and vaginal ring may offer advantages over the pill form, including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       They deliver the same hormone that the ovaries make",
"      </li>",
"      <li>",
"       The estrogen does not have to go through the liver to get into the bloodstream",
"      </li>",
"      <li>",
"       The estrogen gets into the body in a slow, steady stream, rather than all at once",
"      </li>",
"      <li>",
"       The estrogen can be measured easily in the bloodstream",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Despite the advantages the patch and ring may have, other forms of estrogen replacement are also effective, and women should choose the form that best suits them. Some women do not like wearing the patch or using the ring; others develop skin irritation when they wear the patch. For them, hormones in pill form may be a better choice. Regardless of the form of estrogen they choose, most women must also take some form of progestin (a type of progesterone). With progestins, women also have choices. They come in patch or pill form and there are synthetic and \"natural\" versions.",
"    </p>",
"    <p>",
"     For women who wish to avoid pregnancy, some healthcare providers prescribe oral contraceptives, because the estrogen doses used in hormone replacement are not high enough to prevent pregnancy. However, some providers suggest barrier contraception or an intrauterine device instead of the pill, because occasional women with primary ovarian insufficiency have become pregnant in spite of taking the pill.",
"    </p>",
"    <p>",
"     Women who do want to get pregnant, meanwhile, should opt for a hormone combination that changes cyclically, the way estrogen and progestin do naturally. Women with primary ovarian insufficiency commonly experience unpredictable and intermittent ovarian function, and it is estimated that there is a about a 4 percent chance of ovulating each month.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Duration of estrogen therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women taking estrogen and progestin may worry about the risks of hormone replacement therapy. After all, recent studies have linked the use of these hormones with an elevated risk of heart attack, stroke, and breast cancer, among other things. The fact is, those studies looked at the effects of estrogen and progestin in women who were in their sixties and seventies and who had undergone menopause naturally.",
"    </p>",
"    <p>",
"     The results of those studies do not apply to younger women with primary ovarian insufficiency. On the contrary, studies in women with the condition suggest that they are more likely to have cardiovascular problems if they don't take hormones than if they do. Plus, forgoing hormones can lead to osteoporosis.",
"    </p>",
"    <p>",
"     Most experts agree, in general, that young women with primary ovarian insufficiency should use hormone therapy at least until they turn 50.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Infertility treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;As noted above, between 5 and 10 percent of women with primary ovarian insufficiency are able to conceive and give birth normally without any special treatment. Treatment with estrogen, fertility drugs, or other hormones, has not been shown to improve fertility.",
"    </p>",
"    <p>",
"     One treatment that is successful is in vitro fertilization with donor eggs. In one report of 61 women with primary ovarian insufficiency undergoing 90 treatment cycles, the cumulative chance of pregnancy after three cycles was approximately 90 percent. Success rates for this procedure depend primarily on the age of the egg donor. Embryo donation, in which frozen embryos are donated to the couple, is also often successful, and in general, less expensive.",
"    </p>",
"    <p>",
"     If you are interested in becoming pregnant, work with your healthcare provider to identify the cause of your condition before you start trying to conceive. Some underlying causes of primary ovarian insufficiency can adversely affect a pregnancy or a fetus, if a pregnancy is successful. For some women, adoption is a good option.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Being diagnosed with primary ovarian insufficiency (also called premature ovarian failure) can be emotionally trying. Women with the disorder may need time to grieve and adjust to the diagnosis, and there are resources that can help them do that.",
"      </li>",
"      <li>",
"       Women with primary ovarian insufficiency should consider taking estrogen-progestin therapy at least until age 50 to prevent osteoporosis and possibly cardiovascular disease. Taking these hormones will have the added benefit of reducing menopausal symptoms, including hot flashes, night sweats, and vaginal dryness.",
"      </li>",
"      <li>",
"       Women interested in becoming pregnant should consult their own healthcare provider about possible therapeutic options. Those who are comfortable with pursuing assisted reproduction may want to consider in vitro fertilization using donor eggs or donor embryos.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H112399600\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H263301290\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/5/19538?source=see_link\">",
"      Patient information: Early menopause (primary ovarian insufficiency) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H263301307\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/0/9220?source=see_link\">",
"      Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H112399621\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34697?source=see_link\">",
"      Etiology, diagnosis, and treatment of secondary amenorrhea",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36903?source=see_link\">",
"      Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8202?source=see_link\">",
"      Patterns of relapse and long-term complications of therapy in breast cancer survivors",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/63/37880?source=see_link\">",
"      Management of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14329?source=see_link\">",
"      Management of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=see_link\">",
"      Ovarian failure due to anticancer drugs and radiation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/40/7817?source=see_link\">",
"      Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/26/23976?source=see_link\">",
"      Pathogenesis, diagnosis, and treatment of autoimmune ovarian failure",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33800?source=see_link\">",
"      Clinical manifestations of adrenal insufficiency in adults",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Premature Ovarian Failure Support Group",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.pofsupport.org/\">",
"      www.pofsupport.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Society for Reproductive Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.asrm.org/\">",
"      www.asrm.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Resolve: The National Infertility Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.resolve.org/\">",
"      www.resolve.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The International Council on Infertility Information Dissemination",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.inciid.com/\">",
"      www.inciid.com",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The US National Institutes of Health - Information regarding clinical trials relating to premature ovarian failure",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://clinicaltrials.gov/\">",
"      file://clinicaltrials.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     Dr. Lawrence Nelson's work was supported by the Intramural Research Program on Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 5, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?11/63/12276?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12276/abstract/1\">",
"      Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12276/abstract/2\">",
"      Groff AA, Covington SN, Halverson LR, et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril 2005; 83:1734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12276/abstract/3\">",
"      Sterling EW, Nelson LM. From victim to survivor to thriver: helping women with primary ovarian insufficiency integrate recovery, self-management, and wellness. Semin Reprod Med 2011; 29:353.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f11_63_12276=[""].join("\n");
var outline_f11_63_12276=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           PRIMARY OVARIAN INSUFFICIENCY OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           PRIMARY OVARIAN INSUFFICIENCY CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           PRIMARY OVARIAN INSUFFICIENCY SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           PRIMARY OVARIAN INSUFFICIENCY DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           PRIMARY OVARIAN INSUFFICIENCY TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H15\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f11_63_12277="Hysteroscopic instruments";
var content_f11_63_12277=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hysteroscopic instruments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Scissors. (B) Grasping forceps. (C) Rigid hysteroscopic biopsy forceps.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12277=[""].join("\n");
var outline_f11_63_12277=null;
var title_f11_63_12278="Breast duct ectasia MRI image";
var content_f11_63_12278=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83698&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83698&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Breast duct ectasia MRI image",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The MRI of the breast using a precontrast, T1 fat saturated sequence in the sagittal (A) and coronal planes (B and C) shows dilated ducts (red arrows) with increased signal suggesting that the ducts are filled with proteinaceous debris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Priscilla J Slanetz, MD, MPH, FACR.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12278=[""].join("\n");
var outline_f11_63_12278=null;
var title_f11_63_12279="HCV hepatitis";
var content_f11_63_12279=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histopathology of chronic hepatitis C",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 286px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEeAZgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6d1fUrTSNOmvtQl8q1ixvfaWxkgDgAk8kdqp6X4k0rVLQ3VhdGW3D+Xv8p1G705AqzrkVrNpc0d/FHNbHbuSTG0/MMZz74rz3TdM1PVfEGt2Gmawml2Fj5GyCKzR1JdCxPNGtzaKp+zvK/Nf5W/zPRrrUbW2VmmdgApY7Y2Y4HoAOfpVOTxHpaMFa5bcQDtELkjjuAvHTvXA6dE+s61qOgWPxAS51LTSDdWw06PdFnjqeD6cE46GpfDwvtO1TxFod1eJqk1qsUkLsiwsxeMkg44696YQjTejudtN4o0mHcXuJSFQSErbysMcdwp556da1UuInTcjgr64rjtNvTcW8cclqyTuApil4fK/e25+8P9ocGm3tnqF7dxQWlzNZxlsyFGClVU54GDknhSPQnnpRYqVKNtDsoLmGcMYmLBTgnaRUUmoWsc3lSTBZMZ2kHJHt61i2lvqdhb3LGVbkl2dVY4IXOQoOMcDpnn3qtZ21nqwilv49sq5kjWZRujYgjKnscEjIPeghU07u+iOhl1OzhjLyTYUdflJ/pVez1/TL25mt7a5LTQ8SIY3Ur+Y9wfoQehrk/E1lG8MYLTGNJlw8chAAIIy3Pzgk9D9e1VfCb2l4gvoftEFv5j27RmTITYxXkAnaT359KrlVjZUIct9T0FtQtVTc0oC4zkg9KzLfxZolxdG3ivgZgm/aY3HH4im3VrZTRMlnFC8zd1wevGSf8a828baXfaXqVpLb3d3bx3Oy3nkRo1AJYAEbu5yOBj7v5pRTDD0adS6k3foerRa5p8rbY5yTt3f6tun5VYF/bE4Eo6Z6GvI/Bks+lajeR6lNeSWN1KxVZkylqwHRnzwCOmQBkYzkjPo91NbLpqrGA0mMqqjcwPqRQ1YVahGnPlV2a8N5BPnypN2Bnoary6xYRECS4CljgDack/lXDWGr6k18YprN0BVSkyHahO4AoUOWDYJ5yRxV97KWHUAZyfszb3/0kh3VyRgJkY24zjnI545GFawnRUXaVzrI9Vs5Y/MjmLJ6hG/wp8WoW0ys0cjMqnBIRuD+Vc5a6OqrNeLeynzlVliJ+SPHJx3571N4Uubb+xwigxJBJIuCpGMOQaTIcI8t0bn9p2nmNGJgXUAkBSeD+FI+qWiQmUu+wdcRMT+QGa4y/l/sqW8v9J02a4QqWaOJMNJz0XPU8k++TWh4efz7a9a8VYvMJdQ+VYKc8EE8EUeg/ZR5eY3dP1zT9Quri2tZmae3CmVGidNoYZH3gOxqxJqFtGXDO2UOGARifyArg/A6LHq8iX5i+2xRGNJQpRmTIOMHt0OK3igkhklLofLmbB3YZj06g+/6UmyqlBQk1fTQ1l13Tnm8pLjc/wDsoxA9s4xmln1zTreLzJ7kRpnHzIwP5Yrz1by7sJ5oGsDHBI8s8lwX3JGobjLAdTnOO3PJrRtbwXEsaS2vzRMCjYB3j/OePUUm7GrwsbXVztxqdoTgTAkjONp6evSmafq9jqGnfb7SbfaZYeYUZfukg8EA9Qa5C+tS+pwX0bXEMSIyNbwuVjPIIZgP4uv8q3rR1g0cJcBSryeXg8ggnHPtSUrnPKmkk0R23jfw9deb9m1DzfKzu2QSHGOvReaenjLQXaVVvWLRHDjyJMj8NvT36V5zq3gq68ReOdV0ux1ybQ9PsrG0uoorCJQGaV7hTn6eSOnrWH4dl8NahrVvYaX8ShNqMxMESyadtMrA8qGYAMcjpnmhOTNWsMu/4HrM/wAQPDMEojl1Ihjn/l3lIGOuSFwKkHjzw22dupq2MZxFIcZ/4DXlmu6OukeI9Ys9TuYNQaPT7OaJvJWBj5klyrLhTg4EKnJ981D4fSy1h7vTjaeU9tzJDsEfmjBGTjr0x6UNtHTSwlCpT59fw/yPcNM1ex1O38+xn82PjkKw/QjNWpbiOJN7sQo74JxXiHjOw8QDwzpF14OWXS722RnuLVP3bSYxkZBwTgZA5z2q7ofirxKsGircp5sxYfblucRblPUJn+IDB9DTUujMPqblH2kHp26npF/4w0GwcJd6jGjHnARmP6A1Xg8d+HJ5nij1H96knlsjQSK2cZHBXoc8HofWuX8SSeHvtuoy3VtHcSWxjeVMHCowHz4A5Xrk81maNremahcq+m2M0EQcKodNwlQDC7PQc+mOtPW5pDDU5Q5kpfh/kemzeINKgkjjlvI1kkGVTBLHp2x15HFWf7Ts8E+eOE3kYOdvrjrXkPiHTLm8vWMptIXkYyRO0OHRTnG0j+IEYPXnBrfkvLW2tofsJSRTJseWMqpBxkg474Gfw60xSwkOVOLu2drJ4i0tIfN+0M0eAcxwu/B9gDU8mr2UaF2n+UDJIRiP0Feb+HNf0zWYZLzSx5SLKYlQoASwPLEdx6VNq1+qwSzQJG4RjhVyuecquPXOPelcmOEvK2p3J8S6SDg3JB3bP9S/X8v1qyur2LSBFnyxXdwrHj8q8vtrqK8jaFpTFcD/AFgMTYBz644GfWp9RLaU6fNKd4ILJzuyfbtyKfqaPBQvypu532meJtK1S5nt7KeV5YDiRWtpUx+LKAfwqC48aaBb6z/ZM2oBNQ4/dGJ+/vtx+tYVyL2LT3ltQlz8i+WB90Y6jCjPT0rMuNHS9udP1rU7cR3EKkvvX7ihc8k/eGf50GUcPTbu3p6ne3ev6ZaRiS4uSqbtuRGx59OBUM/ijR4SokvV3MQAAjMeenAHvXKS3dm961vOskwmx8gT5FJwAenTvmqviqwtIrVWtoVEyHMciAjHHJwOw9aZUMNTbUZXVz0CLVrKWF5UmJRG2sdjDB/Kmya3p6A5nJxj7sbN1GewrzTwdrobdaSMC8xZ0b72DjGf5/nW6lyq3rxgxBY1BBwCxOP0x19MGiwp4Tkk0zpNO8UaRqMrxWtzIZEOGV7eSMj/AL6UVqR3cMoBjfcD0IU1574smnsrEtYLHJPJGec7iox125571Q8LatqsUQs9UnmFzbzGSdyow428ICegxg8Y9KXkL6opQ5oP5HqrSogBYkD6GqF9rmnWKFru5WNRxnaTz6DA61yy393dXeZ2AiGSqFvlY+n0qtp0F8mnCW5jW5v1ZpPKLglRg4xnjOMU7Gaw9leTO/tZ47q3jnhJMbjcpKlTj6HkUVBo9ybzTLa4aJ4mkQMY3GCp7g0UjmasxdWiSfT5opVRkbAIfoeRXE+E52g8QeNprSE3DwrbGOBCAXZYThR25I/Wu31NkSykMqhk4BB75IFeff2Ld6brWqXuia+bAX8ke+I2azAsq4BBPPOeaZa1jY84+GfgLx34X8baB4o1KwspJNTkuE1kWznz1WdvM3S5O0hHC/dJ4H416NcRRt458XSPGkrJHaFEL7WY+WcAGlh/4TJwyv4jRJQxwP7OjIK84OfXpxT9G0m8t59S1LULw6pf3jRBv3KwqAg2jAH4mguEXF3ZrWdrJdzvNasA6/KGlX/UHAyF4yc8Z5wcVWvobzbd29xvBVC6T2khSQH0A7nGOv0qbUdUm0mBJLeENI8qQJFI4AcFgAQ3bgk4Ppiqa28x1Se7kur57gr5Sx7l8uPvwAOvI556dqrY3V3ds1tNS/SCRJbkTxhB5SFdsh453HOM59qhnmhitgLovDHwx3AgpgZP5de/41HZ3gtNZCTyTSyyLnBUYRR0GRxknt9Kk1nWLKXULa0iYPcOhldOhCA9x1HP8jU+YlGXPZLcxNR8rU7ayubOTUEkeaKSOVYtm8AHG+NyMqenA7g9qfY6HfTxapBNaeVYTzEtBxGZF2jLbkIJLH1x3rrGRrq3iuJDErwkuAvI6c5/A1Zi1GAwJJKkkQb++tVzEKtKMbJHNaS9xZoZ7aKQq8nzwSMNyEn5sHPKjsMdvwql431dpm022gszPIW8+TzF2xiMfKck9T8wOPYn0rVu7t4bkvb2zT2by/vHj6x/7RXuvuOnXGM0yayj8QTRzpN5cUQby3ibrkbWH4foaNtS4uKlzvZHmx065ZkhnsbyOOSJWkhDqIwxlDN8xzv+9jB4+U8c16L4T1tbrTwkluIL4xktAZFJyDhuh6bu+O9ctqWkyaZrbrdahO8EkUcEMDjzC5B3bhgDBwrDHQ/U4qvaXjWl7aX1/E1qV3TElOWt8YIY4+U5KErnqvQ1T1R2VIxqw906a9e6g1rS76SBfs63GCVDF2DqVPA4wDtOTwAK2tU1KC/DW8aOxUht5X5fbB9eatTzxalDFDAAxbhty8AYII/LNc7qkFnoOqWc935kVqYxAQhYxhRltzccdxk46gc5qHrucSalP3tGT6J5kuqXVk8wFpGEMSsDu6Hdkng89vx71qo7WlxcrAd6yN90DIHFZ6XMM08wsvLMRIXYevQZIH06VKiqIhFJKPMAyrO2C3PT34H6Uhtcz12FJUXrLGbht8aAgtlBgkfL7+v4VBqPlxwtNczKIwxMbBiuMDK7vxHI6GkaXygzAHzDkgFOoHG0epzj86ddWSX1lPBctJvuo2iCABMbh24/mTSKso6FfxPpemSad9omuJbXdtAuoGw6jqPwzjjBFQ2Jks0MS3azxuodGmIz068ep59OcVd0zQXk0XyftMzqQqgT4bhQF24xjB2989c+1NgtLuZ7m1dIEjYMImKAsq8ZDcAdc9OwFS2Cnf3W7opXsVx/Y95LCsUzMhEMLTBDMW/hJI+U5yOc1DpOhyaBp/k6KLZLu3m8w2txI211Y5fDckEjOOozWdBpm2a4s55blxHN5oEj/wCpy24oGH8OcEDJwGI6Vs2ty9q0Es0vnz7iGZkwOSNuOvYqM1GxrPm5bJl6W9We73yW0kQ6YYZEnQ9PTnHI7Gq3iC/H/CA3V1aB32SKVL8bTvGCB3A449sVBL4kh1eeI6RGLqOB5EnuFbCxsozsHHzEnHTgfpVbXnx8KJJNZdY5JSm8xnhJGcY25HZiMZoi7mDjfldrai/DN2fxx4jEkhkkXStNDPt27j5t6cge+c15J4G8A+NbLUfCsT6TrMb6ZrL3kov7i2bTYoGdtzxxg+Z5u1hg5ODnGO2zaaj4k0qS4v7HU4bLVp4YbSWOSzEiTiJ5SuD/AAsfNPsfwratvE3jhbd/7S1yGznbIiV9OTDN6HnPWqUlsVPCVJyc4rQ2/F8cL/FLVhchRE2hWUZc/wAGZ7z/AAqDSDpdlqavboIrm4hEWCpAcg+rHr+FY+iNeaney694kvkuZfKht7iJ4RCEEDyMpXaeeZm5PtWV4waLVNVW6sH8lbcM7SHDADueOpH+IpNrc7MNRlyezlp3LepeOPsviE22r2c6RBzGHRTnA4JBzyDz0/OrHiqHUdRa5udIWa3kmhWeBIxu3IAfvD1IK9Dx0pljdWd74dt3t5oL7T/MJju1QiSMkgmMk8pz2PYiumtjKLeQW0ai3tvkjkdd3mKR2GRkD/GjU6E1BqUV/kcB4lu7nQNS0DxLJcos+oW5s7pZlMoVdwPmbVIz0xitvRNc0DU78G1geDcyxJPGhiG8Hn5ckhTwcjnnB6U3V9Lt/Gb6TGDPamG4DLKgTDADkFBjAIHBqbxPoem6prs0Gkm50XxDAglt5G5t5CGxgjHX5f8A9dRaqpabFOeH5eWompO+34fhoX7vxijzyW029YdwjZkB/dDO3J9Ccjg+9WrR3visdg9uUWQSKwjAcqRjkYx0J5rX/sWFk+0i8t4rw2+bp4wAJPl54x2IyCelUvDllDFoVveeFbqHVHaVIRKcMqAnln24PA7Vt6nI69PlfJox1p4at9ENxBCHhhly0bIRhAx688cHt7Vn6ZbHU72eymWBfLZvMLN8zIeN2OntjtXRfY9Uhvrm4vtRingkj2hEUhQw9FOccdsmstPD7Qa3Df2d4GWEM4Xj52PXJHNKw6db3XeWttGRpY3sErm5nX7LAhVrgP8AMcHpz7Yq/YpaancGaKQOYWxkj5t2fXGMc8D1qv4n3TWMZu0AibLSRScncewPH61U8E6haxXBtLZCqzEsGOOSF4B4yD2qtibudPni9UO1TxVJousafYWlnLdvM22UR7jtGSFAHrit/U5y9nOrTL9qmyIkZ9mw9kPXj161i+ERNpGs3Vprfly7GAsrp1CySLjJT1JAPXpVi4tbeDU2uXt2y8pcLOcE59B7ZP5URk2TOEHPlXRb9xZ7HU4dFRtHka0ullRngnlVzsH3o1fB4NafiPWYIfD63OoWs8NyI8NFDh2UsPu5HGOnWpvC8K38012QAiyDAGecZxmrE9tFeXV3dXCq0OfLjz7HBz26/wAhTOZv3+WXT7zmtHi0vV9OH9nxLEQT8qx7JFPIycdMZz1plhpMMGqTvfCR2VtsPzEY4xg/XJOa145rW2vZGtBEzkbWWPAAzj8+lPmt47gSXdyoSZFIVZcqhI5B47e/tQdDqNXvszDi8O2F94qtdYuHmS6syBGI3O0jGAPce3cVc16OJJ7W6t0JUz/6QI13bsgjcfYfLz2puh2MtvHbtdTRuM7mmB3DeSThT7E4H0q9dyQwKzO0snzAFYmxjPP+RQRJ+9dPoRpeK/2hmt1SRW2KDkZ981FoD3s+ous6eWgViJCMEKfQ+tT3l/EunzjT3WQL8u8rnae5HbHH51NHMRpyRgyrM8eCcZHqcnt/9emVJ6NJbnV6FaCx0i1tllllEaY3ytuduepPc0U/RxjTLcZzhcZzn9aKk8ySs2TXefIOMdR1GR1Fc1qFjHLcrKGkUxyo6hXIHTpwf06GujvkMlq6A4JwOuO471zt/BH5jIRtkOTkHpnHI5+lBpSV2KIJEuCwIdXYccfKMdPf1pl2XjujJ5kZXywcM2CSD6dOnFZtvaXVrrH2lblxZ+QI2g8wsDIGPzDI+U49D9e1UfFDrLZukb3Ecrgy+fEG+VUIY8r6jIwDk54qlZnTGDk9zUbT1nluxbwsfPbfK27zFyQAMbuBgdhUgvbeG0ZQJGeKXb8gJ2nPRsdOvftV/QdVtH0a2mRXRZIhLgoQTuG7njrz3rNtreJDL9jSTN05uJMICm/PvyDRvoSm22mrIj1G9tblikRMZfKGTHlhCw4I3YznoCAeR9abb6BHBdrqbQhb6NdrzFQJJRjByccjnIHqKWeAXU0ZuPKkRDu+ZM5I5U+xB+tWNYur13g8qSGOCMMLjcjbmBXI2nOOOvftTbLs1aKKmovFp8wi1HUY4oZsRxo21Q7ckc8ZJx09AetaBW6nQTPZygKpTPmHABH93vyaksl0u60hSkkU7vgeYDuO7tj056VPPJc2NtHG06s+AGbb1+gpXI5rvltqjA0fV786hfWV1GEhQlLcFSZJsfek3ZwBkhcYGOuews6JE9i9vIEmtonjZTbFtwVt+d3Htn86sJbxOqtNBNK/mCRWyc5HTv09qoXUr6ld2U6WN3HPb3O1o22qQeV3EhtuMMx6k47UXsNpXa6GJf3V1fX41fTLq5kd02R2sg2DbkgsUfGCDzkj27isWbWLT+0TYXV6Ibh4j/o8n7xopJX3DKnj5cLwGIxnjpXpGpaZNb27XgZpZYAziOBBukGCcfMcZ9On45qv9i0iG2DLZRi4usysWT52Y8liT1PP0/CqUrI0hiIvRLy0MPQP7Qs9TaBJmjigxITIgJk3E5XnBX16dMc9anmv5vFepyWsLzLZLbNHKoieNd7My58zhgRsPA9jnmr1xBqdvdPqNlcrqYmhVBbkKgXB6hu456H8K0NNukspCmGeVhl4xgMOeDjPrmlJ9RVJc3v21MbR7G58L3UsE6xzRzTZgeGPkRhVGJCTlm4+91xirGoC4vL0X8MBSdQoEMmCHUHJUZ4zznPvWpeWKajqXlXkYVAqSxIwz8yMCD9QcH8qq6gpQtFdq0hjIdViJJ4wBgcZ61N+pnGSk/Mn+wr9ok1HEgVtq+VvO0YyCwHYnPJHXApmqrPN5S2csQkjYMN7Ecc+npwfwpJbuW1s1hEU0tqin95Gu/aABwe5PHQUumRziD/S5BdT7Szvs8vIyccfTFS77hH3XdjtOubyxhWO8liZjuaSQNhQxPYHoMnpU8Nzbv5wt7qGZkdozJFIMq45KnHQj0P41Vj02C1E8LW6pG5MhR23iQnr14/Cq9tZJZJdyymKYeY0rNtCgZA5OOCcYGTzxUMSinsZeqXVpJHd28bNNPGu+6itSDJ8wwCcd+/qQtYerW2pahYukdnNDvjkhigjkQrGArgOxJKkMu0YIO0nPvXUiSzvRbyjD293GZY5lUlNgAYEsOACOmaxEtIItAtbTw+ymxJV1kMzr8hYMdhAJ6H8enApHTF9I6lzw7prw6XaJNA1stsSkMaHO0cgbjkgkg5PbJra1Xw7ZeJvA91o+pLstrxeGXgxnOVYZ6EHBFYtncvpmhodTuDM0Uf76VycsxbrnPI5wMjPStK9uZYvA7ziG4R/NAEaj51ywHr2+tC3uY1Iym1buee21l4l8F3OlWWoBrjS0P2WS/X5g2/Ox27ggqAe3PWqWrpq7eITZXyXMl2ALhpS3+siGQSgHBB9Oo4rrTc3jzRR+ezi5Uo0MzMQ+O4Bzgj6Vu6ul5Y6LD9nW1eaGL/R7m7GPs7YPDkA8cDJ9Kdro6Y1Z4Wfv2dzzvw1qOkaVruoWury2dvZ3kWIZJrgf6RIBl0Kn7mODk4yadpnhm3upIjBLJLAsgmjlhdXTCk4JIwrr6irk154PubvxFdXWkWU+r2Vis91dCASJcSNFklOMngfjXQfDW3jvrJxp8dsNDurRJIvIAEbMTywA6E9weRiny9GH1qS5p9X3ORijawhtbnVtUSfWrK7ZP8AiU24ZZ7ZiD5ckYAU8A+44rtFuksgbVtImXw/chCLiI7jHkZyU7KOhxVK61HU/DguZNasmkjeTbBBZhcRx/3jzlieemccVgfCybWnu7iFbp30y3nMjWuoROlyiMSVBJJHA96pJIxveLa2Om8P6baeHpjdalLaPd7HjhiR2clNxYYB74GfatCC403V4/OaYGVdzRs5Bz6Y78Z/Ws3xB4YOtx/abS8Md3alghycKhJ+XA9MgetFnpn9n2UUWpBYRkZKZbnOTz274ovqbJQqLnk9SO2kntpRcSSRC1Rdzln2rsGd7enAGf51DeHQv7MtrDw40Vppd9MZ2utMceWzZA52nkcjp0ArG+M96uj/AA31iWwjkWW7T7JCIwT5hmO0nGM5wWGK83+AekXnhW6mk1u6uALmPaNMDHy1DdXfsG4wAPXk9qadiajlVqpQjse/SWcNjbwW8k26B8bSTwT/AI9P0p2lafqEZuWgdPKETtExQDa5Ixkd+M896vf2hYi2L6hcRQRxEIVkA2gk/LkmqXinX7qLTtRi8PeTJrFsqMLRuPlz2z1J6U7XZhKc7eza3LN9C97bfOiSXCYLgd/lOcj0OBXGDULLTNSNvaqv2kN+8JBOzoCP6Z+lWoPENpo/iCGXVL0q2psIo7Z13GNjjI6dAcjNaur6Nb2lxDNdRQzsGG2dFPmEYOA2ByB2pPU6aNqMuSWqJFa3crJdXRuruOZp7YzqN0AK/Mi46rwODVE6teXszyyIWVHIMTfeU844xj1rTj0543k+x28ZuJozveV/lU5GCevOKxLOK60C+vLi+ic2nkFxfNMhhJ3KAuByGO44yOeae46bpwv36G7pupyrDNNLFNExYKY4uuAD8xB/CtWC0LaK3mSzOJpGmTKA7N3OPoM/X1rB8NWYWci4ld5WLFwcAAknjt2P8qu+KrCePR0trVJxbIVwkbgkr1IyxwOM8849DTOaaXtLIwtA0TVo9buLmaVPLljK7HcEocjHTtx+tdDd2xlmjsg7MsY86VgSQT6HFafhbULBtEtEtYRCpXHlMclcdcnv9afHLO09w1tZ+WgHzF8Zc54IIPSlsTOvUlK7VjltVS/F3bpakRQoCwRyVDZHPHQ9a3LC1hvbCNLlZuSuVxjDex9BWLe3sjIj3NvFNAGKswlBUH69R9KveHPEEF0jQ27KpXLc8gDNNG9RTcLo0W0RFgMSgRovI2jOP896II41xBI+SeCqnGcDPaql9e3UcQWJHBeTGUPUHkn/AOuKz4dLvILiWaSYyRTYMbgkMpBzyOx7deaDNKTXvM7/AE0MLGIMMEDp+NFLpx3WUTcjIz1zRUnA9x95t+zvv27ePvdOtcPc6nHpsl5LJaM3nSSbIY0Msjqq/fI7ZxwOO3euy1e2iu9PkinhEyFlbYfVWDA/gQD+FcxMQkMqvEqSvNu3DAO0HsfYcU0a0o3L1jcs4NwsZHmqAqOuCBjPIpsdlHcOlzPsSLByy/Lz2/CotJtpEiQX021tu4FfkJz16fhUV1NttHs1YtHJuULyWfnoufbmn6GnX3SJ5YFuZxISkEYJ81sYA5GSfz/zir1x9kmtozZSAuMZELZ6ZyD7e1ZsUFyfIHm7rXyikkUqZ3Hocn/61SSxpoJtRDawxwqDjyEAVR1II4wD/Oi3Y0lG7VncrWnhGy1C+ur25uL0TSFVeNZCqgqQVYDqCMY445Oc1F4mXUra0FpZD7QquNzyHAhXB+dsY3AcZUYJ6Ut54luppba407Sbq7iuOC8LbQqZ5LE455OB/wDrq/oupWNhEyM87LJKFVnVpWOeBnqcZB5PFFmK9SN5NX8jlks7yCebUNLs7a301oljmC3BjK7Ru3qoBUHJPpxyc8Y0fCPiC21SOdLlZI5o41c+awYkY+8Dkg/UZHI9cDQ1SzglurrM8mnpdqqvLbna4UHADZHB5xn0JHpXNX3hL7BbXa6GZXMkhZN5EWeQxXcAMrkkkHrk9Ka1OiEoVVaej6HYWmopNia3aRkU7Au3JIPTH6dKs+EL1dQ0jznjCzykySLxwWPA/LFcR4PSbTRqOmSzXEKwLF88bF/ILICwycnbkdeQOmRg12thcxRWglsHjuEkfC4/i99w465pPQ58RGN2ofIpazquoWdhIt3HDCzZReGkBB6ZK89M+9PjuMwP9s8yYYRXUrhRkYIQnqM1U1Lfqi293dQPbXcMjrCrTFQQRgZAPzA+h9ARVqzdLPSrRtZ2/aJI90hRGaNDjJPPQcdT6+9D0QRjGMU7al2yjtItPV7VxEyfcQcAegx/nrT4oLBo2nlhhF9IhDS7AHbB6Z64yOlY2kXlzNeXQayMMKHME2VZZlPp6Y9D+dVp/Etj/aM9sjRO0MAlEikvuPmOjDCgkYKYz9R2NLlYOldmzdK9xaRyBmIVM4LYOSCDg9utY1nc2VnFbQRSTH7CNjeY5mYfw5Zs5bqc5+pxii88RW2mBbUqt3KQ2VtypKHrgpkuc5zwD0OaxfEMialc6QNGgiM96PMe6t9jlI9uVaQgcgsMgbuSnBxnAo6lRhZ8rO2gunKmMKhgLEZjPf0IP17Vl3msLZvNHC0TX5VvJhmkEYmfaWCdMdBztyQOTXI2mpyaPJa2UN0HeKQD7IBslkjkfCAKVGCu18KDnYnTni40F8dX1C51CIJZW05lhMkm5l/dENMmWOFIwCpAA+Y8k0OHcTppM273VzqmmgMl1A9x/owkiG1o3PBZMjJwc4YjBHPSoIr6EmJry6YRTSx21tCynzFlC5IkKkgE9ewx1zUttqcMit9n2yxqi5uGAwsjAEAp1B2kEjjHHrmodGcQapJp1ndhprUedfxvE5855BlGV2PAHpluABxipa0D4djShsLeFCke+KHczlEc43MSTnn1J4p0NoN2IA5JYk/N2J4x7cdO1V9YtLq7vdOaGQJawP5soSVldsA4GACGUnAINaF3a+dApxLIS2GAyP5cg1ky726iiFkGxtyx5CYwM7s+o7VFen7Z4LkFzEQJJF+TaVPLDGQeRVi3tLtSy4CMRhctkZ7f0rI+KtnqMnwt1SHT5ZxqQhVgbXKs7gglVwc88j6GiD1MpO04q/Uw4/KgsrSeGLzG2MYkf5gMHP15x1qt4b1nWD5TavpbWmlSkwgSz+cdxyd7YPTkjH0rznw9da9o2gRW00NxBID5bTurO5OR0Pc47Cuj8EeIWtIdUtNWkhSwkjFwJGdREsoYA4bjlhz6561cJa2O7GYZulKSZs6vYSaXqdzc22mq8ksSxtdxRE5A+6rL93HP69aj8Nad4lg02FLG7tbZIA8pt7eExNLjmNAANoXd1xz2q34o0HU9YsdOudM1G9sGtOTJC7qWjOCDtBAPGOf6Vy2pP4l8O3UeuDVJNW0+4tRa3MEiBQH6lwF45x9etdM7ct7Hz2Gly1Y0o1LuXRncXeh+Ibw6S2tCLUFLl5YJQB5GRkMGHO4cjjrxxXYT3ENuY5o4YQ8qqJXQgEqOCTnqBk15b4B8anytO0meC/RHMgjnkdpxGwJOCx5C4Ixk9OKr6he+Jb2Sa40C/wBD1LVInHmR2rExmNgSWZHwOflHHr1rLzPSUZNuM9LHReI/CNj4d0LUp5PFF7ZWl7cK6uVLqr5JwQoyQckE8dBWH4tuZb1rWx0vW4P9Mjhb5WcM3y9SMZXI6V1ekDxLItnba1/Y17p8sA+3lSY2ic8kKOVIHTse+aT4hY0aO1vLTR/ttwCqK6RKZXAGAA3UdeCPU0WbNKNWUJW3MCaxvnsLW01SBtQvbN9paMeaUccB8j7rYJ689+tbkei6VOY721h8u6AC4D4wAMdDj1xWd4k8KWZA1o6jqGh3F40dxNALlVVZQOC2Tlx2wCOD05q5FJd6Hf2H9uPbym4uXWWeJBGjg/cBUcEn3579qVjoWJ5tYuzL2peFbTXdNvdO1SNYLGVFJmU/Or5+baWz2A/M1Yg07TZPEU2s6Xdl5pohCYmPyfJjn1zxiotPvJLeeeK7EksDS4kgZS4QH7p6dOn1zU3iVr+w1HS10DSoZbe8b97LtPByDg8cAjJ9zxVI5q0ZxlZvf+rGN8RNWjtJbSSTSVklVwys652njkHB+vHpW5Bez3XhEXMkP2e9dR5TOCep4z6Z5rW1SQWr+QksA2MrOJk8wqhxwB179a2JlE1qF8kSKcNjoMfSixMsTHlgmtjkfBWn38FtKdUvFmm81ni+TGUI6f59Kn1TSHutPuo5mEtjJbuHtnJy7dVx6dqfNCLW4urPR/JmucCQm7dsRj2wOR3wDWoFdrXfcXEa4CsxI2jcODj2NFjOeIi53R514R1rULzVbeG9gaMWr4COMnGOpPUnmuU/aV+Iup6FFoOjeHppLfVZ5Bcv5XzExj5VQr3DMWBHfbXpVprY+3yW+uaa+lNHdiGOeSRCkpPKsCMfKf8AH0q2/g7Rodfv/Eslqt/rsgURG4AZrdFACpEDwvc565J5pWLxFRVZJxVjnvhjNrreFRqvirRFt9RmUj7MjZ3Lxg7T/qye65/wHW2uuSTRPBdRGKRA26KPHboo9OKgj8SoWEZRi33QuPmzzwBWPo2tWOs6lLMhdPIJTk8H1Hu1Hkbqk2nKor26la/0y611pDDa3MMTMX2OfkPrz2/CtLw5ptpoML7S3nuNoeTGO2AP610dvHeSpujGY84O8kDHsOxrNv8ATEmuROb7Zg4C4wOO3545osU6/N7jdkUrnTb64uDHDdTrOBuSRfuHJ5B4/L1rSuby9tdKMRhl86NgN4UHcM8mpbecOirb3EBQngByc9jj1q/BayJG0l3Mrea5LIeQF9OelMxnU77Gj4clmn0S0kuQyzMmXDDBBz3oqzpqxrYwiF2eML8rMckiipOKTux94wW2kZhkAdK4nXBNPPEsUBdBKhcLJ5ZjUHJbp83IA2jrXY6qxSwlZRkjBx+IrmZZbZIWZJVUBcy5Bxt69COuM013NqNlqR6hNeapp32ezMHmspUu24DawPII5zwOlUbDT3tYoEuoibqzkysiSlwM+ucZB64+nXApRqsbzyw6FGNQuYJljmt1mETQDqWbI7DBx3zxVr7W8dy9w1pM8T4HOMHtkevb9Pem9DdOycVsbMYiW4idg5QrlyRwCR1qhr39nrcQyzFssQsZXJUuTjkenbPQZp1x5v2SBrOJ5GlIL/MV2qe+Mc4HapLZdrt56gZ3bW2D5CeOPypWMUutxItQsrqeSO0kRnhAhKAYIJwcdOOCvtWZqkVhYS3GqLJbCWM7bnzJCsajjJPuMd63La3ZyJTujLHOMfzrIvNQtbfVJbWaRfMA86RI1LMw6Zxj1FMuC19wqavphOlRXMt/NAVcSloGJMhOcAjByvtjtxT7TU7OPTIptTEsQlk8hQwznH3T8pIwQM59/wAK1JfMhngi2tJbzAtISBlPqPTP+etRahpC31zb3EDyv5Ll1wRtyVx07jHb2obWzGp3smx2p28MkDWzkyxSoV8pyRkemff1rhtRi13Q1ik05IrhJCWRHzujYc+W7jgjGcMeRgDnPHUeIFe4s0S4hNwglUyhnMeApznjGR3I59Oax/FWoPpFpdajchJ7Szj89oY43yGDcEYJA7HkHk5yAKpG1KVmluYt9qT6tqzaZqq20OqLbpdrEdyIZFOEJcHIAbPRfzqBNfufuCG5vHMiWk8MUpZJeCG8o8MDkj5nwOO3Ws+eJ7PT9Q8QypfOIoiV+2sNzKQC21QACqg4AJGShBBzk09I+za3bXDSzi1gK4082lyyG6kZXGyRVO4uwjU/QcEE1d10Ox8kVe1kdDrmvXdrpMs66ddS2lo5mhCSBTFtVRtJRm3H5m4PUg/WuTs9Su4L03DlL62srf7VOxkeIOCBslA2BS2zy12ggDnjq1dNqSzaXe2qXl5PPKHihneKIosEG5lBBJYMXYIMEEtjnAPFRdJs1vQi6hcva3V7LmSJkMU1ugIlDqQASoi2kAEAPkcscCOdV4wVorUZ4b1VJZJ572ze0RZQbpVhSWRJFJ3RFsnCsBkN1ODkjiqiasuqanLbabq0Ttq0gkgtLhZVeFFO8MoKjngEoeCe/Wuj8mW4srOaGWa8gk3wwxCOMJ9mIJBTgLu2DncSvIynQCLSrTTI1vm0qwljRt9nG8s3mI6OV2hAudqhQcptBGeoyxqWT7d3ZiaDZ3TNPFb3i3khlEou7l8pE8RzyCDtZyxTg4AUkZwQd5Z3Buba4iNrcWjFoXvbk+S4kycbwcgcNgENhQOc5AjsreHwpY2Gmy3B1VpYYre82/KnlMdob5gxYKTt2lvuk8E11KwtNpNq1rLDPAbdrcRLACrk42kLkAKB/CeCOMipuEpyfvk2nQ6VHa3lnbzJLNB81xHE4ZlZ8uWIySCck1f0XU01rTor+2SWCKZSdskRR+DjlT05/TvWNo9mnhbTdQvLydfscS+YFhUlYYUQAKo5PQE455P41u2F9bXdvDcpcL5NzEskSsNrMCAc4PI4I69Mis5JPYxb0u9yGOG5toMyPn/So0E2xppJY2YAoQqjZgtjIyAoBPeugtY0F1KM7nVQShbJXPTvx3qi4vY4bQaW8KQhwZRKCWMfOQvPDdOuRTDasmqG48mNbiQAPKMBiF+6Ce+Mn6ZrNq5ik5Nq5ti33TeZvbA4ABB/CqniVhFol3IDtEcZct6YGcj3p8V80TGN4twUAlww988e2B9c1Q8cX89l4aubuzt0unjCuYW/jXIJA98ZwKIxSM4p86R5ibm1utMbWIMpZBsXls4VhjGN2M/KenIxWDqVx4dvtY0q61G+lWxtUM0OnCH9wzYwGbjnA7fjT7mTSrC3a4sr22j0q/k27J02lM8kHGDkc/y4qs/hC58TWC3UFotolrOYz5N1vWaIAEOvpkEA9OQetaQstz0sVCElF8zS12Ot8e38kr6Olpez2MLTK1veWzb4ZCAD5ciD7ysD68Vcewg0jSjply8j6XKjOs2GwUY5644IyODXI+AfEt/bXsGleIfDsVpZrIbWKZELGBwpUeZzyCM4YY/Wut8Nfa/DUptri6uJFEsiRwXM6yJJEZCVcPtBBwc4NbU5PVI8TG0aMHH2r5bbPuZ0OnWsFtFN4O8RNZs+A7GNJoZnUdHPVcjAyOO9aEsml2Hhq61DUbKHQ9ZlUJNcWaLIUYkYJI++m7BPrWtqrWmvajJpcTxxXQG+NduA69zkdxXn+u2mt+GdV+138MTaPEpLpJGCyj09GQ4x+PNXGnFrszCeMxCqttXj37r9S7onhXxLpltqF9f6/pU6pbFra4YlEAfaS7YxwADgc81rav4qN18PRf6fqN4J0uEiivba2ysrZAJC/wBzqM47VU8N+J7jUlhj8T6alnpiWpuYb2KfNrGA2BG4wP7w+taGmtputanqWkXutO0D2QDx2CmK3RDg5EmAu7B6Z6GseW2h68a3tUqj9UW9TmWOw8ODUbWXW76RTHFq1pbK4ibIwTg/Lk+npWtKlrpWkafpur3qpfzMZdzRcSOSSc8Hb1rMM48HJqN9caih0KJIo9OsbaLIiU4APHUknqD3zVW6vte13TLc3ei20d1c3X+izBjIsSBch5hnIBwRxjGaZCTvfodppsRMZaURSOcjenAcduRxms6bxRYaZqv9lapOlrcSkNAHG3OTgDJ4P1qbQk1MW1mZL3TY4o4/LntbSHdFv5zscnj6EVQ8Xo8sYEvh9NZtFId2yuV9Qo9f50rEKcZuzNm1fQbnUJ5kuIZbpjhvnzjp/gKl1HVLSG7bTXuDFfyW73I2ruKIP4j79cfSl0rT9Ps1V7S0iiYqpCbeV+vFFxJFHBeaxa2Ul5erCYtqKFklVGPyqDx1J+tFjOVnIyNGng1TQra40mY3cLg+Zcv8nT+Fh3PsKy/E2vQTWtrpQvzHqJlTb9mIVsd+H4bg9M10OlTDV9As5Y0uNMAkWR7dHVGj2tkxtjjHHIHY1hyaBpkmuw6oLrT4reVZFa2ULIbhjwCr5yMY6DvRdmsZQu1NM6NY0vLKYTra3RibEe6MFVK9M579T6VmaDJe6lczG/ktJFXEcRtzkn+8zc4Aznjn61X1HwiLgH/ib6xBFISJFW5yAvp0Ix+tS+Hr3TNE1SLQdKtbu6n2s1xMfuwgDPzMcZJOBgetSm77aFNw5Hyu8vTYxfiKr6D4YvJI7orcORFF5I5Xcc5P681c8MWaeG/BkM8ssdwyjzZXKYyTyeh6896rrplxD4sv9U1KS3utNuAoZiokdnyQkSLn5VTuTySTWnLeWs+s/wBjxho7koJSrrtDKR/McflTOmNRzjyvXqybw94ghvbNxZJCioShjBI55zxUFxaee6tdNceaH3ZLYAA54yO2elaItbbSYArRRxZbIWPjJPU+5J/nUI1CwTJkRyo5+9uKkHk5z7UxLRt01ozYsbO2lsVlWTejJjzV+U49iOhrjtWsr+216KS3ZV0uKMRxpuJwpHOffv71013qHlaOlxaQSGP5W8sj+HJzn/CmpeRXDIbd0UFPmAHU/T8aDOnzRfOzoNFXZpdsv+z/AFop+mLssIV2heM4BziipOSW7JLtd1uw7nGD+Nc7fvZ2yMt/PFEGkCBmYDezHAHPXJ4x3PFbmriVtNnWCRI5iuEd13KG7ZGRkZ9xXFRaHa63Ok3iKZ5btFUGKGeSONSrhwdobG7cB83XgdKaRpTvv0NJlggciC6l2sAzAbQBj+HI5zVPUPEMFlM1rPa3zlsbPLheQEY5IK54HGfqKn0+6sXtUm0zE8Z8wC4HPm7SQfmPU5B/KsOUyRi0v7WdLbTppHlvYbvc/lpjO5CMhOVzz8pz2NUvM2i1uyxZ32oTQ3N1p9xD5F2gFkGjJMchX/lqnUEHGR+eKvaYuoW8Rk1G5hn3sPmSIpnhQwOTjlg2OmAcY4zTb2RGEf8AY01mt26748plJlODuIHJ49ParqzrBcoZI9yMcYPUOfXP1NLyRV762MK91qea5Npo09ut+kgWS1kmKMsXG51RhzyRj+HnqelJqF+NItZ5pVmna2AdzbwCaVstztCjp37966DSiNSWSWSWJ2CvGssSj16jr0wPxrMFjLpunpDaoNTu1dIpLm6cRyMoyS27GCRnH+PShMFNR0sM0TXr3VUuZpNJuLcwNtjFwQGlUkYYY7EZODjGK1fDviCC508t9nu4xHI8X76IxkspwcA9j2PQ5Fc5qF3Ho2rWdvJq0gF/cGOESIreaQMlAQBgAA8n9a3tHuotT+2W9xb3KzW05jzOnl78AHcnPzL82Af60NDqxhbbRmH4gv49V0/Uor+G6g08TbZyjlX2hgCMqedw/hzk+nak1Pw1qt3f/wBp6dqbSxLEStoWKR3KtkgMCSBwx5xzgZ6VU8Z3F+bloLHYtmflJi3NOZSW2tgfKEAHOc5/Ct+28RQ2egOby3nt3ghMayzqsXmY3DC5PX5cgcZyCOvDKm3BKUep5y2qJfQbtQt5BqNjLJFcoJysahAAVAOA0ZyT2wVzg4rV1M6f/adppdpNdSSzsjwtC6pHcI6yhnOQc7E53AZyEGcGudjt4bi6W4jScbxFd3SXU6sssSxlhKCfvEfuyWAOW+QnHI1Lby7WxlkgvRp95LbYaKfbAyniGJmeMMqfdZcDpuzyV4tKxVZ66f8AALmo6yVj0+3VrpbWR/skP7keRIhG5HWQ7lL7lVFbuWPHIIz9QWC50WzMT2RW5ERsYUswD5pwSoDrlCqIMZblpCCQCore1TUYtEm3axdI1lbxeV5cx8zy2JxA7EsQGJR8uwAOV6HNZFjp6adHNeX+owWO2CN7YSNCWQhFjEpi24jYMq4UEgEkc0GSt00NSO1u7DUrqwVIv7Me9iNw+2VXZiu5Yh/DtCrECwb5jkMOaz9Ou/7Ns30xraztjDK6tdSo8S+ccytgMTvwo4Yltx3gkAEHnvidN4x1XVvCyeHXum3PZ3Um9o2hWXLhWG1X2kZIdmOw/LwQK6+wtf7IW2kuLy+uL/UbWNJra8vlV1dVkdSXjBDytgKdvVVJAIGKhN3MVK7s0UfE62EmkWd/Ey2cWlS/ZJreCFFVWSNZURB0wGGMY+bPbiptDsryHXYImu0eCO2EkiRO6ogG5VhUZKtt3NknBICE1NPfS67p0b6vYzXtrI6xTWyqirE0i53OpyyFFAAyQSXIIAwaboctsby6vLpIAssQt9PuSBFFLEQCscYPKthMMo67FPHODobwk2rPoagvrg2tvZaFLLey3BDnUZ4t6RxFuN3TcdpwBjnHJGDWxd6LbXulPpuqM+oRSkqTLhWYF9wGVAwBgYx2UZzzXP2qXOmwvdpBcNeMC7mRo3jR34VGYEEJHsBOFHHPJzWpomr3N6Yo5bLymZFfewKkKV7ofmVi2SF5G0A5zxUvyB2W5r3UuoS3Nkumzwrb2zFLyJoyxlXZwqnPByQc+lQg3lnpcCQW6SXWFULczM21c4JL4OSBz9afYiVbieQm8xM25Ypto8ocDC57HGcHPWoZbprKSztNRmlnuribyo3WIjkKW5wMDgdfeoaRKjZlpr62kneC2uiJrdlkmijYb0GcgMOwNL43ifVPB9wtqzJJIEKMAdyMGB4xznirOl6bBbajf3rmR2ukjjk3kFVCg4A9B82epp/ieG5bw6yaXOlvNuRg8nKgbhkflSS1MnJKSceh4n4y0K3+22EtxchH1qSOG5EQjMgkXH7xVIJPGQSOeRnpmtjwZ4Wawm1WDwxqMD2yR/Z1eUBikobLoccN9R9DWhrXhm31K5szf20lrqFofNtbqFuVkJ5Iyfm6D5TVTwt4W1jTNTcX17C+lfZi0dxaOyXC3LkhmUd8nLfNnBp2u7nVKr7KnydHe/mA1PWdN8LXM+pR21zMlzsjaLGI0LEfPj3xx1A+lUdK1S/8RyefdNYx6arMky9J4JchQo7nk9MV2GpJqWm6PplroqWl7C9wqXrXoxI6NgGTAGC2c5z1rjtLtpU8YXdprcPlQ3M24eSApjm3Bg2V6E4J561spOLvE4qmHpYilJVFp+nkVrrUzJ4pv9L26jaaxaKwtrnATzYGABKeuDkjv19MV12m3lrNp1ho+t3r3N/GHiEk53iQMuSJVOcrjAya6vV9MkvbUGzmWOYEMsrJvG3OWHPqM1galYtFDct4aii/tJ4Cs2ogo5t+DxtJz1H+NVKalHXc4sPh5Rq+78Fvx7mF8TbHWtLsYLjQY5rbTFRY5ItOQeZG3A3YIKtDjqAMjisfw3pU+qeSdf1WO90+2lD24SRY42yg3KyhdrKcD6HdzXc+C7y8vdMl0HxNDvuokZJpoz8kysCNyYA28GuV1XRtA8N6xpGkR6Zqj20FwNQilspVb5yNu11Y524UHA4ojK+jN506lJ/uXZ9ezM+60UXl5Fo0GpfZbe1jee7soG4ij4ZfLfsUJDdT1/Cu68P3TvFBZXK3cqfZjvuZgFY87VBTvkd62zo9hO63SbI5wvLBBvZSehrNgimt9UuL2W/u47ORdix3EirAhGOQQM9u570OPVELGcyUakdfUw5tSk0nxSlhbXmmQ6Tl5p7dl2OrbQEUHhQScEsT7elaOmnULnUtMuLzV103VPIdZ9K8wSRzoN22RF656fMM9DWrNpNjrNxDPeW9vcjkuwjDYbAwQcc/j61T1vRvD+tpPaPEP7Qs7YwxzW6eXPAmOAnt6fjUu+xvCpF6qNvPcS08PyC8HiCR77+00i8uWGOfMT4xkqG4AbHPP9a0tP8AElu8EUF1us7+WTyxA7ebtPYFkyACB3rFDaje6BF/Zl+ZIioQNfEgSnO07yACD2x3rY8I281pp8sGq2FjprxsQpgl3q4wPmGeRznrRaxk5QqR5r7fIrXay6WbTTtN0Rri11K4b7UYH2rFuPzyOffJ9M4/Co7W0u4pZrPTNG0KwFtFItmZGyQ+Rt+UL909Tg5FJe3Nxodvd6nevdXEMXK28GGLc437ew6dPU9a574cWsT63d3CJqbxThntWuISFtg/LqGycZIzxxxUN9DojStBzvorG3Z+Hr6/t5X1ye6hmkQxTWy3PmRlcdVYYIGT3wcip/Csy6PbXNpfa/Bf7XMUHmSqZQqAZDEclgeuc9q53UZ73RZpNM0m61QXds0V1Pc3cqyQrE33iWbBYAZznua0jYeDTb2OrWs0Ko975qvASRJPIMEEDJAPHBx0p31NJJuPvPR9jd0a80ttbvdPtp7Tz1IuJLNQMxtxl+OuePzFb9/AABdxRPJOgwFGPm9q8/a8ttBvf7Vt4devre4KW6xIqukJY8fu+JF27cenPfrWppPjJJ5ZhIps0MuyI3jgGZycEKATgZ4p2uYyTUnJbGzr0FvqeiE3ipZSgZBkI+Uj39KxtItLS2u47eSeKRZ42kUI2SUHVs+gyPzpPHcFzcW8Mdvp13PFcsqTfZ3G5fmAKn29fxrDtfDFx4Q+w22iafJqF1LcFmkFyESBccknGQuMcYOSKnY6qU/3dkzoL3xFomnWUawX0YNw5jhBz1DYY49Ae/vVnTrW9ljE1yERWOSy8rtP933NM8TT6fb2tvDf2d0BIxMT2dq8jQPxlsopAwTnmrWhaRqEWjSWl7q090kkjPHdKoSXyz0Vj3PXJwKLmKrKMLLe51WnqyWcSuQWA5IGB1opNOgW1sooELFYxtBdixP1J60UjBlbxDcpaaW8srRqnmRKTJIEA3SKucnjv07njvWJZ2On2U1zcRWyxm4fzJSo5lfAXJ98AD8BXTXyK9rIrruXHI/GuMlj1mK6kDrataecGQAksYjySVI+8D6Eg57Uzan2LV3o9teWF1H80dswKFY5CjKGAyVK4weTV6SIWNmltFEghA2Ls9Pcd6wNQvoprm50+2ufMvo40mkt42KsoZjg5A5BwSPXFOlvhotjDJquoqYHYRLPcuFJlYnA6Yx27UzRLrc6A3EENxAIowzbT90cjGKx/HDSaho0lok0+mCb5PtcbbJIj2IJBA+px9RUkFtqkErXVzfNcK7blRYVGxe6jHJ+pOeKS5T7QCmoS2jWbMRJFcrmNocHOMnGc+vGO1JbiiuV8yM2z8LrPYvG1zJH5kfljym8pihHJIHRsljkY5PStBpLu20cw2bRS3UMYjX7WSBkcZYjkjjPvSmFtR0wR6bcl7YkNFPBLg7c5ABB5Xt1HFZuq3M8OnvHcSSWrEJGtxIgmKsDjcy/dP1J4pvU1TlN66giQ34EAu4ZJhI8R8uYLJuXlioxyRgA49TT4Y30WzvXubi3is2wLUhNpiDDHzM2c/N7Cq/9o6ZFNb3kVtBPGo3x3agEbm4LhgO+Tn061Vu7oWdjc25ZbqFF/eL5fmkiR2CrtHKqG657DOaGW+Z6S2Oa1R3tYdSkjml3bX3yXDBzhYxztQ5CbsLlRk7jxwDV/wAmcW1uWhlklMxWcTWbTBZCqugRmkyihxnPC9funBCG3gFzcut5balBbq0aRRRAPApVVMayZyWJA47bxntmOLTwRHDBdWKx+apKzWqPO8wjKCZlBH3QOwBABq0tDSp7+i2RDLDO2upqU1uLctGHkErFVCBPmKsp4IIBZXLYXBA65TQbqx1uV7aJktVmZXO26Wa2M0b7XVE4KHDhtw2kllOCcikudNn0hkLwQyNIk3lQSmPak2CI2CgKSWQKpCn+7nJy1RNea1JciFbV7iznnS6klncRxwZLSFS2MjOBjnKYRTnJJoye12T6hYHW9VsIhBEjPhGWa3KiQxOSziNhvjH7v5PmKtnoDzWx4LhsLy9t7+7aG31GVpzdwCJFjWXcgYDr/wAtPm3bidzEZ7DKgBfRnTStXDSRz5gW2JaSQOCAdyMzOpPzksCdoYkA5xoRadY3VxJbWyXFzdiEqNQ8kSMXSRZJEVpF8sFmwQATg7vu7amRi9tTH1rT9U0q8W4iW4uHRkt4Vt3EMc8juGXEYYgRooLHOPmLY+XgWtSv7vWbq1cwzaXcQ27veFY1BJQ8EgKz5XDFfl2HdwTnFXz4XkbUZZVv7SymW3kW3hRAYzGcCN54+AzRLhN2Tx1POKh1TTY7IakbhXlgikEsaxxQ5vpSgdvlVSzSAq7H5cHceNoOFdD5rJEJtVLXVlrF7/xML4SOYdvyTfMAGDEc4BRE39CGPzAVVstN/tOe3jM8s8axotwZB5ggJTzAWZmKGTe8f3AAcegxVmW4m8uCK3LzG7228CzW7sY497sScyKrjaq4252gZ6EVqvc2okgjvLmeaayJG5yyo527mdiQFIAYnrjgY5FJs0hfUkFrqFx4iZXu7Q6dA6zNHtJkZmU5Ein5eMZVvXOffr/DKR2kYs3eWSaNRmaUHMmck8/XsOmRWE1i8xiurG+S3yBKVWMOsuSDuJyNw25Hbrn0q6kwkuZ18uSNkfCs44kyM5Qg8jnHrkVlJvoKS59DV8Tw2ktq8N0cLOhiZVYhmB44xzmqsM0SQoYHSZWYKGDZLHpyRTfIS52vc2sc7wnzI3ePcytt7ZHBx3q1oenW0EZK20cKbiVjRQqknrxUX0M/giVrqG4u92nzQzrDdFjNcQOFEOAMDdkNk8AYB71ra21vDpjm6kCRoVwT0JzwPzxUk17bWxaOVkVsMyoOXcDGdqjk9ara7cn+xLie3AlKrkKRkE+hxTizFNzkjgtZS7nmgBuI/wCzHICkEjkc7sc8AjOKkXV7yecxz6a6MJGjQsRmUAZDr6KeeTg8VK6WL6DeaxLBIUghaaS3cqwwoJwOxHXH1Nc94Y1fT7+0bWbu5IW+VSYp35jXnjA4GPWtE1fc7amsfhbsdgtxDpujQXJ2vFPcrC29gQSzcgHvyf0q01hZ3Fy15IA7xZVH25OP4T7jk1k+GtLntNJu7bUUgl0+2unntGlUMwHXdz0wScEVVj1ZtZbVNKhSeFYEW2jubV+SHGdwHYDPH/1qs853nO5taI88FhdjU9Qhuo5TsAhXbhs4wO/THHsajvvD2n3ejTafYy3FvHOHV2tgN77gRzx0wT1rM1fwo32awS0uL2S8idJ2fzMMzAFSxPQZB/SrgsDZx/ZrLVJ0lVyZJgxGGznYFPbsAc0ram8WujJ/CrrbWw0+O3WGGyijhhBkDOVAx8wxwf0rR1Tw3BrF4005aMwFWtZY+ChAIIJ7g56Vyvh+ygsb7UtVuNFttNv5DIJZ1laUOg+YNuPQZXkAVt+Dry91nw9Dcz30IhDlhPA3yzLjkkkDaAc8deKexlOHK5Tjt+Jfj0aazSW6F5d3roSVt49qqeOgz7+prkodE0jStGubHxVGtr/bEpkkE16ZNpyMDc5wGGeg9DXbXXijR7LSJ7mG5F3Hbxls2w8zeR/CGHGcjpmuJ8PxnxbqUt/rd5b6jpt9EPK0a5hGbdc53FTnnjhu4NTd3CnTSi3JWRpeKIPD15pSRXCXUlramG4RbSRo/NJ4QhlwG+lP0uW3/wCE0ZbbR9USa5hWee6Y5ghYjIQE9z3xXL+L4PE8XiB7XwxfWhtYYFWPTLKREuEReAWDdBgjGDW+tzfX8enWs1rqWkuAGuIY1LByT867hjnJ+8OeTii92bxo8kE4217f5G/4nsdI13TZ9O1JnNuJArqjFSTnjJAzjNJdr/ZnhoS2un3F6baPYkKvh2A46t1PH41RsfB8elRtJa65rKI5J23FyZ9pIIzhs5xkdeKvaZa6zp4t7afVbfV4DlriW4jCSKgAxgKMHv19aLsxlThZJO6Mw6oyNC0ljNAwgErvckAQqRlgSBjjp9elZtr4n3h7XXprOz+dTC1nMzecoBc7R94HCn61t6Prthr1kYNItxc2Udwbe4R02BUOeQD1A7j0z3q3Pp9vHqVoY9Nh2q5xKkYDRgDg7uvOTTTG4QS5bWKWj6q3irSZ2n0KSGGZHiQ3DDEyY4z0O1v51jeGPDUBt7yewlubBbm4V57Q8C28sYZU+p59/pXQ3Wo2aas9nZzFtQiAaa3RsOFPQ7e+fWrl5d3VtMLtExYJETL5hVNvOd2T2AyCM8U9OhiqtVOzVk/xHabeQa1YxXOn3AktzI0W5htY7Tg8/hVfWPslqpeOKCW4gkCIAoLIxGR9DWBayvquq6dJZqmmxWMzM9tLCQkwcffQrgZH9TXQ6xpEE8tvLBP5CR3IuJY4cZnl9Ce+R19hRexpyxjJX0/rr3Et9WkUqspKSDAnZh8g46j3qJNcklS6jaP7PcF2EOSD5kQ4DjHY9avpYJGshmuCwlbjfwF+vNUNatWWyxoMsEl5GwIErB/kPb6GkzWnKle4aB4hubq/Fnd+WW2k7whXp2x+FaGu+IrfS7W4kRZLySBkWWGDDOhf7u4dh71wuuXep217cwXOlvpli9uA2sJICiSEdl69eK7bw8LPTPDsNzNcwvG8YeS6kIUSDoMk9uwzSTHiIwT5o/gb2jjGmW/3+Vz85y3PPNFSafLBPZxS2jo8DjKMhyCPUUUjnHXYBt3zwOM/nWPcI/2G4ZWcSPGVimYA7CRgHGex5rR1h3jsHMcZkZnRMBguAzgFsn0BJ98VTnjbbFGznYO+MZ4PWguOxzdnLdWX2CKdftN6IQJZokCB8YySOwyeBnjd3AJqxqN7ZfZbr7XbhoUXzmj8sOd47qOhPH1zWlbRPBClu0jTPEmC8mCW4PJ//VVbUHeRVjgt45HPALjjrjGRzTubq0t0MtNWYmVWt3W1WFZI5QQXdu67eoI45JqC026nYMJbS4jNwu5lkAjeJSOEOOjc9Bn3qRdLWKRVaYwRMpcqj4A9foP8KzdXvZ9Hlt9gR9MUkGGFTJM7HowxwMck5podo/YJri1vNH01Y9IsrfyItsYhMhjG32IGM+3GfWsyS/ctBZanAbK6lhZ5FjIZEGCPv9wDjt3rTu75ddsrUStNa28r4VdxiZiP4SMZHP0+tNj0m2s4itsf3IXayMg3BT97DHnPf60XNoTS+LcxI9Qj0yzsDYu2prPhYnGAsuedxZQVHGewBNE8q2tytvLeLLe6gDMkMa+UfKVgcjPy5Vcg5PIA44rTKaPay2GnXS+XNcLLHaRpCSgVPvEkLgZGDg4oe/S106KK8jVTI/ko79XZhnHHTPTHf8aCpT5/h+Zz8AtriO4muLa4E9gWjYhjIxjRBndGgwzNnO1Qc4HPAquHsRqSR6tNbvHLaiWW+ki8kzGNcfvGBB3YO7aAPlJzW1p5aBZjLdpBY4DPKXHmhicZ6cDI+9U129wdKtWkvzMIljKXnlJ5sqlwWXJGPmUYJU8jPthc1tBVE+a0Tjk+138V3LKsUd46LawwzrtFu5CvKdpbnAZ3Ukg9skYree7MkVy2m2O955GhuVyjxk5MUsqhcg87Sd5BYAnGQRVKaGw1OCVpYkttP2pCTOY2iJQnfIODhvlQAuSDt+7xitKxtrbRbl7w3AtIH8m2tZFMfmTgYYpjaFG4lsqF3feIPIAu6Inbc5nUt9p4kGkT6gYZboLI/wBhZpWVmYBUQlRsURxsG24Y5yAMZrbsGl1m/ImtI4rfTZJxFdWsjQMAfMRwqKGy+VQnkHD546Vr3NnDa/aRp6WkQWJXO4ERxxqz7H2EnJByCRjOc8dqvhMppt+tjdQy3duzGXeFYtFvdsO7Enfk53HOQeSMHg5tBN8y5mZWmXfk6fZSvo0mo32hBW8sSqZwjKCHRgqkngjYQAwGTzgVFqtzdW2m30gtLbT57i5eNZLSJ5Lhwylk8pegkG9854IyTgZFela6lrdWaQw2tvIqsMl4zhR/sY6Hpz0HvXHT6Vf3+mmMQtaC0k2RLcFkjmwykSMFOdvBKjPPU45qbomHLLVoq6RAstvZrZx2qaasRSWUZjkJJDER7SQqZwcFuc9MYrf0m1sbK9msLlJRKsUcqo0Z8ra3HlxscjA242joMUltpgi06ZdRmhkhlkUMh+RQOAoHO0dBjAAzyOtWtFtjFCLSRHQWqhF3FnBGAVCsxycA4Pp68VDZpLsRTMdP8+4uJ7q/VpAywRxqxQE4AVFAzjjJPoTWosiFWXzNzMcgM3TP6461FJDIAjpkckcnk+w/z2qnPfzxarbW0VhJOlyG8y6422+OzA8j27VF7g7LRG/a2KfZ4nDOjZSTcjkDK9AcdR7d607hzFb5Xh+AMDueKwI/tKk7GdY1G/BBwTnpWrqMyfYeWwGOAR3/AM81EjlnD3vUztThSRkSMhzGmPXkc549ak1y7c+G3ksoxvYrGqOdmCSB1/Gquq36RWcdxp8MfmBk35YIqqTyx9cDPHfpRb3lrrvhM3NoQ0M/IaJg2efvDBOOMHHUd6uKb1Gvs3OXsI5VT7JNdJGs0jJLaeUJVMRz8pJPA68k+grko9c8O6VeSaPZZt1tDsAZMxBwc8ZGSPfpW2tvB9ssxHHeS3EBLNdxZUblOAjnnjkZrZ1vR4dVtpI7y0s7S8eBo0uk5YSMPvAHnHJIzzwaqKR6M5ezlzdDD8H61q3iTxPd2EtgD4aWDZ5zIQLgnOQD6HmrHg/QtR0DVJvteh2Nshkwk2nzFYFgXJ+cMcl/8aztC8O3/wAOLC6vp9TkvrbT1LuN203DYwEI5xya697rXmE5uLS3liluwsMcq7R5JRtxIBOeijnvmqTfU4aqjz+6lZlFrf8A4SW5s/FHh3V/3NoJYnhkLJDIQ3zE4GTjGPwzTBpt5rHmX2n2sAtJZQ8DfaHVpVJBJKkfKc/T8a27OawttIntNNit0itgtv8AZIvkSNyc8H8+a5K08Qa9aa5YaZM07rMd6lLcPbspYnaZB0OB+HHvVImnreK6HQWMGrPcZtbuG2tUYrKqxLI5PIHJ/pVzUz/wj2kSy3VrdX8DAg2dhAm0hs7iyjA55yc9TU2IrfXI2iuPKe8RiIWxh9uDlRjqBn8+9Wtb1Owt9KvLuRm8uxH73HB6ZGM9c+tNnM5Ofwo53S/COhi2ijgspI7Zo/8ARrKYgJbsynJC9mAZgTz1q94W8NWPhC1msNGtI5MgyFppxvY+pGM7RnGea5OfT9T0HX9Ju9Htpryz1m5El49yXL27PhvvcAIF3YyOPfitE3NrBf6hqA06SHVwv2NZSXPmQjkDceFyec0jpjTcmle7f9bFO20+41C+ksNcsrm2ubqYXMup6XLiI7fuxAnkAY56ZIrotVhuZIIbXRPED28emxIJ4NqyTvyNpJYjgjv3NZUWhJruq2WtaXd3DRvAqSxxsMIyk8Hnjmq9vZXkXjd7jUZ7WW2BKQqTiUAkccDgDHqRkVKOiVJTWktUtUKuo6zo13q2tW9vq11p4ieRbO5mUqSGG7aAPlPJwvtXRpfr/wAI7Bc2BWxvriNVWO4G5oncBtp9fvDiqmuWsH2y7jk1+S1t3g82WJTiVUB+XaxBG3ggjBJyc9q4H4ueIIdB+F1reaxcWkfiGeRZ7NLCdirsOFZc5yAoBPQenamzLng7NqyO7jsNffw/rNhfm2uLydCsEqnyAA3G3co3Bhk/Njiq+ua3Z+CIPCehCVJpLiZLc/vi8iDGN+3qRk8seK4LQPiXq/jgaDpOgQvbGeBfturzAMyOq/vDHCDjg8Bn4z2rtm8MaX4c0vUXtrC51m7vbfM99NIZry5OQAu7qBnHAAUYov2MWpTkk1ozp76WK2msrk2ovLwARF4UUP5Z6nk/dyO3StSWKRka5ttskci7nhLhlPrz0x1rj/Dc2na9JaWbxtb6pYRJMYppAzNGwwQcehBB9DXcQG1tNtuGSKJSI40BCqvQAfXPane4ShySsc74j0Fb/RYW0hYoZbco8Ecm7yY8dsLjPf2rJuvA9jcLLeR3l1Z61K63ZMLF4kuAmNwUjkfWun1/ULiwXFpGHQEbgoJIP0B6cHpWFZwG2S6LmWaORhOyFtzxbjyAP7tCSe4n7Tk5oNadzOt5rvS/DeoR+OL9r6x4ie4iiKlg5KgYHI68ntXRaN4X06wU3FksQM0IheXJwYsfIBg444x7Vq6LZRx6fKvmSvHI7kiRcbQWPy89QM8VXgsrXw9pC2cLzLaQocbsu3rkHrx6Cm9zH2kmtd2VNEtf7J1G5jfUrgWKqqLBdYVQx/uMev096uyyLqep3miarppms9iyrIybonQn7pz/ABA9vSuS8WSaPLf6Hqt3a3Oq2z8WxTdIm/1KDvx1Pp0r0O3DfZgS7gld/wA/BXI6GkU9ky9bqqwosYAQDAA6AUU2zG22jG/fx97Oc0VIDdQx9jkyMjjj8aw41SebyZCfLwQSRkEY+7XQzIHjKt0OO+K5LW7qODVf7MsrhVv5rZpo4JFJXAONze2SAe9FjSD6F+a3tvPhlRmZRz94nnHXH40tzPlNsWxgT8p4yCO/H06Vjavbt/Z9tbfaJLRmkTY1plexwv0HXtyBnPQ6K3OyNI9sbDAyQrMV+vy9fypsu1tWQW98ZHlS9tZI3ZzFsdBtYew54Oc/nmi/mtlSITiKNZJPLhWVRh3PGB29uarOkcWrC6k/1qqYkbaWcgkHnjgA5+lXZ7pjaT+RHHczQgtFG2A24ehPQ+hoKlG2sStBhbKHzGeeaPJcmMAgjPbHXtkfnVwQvOh8zarnBKg9CexP+elQXLiTSEaeHbMQrD5hw/HG4f04rD1UahLZOIrl4RMzMbqBl8xRwVVQVwcjjn86RpCLlsXb7VrixitobWwkuDJdGBiinbEvzZc+g4/MisnxHbR6aq3Fw7NFdFI5uUCwR87mYsPukAA57fSr2jTXM0KRXMUIXyyS6T7zv3fKMFRyV5J4weBnrVTXba5vL+0ktrxYrJSY7i38sHzwfRm6AcjjrnrTvZm0fdfKc7aaQQ8+oWS2t5dSxNKo8xnDl0BEfm5IEfzABeQN3HHIksLh7OxlgtrmS1aOSP7NFKp2pGcII8E5Jyv3u+QfrLclbeC3ljuI4LSOaQi4u5GjLERnDrHgbiMAAHGMEjtUWtgEi4mUWUqzAmWOcQSTuVwSofAK+Xng9CDxkZp+Zad99i7e2QWZI7CylkhEkzTWsdz+7G9QRvjPAzknsASTznmn4huLjTdP0D+yt1hZq0MksOwTKpI4Tg4VcZ+YdwSTW7qBaJhbsk9zDOqRRtAnzqHj++z5+7kLlu2Bx3p914T1OO2mnkvd2C2YEwVdcnBYkZJA28/7Pvik3cmFSEZJz2M/RNTOq6HNd3yz2D2yyiZUAXyWXG4gP8uOS3OQc5qxpVnYtJOliVjsmk3slrI6fNkMy7eMIcBiAMN5hPRuXadJ9m8PWS6vH9nuPsjPcmVuEXaA29hleg9ee3TI0X0+1ubZ4WCm1maP/VkqWCqAGyp/2V6k8ACpuQ7ObcVobKKFduVYsMluofP+fyp0t4ksLQbi75ILjkLxwMj/AD61lpMEt7lr2CRUgUuyxOXaYgAjao5AGCMd8e9O0/yUsFFuixQBVSNAoBReOMdsA4xUsx5W9bFaSHz3mtb61hms32FBId27uSykYGMDGM/hVm/tLqRoVt7kxnIbIQEso+8Bnp9frW/OtrJpj7ERtqnAyByO2e1cnazXUl5o5mf7G0sbPcWjkMxbauAG6ZU9cdc1Opam5a2Ll2HFq8csrK7IclD8yjb95fp7c1S0AQ3fh21iivr+6CjcLuVys5Ktk7iRn2II5FbM1tI8kMkMzbYQ26LgiVTxg8Z4xkEYpttNILdM28YlYhWEbAgdCee/FDFzc0dTQt7T7Qo8yRt6OWBPzYBOc59xn6A1N9igW9muWklbeir5DPmMFcnKr2Jzz64HpVCzubjc8QYLLI2CSOhx/nmnyzFY49mfNjPzjrz0zU2MXCV7FPVrOz1RIl1K2tbqPbxDIgdQNwIBB91B/CpdVvYdH8MT31paIgSXzJIkAUMxcbiT755J/GqN7cXOoWV/FdMbHcTFDcWx3sFOAr4K8HJ6Y49TUniK6GmeC2nZ/OEcsaSFwCW+dQcjpn29auOg+XZeZk6fczXOkTZtBbB5C4W3yqsvHIzg8nPYVQv9Ht7/AFmzu7ief7Zp0haNlxtkLpgBiR1HY/WtXTXLRXMnliGK6UOhlJOD/cxngd+KydLa68NWF/qPiVpdRnur/FnbW6ElI2IWNCPfGckVqhTfvPU1rqS2srO1s7u1F6JpVkKzYIDBshsHksD/AI0XOqyaj4hn00IHsWti7TW0pE6uGAIwOQPf61D4d1q28T6PFd6lpyWt55zoIMgvGN5QN64NVZNJ0fwlPb6jFa7bx43ha6dmLeXu8xo855OVyOM44oTujOafOklrYTWLRdDurq+1O81G70S/O2f7QViSwTbwyjG5j29ayPBVwmjavrmjRzRRLbLmCFYisTYI/eNIx3EnIyWwD26Vr6Nq11rF5NqoeefTbhVgt7JgGVJAxy5OMbcAc+prU8RRQ3kdxDNbkySRqPtKMFZlAPDjqVBJ4pp6DnTcZOEuvU5rSbHV7yafUvCGv/bVknjDpcz+bHEmfnAz347djweK7TV76ysPNiktJrvcfOmMEHmbcdPlAJY5I9TXIeCFg026vbHQ9Rtbr7II4bm1ig2mOZs/vTkYYf4VRn8Z+beS6XaTEpcTvYTXLIY5knIYKVY/KBkY9Rkcd6WiNZxnVnbojS1jxXdanMdLu9F1Cz0i5SVZb1WwYxg4YgDg54+tW4Xnvr0+a95ZaZo9uySpdEpBc7wOSzfe2AHnnrUnhnVtPgu7HwlLp8QujbGS6tx+8SI9vMbGCx4Puc4q9cuPE6axoOpabcJYJGITcxuY0kII4THPGM556c0Dfuu6Vih4KutJ0LxINHgvGlmuojMgHKeWTlSCOPXFYvjbwXqtr4om12yu82THc0ZBY5PUYzj8ayvE/h210ObStU0O4Y/ZJlt/OlkMhZWJwhJ7A5xXr+iatbazp0ILxtI6hiAwIOO4pNO9mb+2lC1aGt9GcRp8UOpWek3XiS805UtEMVxbTAGIsxKocseCwIGD68VyF58HtN8S/EG4k8Xzz3VrHb4tYrWRbaGCNfuxCPlsAHO4Hkkk10vjO70qz06/jvNJbULCOZZDbxKQRscHzSR2HWr2leJ7fXDYw2lnBNPdyPBJLFL/AKuJeW5xnv09/wAabMJU3K7e39amDpHhPQ/hzYXkWiK9zNfyFo3hh3eXHnhTJ6AEd+cZrdh8R6Poerw2UltLdXcMY3zQsZGhWQAjK9lJx+nrXLy6i9v4la9eO6t/DtjbyKNOkJSQlFxxF0Ycg8nv7V2+uavpul6fZ6+2mTGdoVJjSMLK4f5VRx12jP4HFHQ1lFQSjbf/ACOP1OI6RqrS+Er2DS9Niuls52+y5PmEeYzTTNzsw+cnjJ7V1+oG0n/s6Kd1umN19rEazKSq8DeF6soJByOgrUWxae21N541uLG+hUi0kQIwUrhlL9DweAehzzjp51YaLqmkSWtz4X+z6ndQ7bNo7lkLR2gPALeo6EA9fWgzi+ZW2sdRPregeMtTOkNcXcEliwu45VbyxMBjJB74yM1t21gDrst7M8kkbFUjC9Cvb6ge9ef3Gg/adc8R2cNldQaRCqZW227d5G5nBY8/7vuK9Q8NReVoVpDbiSKOGIKn2jDMOPYkenenHbUyxEZQSVKVo+aNS6jV4pI5lcxSrtIXjH0PY1Bc74bAyJEJpY0+QP8AMW49euag8P3Gr3NjcnWYIoJxIyxBcjKjox54zXM30H2u9stJ1c3NhJaXC3lndQSZSTB+62f94jHvQYRg777G9oV8s1q6yRQWsqfdhQFRz6jHHNQ20Wq6kmpRal5aQeaBAIWxvjxyM1Y8VWGktpst7qjR20VsC7THjaPfH1rjtI0rVI762u1mljsluoxCxkwHhPLEgnnI2471Lvc6YQpyTadn2PUNPi8iyhiwBsXGAc4oqWLBjUg5HrRQc+5U1m+h07T3ubmZYYldE3t0yzhQPxJA/Guf1fcJUu2eMYI3b15KdwCK6e8hS4t2jkJCkjODjuDXLXum+TqN7NZSyzFoF/cs5KBxnA9s8cCmbUpJFtLgGGRYVbKH5c/w556d8VY2xG2eOJvkI+fJwQfxqnY7DGC8ZUgDJLdD3APX/wDVVO92apayInmmCRCm+3mIkK8gsrKc9zgjuKlX6lON3oTXV1Z3dpi3ljlmWXaTGwbDg4PTv7H6VmWdm9qrmW5KxgEFZJCxwM4O5uc/XPXrTdMaG90J7G3tZ7NoWeBWLgNhekgI9c5z1zk1pWlnaW8MSEG6AQJI8x3uSO7even1saxvCNihdalDKJw8tlPYOFhtgsm55JsNlCTwM9vTmrmixrLodmt5pUlmGiT/AEcoCIuOEyuRwDj061cuTZm1SK18rB4BQDj14FWFuJXgVgq70XLjcR04ORii5Dk7aI4eOzk0aS8MMulSXUjsRGWWBrhyw8v5znkISMYOSKsWAeX9/dWqwT3ErjEfzgwgZG8A46jA9M4Famu6fZ38MFzdw2lwYJRPGZUVvKYDO8Z5BHPNY1xq2mz6Zaap5rygXKwyfYpS8UcjAqC+0jcoMnOc9V44p7myd0pFXX0gaCZJL+T7LBskllYqQxRyzlVHzBgoI4wOnXtDpNvNDqLXtxEv2OOPy4bYyK4KKz7JAx6AqOVGfve1T+GrOPVtQuFe2iM9tJIyfK2zy90kec5KFmBbPsc9av3cEVvNp720NtHbQyq8ishTbhSilCB1+6NvTG7oOrbtoVOSXumt4TabWLhdRSWI2UbNjy23+Y5zkBuyqMAcc/hXUatIItNmO3dlSoGcZz2qPQ7cWel28SqqAKMqowAe/wCuaz9a1JJrKGSwkiuAXDKyOGQ4bb1HYH+RrPdnF8UzLsvKT/S47aPfOSGlKfeC8L+WBjNQaZdSXUksJs54Ps8/lx+cAfOAwQ4/2Tn9Kfc3sMdolpLNGrQJvmAmBMeTgZB/h4PXrg+9OuybNZZGgM8SoXVQ2N59Aen51Wx1RSafckvLe0Rry8uyF3QFWmRcMI8E9uepPFXLbTJpLC3mtrreXVSxlTdvXjHTbzjv+lZdldNeCJ5beS3DKCY5DloSQPlYj3yOK1INTltUKpEZY14X5gp/XtUPTQmcZJXRXgi+y3QhuyFJPLKhIx249/X2rm9V0kSeJ0dtQZss3+jyr96LyyrhOQV5K5OD35546e6luZHbUfPt0hUBfKHDDB5yxOO/oKztS137T9nn8pIH3NFAssigTvngKwzwwAIxzjtSVwg5N3T9R+n2dpo2jCGBvL0+FWLSM54HJILHoOtPW8hSOWSBnkWJVmIjXIZWztKt0YnB4BrMj1yS+06WKG2XUbBWIU20gYy/MVdSDx8p68846DvtLbCG2YLFI8HygEKAI8dR19OKTHbl3GwGWaItC7xPIpAH8akjjGehz65pLmG6F9YpgzR7G+0SuiFnIACggYO45JyOOuQKt2nyllBXzOWVQeoxwB+VVLwPJd2sivdIIMvtThXyCNrj0Gc49QPpSQn70tCee0Nqsjhcq5yxU9SRg8g/L0H5UqQI3hI2ig3Pl4WNbp8lyuNoZj1Jx1/GrqgT2vnPIAcZCg9cfzrP8RaYmoeD72yNzcWiSEYmtm8t4+QQQ3bBHWqi9bGUpWWvRmNYi4sdU0yG+A86aLEkEafu1wfUdewrQdBNqk90Wc3MgWIIWAVEBz+ef61XtpruPSkhtJ5LvUYrdIPtTRbsMRjef681zEiWVpoGpX76tteK6Mk0iNvO2JCWiXPOeSenfNaoym1O8jd0V5H8Z62JNPiWyt7WELdBvneRfm27fTnqBVTxLc2sU97d+KYY5rTTLn7XYCEEOybNvTOCdxxzxWraXhvF06/0/LWdzbBpIycj8B2JzyPaqukQ3N14keIzadc+HJLdhsH7yRpA45zyMDpjPWhaeoTUpNS6GRaWsFyB4s0m41DyZ441jt5FESwIDyUjA5GeTng5ouPEj6HqMVxeuL06xfJHpqxEiOOMp95sjP3twx16Vf8AFGkXg8b2Wq6PBpxVEEbm4ndfVTtUcY2+3al8ZwXMGgSpoOId0bNbXNsiuYpOoxnjLHjj+9TWxokpTTvdMyNK8SWU10Lqxhlnnv0lnlntYwoAjJChuAeduASeSfrUMHjHTfE1hDHq5s9I1IzpuhnAYKyvuUMWUDJwAe47GtWK7sLOLRLdYE1C71giO4cxYVVUDeSvRcHJ2+uauNp+j6Ub+8LwrYTIkclu0QEKMoI3hMYLHjnH8NTe5vJJbp3f/DEY8PX8WsXWpanqFt5SXS3EVyirGY4lAyr44ZQAwGeR+NP0qzktPDMT+E9Vtp7C3llkk3RF/MBYs+FUg7gegyBgnOeKo3aN4Y8EX7R6zZ3d1qFx9pkNyPMjSORhlUj9COx4yTzUl7q8trbvYxeHYILlpF+yQQ/JmErl5Cq8YBwD9cUXEouej9P66kFlqL3M16dXii0rRLkxjT0u40R2nIySCMjqCcnjmjw5dLGk2mi3uYbvT5dksk0PlmUsThxg4ORjJHB9B0rZ1qzltdHk0mw8PJrMEduLm2e62tG0pblAMYXA5H5VkXcdxo/hvT9Q26jfXjXeLiDzRJJAznIjyOyk4H1psuDUtOjI5ry70abUtTuY3u4oYSkdvDGWJYngEf3TwM1avfEM1t4Ps9R0+2h0zSrm33yyRRb5YZmOAAnGeccn3zV7R7uC4uppLqW3i+xIs1ysdztkR+eHAP3cdvUVl6Tr1s0mrXWmW0t1qF5doi2skiMEhwAGCHGF46e/X0RU1zT2vYpaTqklzYxabc6tY3+palC8kdxPEYlEQyNxUdWG08bhnB5rR0bUtXudGiniu9Ngnis3ZVl/diRQcLK6kswTGD161vpotpZWsVzFplr9sglkMBjTcRvJ3c9ccniuevvFK6b43ul1GwiOliMWiSrE255DglSDwQB39PrQRdzb5V59CLwobux1WXQtS15n22KS+bGAyRuzZfkj0IwelZl+k3grxnY2Hhu3eTShALu/nl6ON21jv4G7GDWrf26WmpwQ+HobAafet9plv533q4BOYw4+7jqMnvineH7e38RQG01U3lq0Vy6SwMWig1Esu4nYc5U4zgdvagc3dc726o3Lu5OltLei4S+tNcvoLaGDI2xBk2NgjORhSazdW06Sw1KO40DVIZNZ2jyrXUbkiCCAHB2qO4xjrUd7eanY6ZG2p6BbWtlYzgp9klBMEIQ7nVQOGHQdOCelams+G9Nex+1WWkJql7KpEXmyEbvMIJZ2zwO5/wDr0zl0Vja1WLUYxNqOizi6vHgRI7SSQeQfmyWXocn1z6VpS28eoRwLfWfzqqykNggN3Wuf0a3tbKM6O7GO6SEbooJWKoDx8n93Har/AIc0eeyvriZNXu7uzddot5yG2NnOd3X2p6GMozi2mjdYQ3MTRMFeM8Mjr/MGs7xFpMWraZJbum84LIC7J8/bkds1O677m+Q2z8ICsjHIckHheeMYGfrWHbwXUevW+oteapsuLdUNg2PJicY5IPIPvSJV1qjpdDtEsNJtbWN2dIk2hmcsfzPWip9PkSa0SSMYVs4GMdzRSKvzakGuFl0udkTeRtJXOCRuGccdcZ/+t1rj/DOp/bZbmaF5lSQblgl2naATkkg8kjaSO2fz63xHeRWGiXVzcP5cMagu+0naMgZwASeteeXn2SRtNF8YbLUHdrgxbQGlIUq5JXr8o5Oe461SN6SbTOolQu7TNPIqsAFCjIzgjP41Us79W02KfTHtpkdyZZ945TcRlcAg9/bjFc14cEUltHcaO4OiynCbGkCgDgsuSc4Ix0UfWtCVriG9FrEv2bTY1SVXilVmzuO5WUqcIRzuB9elKxs4dDQ0bT4rae9niTYbq4eYqCTuJ6sT2rUuoh5DJ5WT1XODu7/jVOwklRpCLp7hmbdCNoCqp7ZHUdOlWrNEd/s84gjVR8scfAYnvk9celKxM5Sb5mUGZrS6t4YoBNFKCJLgSgNGO3Xrn0Hp2qCCVtQ+2I4aJR8gcvkSjHLJj3JFXJbGznnieaNJZYGzH8nsRxg+hIqvqGkWmoahbaibDy7qwRxA5+Vk3DDYwfQHg8dKEyroq3MlxHPaRxqDFE+2Z2Y7lGD93jk5xx6Zql4mvLXTLWeaxkRbiIL5qDGBuzhm2nPIzjueMVVn1i2WW6tnju5pbf8AcJHHGUkck4Hl4HPXOc54zx3isbSWLxBo/wBriv2Els3lEwMYoQFUgzsxLeaQMAt6EdaaNr2avoXvCdxPHczCG8Z7aVphJGAr7H3k4VhjAXDKVxnP5nXkvIQs1vPDIltDEJTcMuIgoJGFbkZHpxVIaXC1leW9/NPcQzzGTqQdxfIX5MEKOBx1HXIqhb+Kkj0u61FUWbTIHCRSW53PIoHzEpgYI5OOpGTQ/edzNx5nodloGqvNI9rchWAVJInjBx5bD5QxPBbIboTxjOM1ia1plub+K3sXS0eyyyw242iOOT+MKON25WwexpIL+UQXcrS/u0C3IkaA+X5ZHzAY5ZgAT0GNy9eantdYS9upPOgMA4Ec7H/WRhAxYdwASwIODkE1Fncx5HGV7FZUs7naq+WzKAdpHzkEHBKnGRndweMg+lbS6dc7YzOY2UkFgQSW9j/jWNHHDiOS3bOVKeaeWYKflJJ5Ixkjsck96sP4hm1C1u4Gtri3hQGM3K8HhPmYAjIA7HnJod+htK9k4mdPdLbalDZXIdprne6ERsVwPV8YB479ane5nhu0i+yTSQsMtKpUmM5GcqTkDBBzzjDZ7Ay2TQ2dqttvnkVI1bzWJLNjOT7scZ/Go5nTVNJjIlmgW8jG1P8AVzIAc8qw4zgggj0qXvqXKTSsJHcQ6mblruwmRBmPZcoNzgf3eSMHn60qWF3IYHkgiSydUe3SRMSwTZPvgKF6YGc96lnltdP0+FLi5HmIAkbOw8x8dvcnFTjXWngsbaRBb3NzOY4fMU/vQnJYYzgEDuRS1uRK8UrLQx9QvZ7Sa5uI5rXyFiEaQocZmLkfNJ2BOF5HB55rbhvNSbQjBDZw/bGiwnmSExqx65IGSAe4xnFZupaBaWupQSRWUUczFyWgbYG3ZLZHQgt1BHPWrumLGscUK6g928AMc8kbAsrjnBx0Iz09MUgk4uKKAbddor3cYlgjLvArA7ueDj7w+6cdM571rIXktWUfKQwIO4ZHoMms2SxL3sdzapbea58qeV0+Z4xkgKRjnPODx14pt5qSaZpl/N9hMdpZRbkChURwB823BwMHOc4oexbV7WJ0vjB5cK29w26YQmRBu2ZGSx9BwRn3HrWjLALvwnNBexArK+HRWLZGR0PHasvw1dHXbT7ZMj21vccRkMHDgfxAjsRjmn6zanWvAeoW92lxYIZ2+eCYF1jWUYlRhxyBuAP0NVT3MMUkrxMvQ7+589Y57cpHKxWI+ZtMIXAVSnXBwfmz6VZt7rTYRewrZW9rDDKzTedHt82cjGMHrkY5xTDa3sFjrGoxsbuOO3RbG2AyZJApyeOeSR37VqXlj9p0K0k8Rm3juIrZZLhg7IFkAyRjPT6k1rfU44pcqZS8NXSyaQk1xZppsKYKqqhYpNxJG3vnkematxuLF7W3gggDSyEt5ZWMr77cfMfXHbmvPNIt9On1K78Q3FxfrbWdwnlI0xeJ3Cgh0THA56ZxV/xJJY33h+88Q2FhfXGp3F1Fb2zIjt5ByQJFTnbjJY46kCm1Yv4tdbG5r9hqEl3qckl8w0/908UTEt5UoJ3fNjhGBHHv2qHQtHNhq9lplvBKmgJGbuWJpWYLc7gQFJz8nt61s6RqI1BpLe5mWGOIGOGF1/4+cDO5wR649DWLD4igm0zX4ZLgWVjYymzhubY72LbeSucgkMRj6YqLs6FJpGXZ3I8K6PdTX9hcQx3dy/kW9vl53ZyQNqsQBwQM55P1rb0S+u7WXW9GjuFuLzKXEEMo3SW8TBRtYdgvGOT3o8Paatpd6WxeGfSbeFxHd3777h5C27OD05JxjtTrMjwvqH2SK9nv49Ula5t7m7cFEc9Y8gZGevbmnsi5zbfdsz9S0DTWukuPEd5cWv2KFkZyoWBupTDHlipPHHJFX9OWz8MaRBHbG/1OwmLTNeN8zM7kYOey4Bz29a6+exRdFvZfs6XFzIjSmJwGDuAcDnseBXBab4j1a5ebRtW0O6gnltPMAjz5RDMFIBIwCM5xnHGKNBRnKcbdEWPC95qukaZqGpavJexaZbyvNHAzieR0OPukY+UdvxpUTxXeXkuq6LqVhJYGUINPlhKqilgXLEc7x2z7+1R3UNtNY6j4b1eyEs9xEWAjJhW4YfMPLAPOMYJ45XFO8OXt7Loug6Tpt1ZaZq7xfbJbfduYR5xkq2S2R1yc0Mqevv2V/wBP66mVoc3h7R4tT1+88PX2lQLKLaRLgkpcksTvK88rzyeMGum1S58Kzs1lMoihulWc3UXyEF+mGHI4x7Yqr4kstT1HUbJJNR8jerRPJEga2ZSDyyMDzz3OOOvFZd3ZWfiK6m0ptSmjaFjYLmDDIwQ/OcYByVyDwOcdxSVy/dkuZv8Arp+KO61fy2D6TBqsVvdTL5qxZBfywcMduckc9a42bX0s9O1nTL2wn1C3sFEa4jAYKcJ19eScjtxVPxD4Zt9I0nTb3WNQje5tZIktrtyImZkz5au/demQe/ep9Eutdu7pT4kubexv9On8yRIZAgvoiB1XODkkDPSmKnFKL6/1/XoZ+oJpY8DxW0TNJojJHIdLtSGlzuzv3k7uvJPPQj3r0TWNV/sXRt8Om3VykCRbEiXBKkgYyepA61g376NLAYBE0d3rW4I9vIGdI1AVijAYG0EnA96g1C50q00Kz0HWZ7nVr8hLby7WTEzZBKO3Ix8q5z6imZzcXa9zafxRpInuoLmfbDLE4WQLkjaPmU5/ix04xxWbolzrb2zadbhbaFYlMd9L8zbTz17uRXO6T4Z0Hw7/AGzrniJblPtUj28dvLOshZSAMoqAHew6g5OfrWm1vFruktbW2pXUGmXkSAOFKyxIM742B5XOOp5pFKMNeVfedVoNnHpr3e6F2Y8m6uG+adsZ49sVo2TLJo4k0mRfMmOUaTJVT9PSuLvbq0vtE02C3szPoHmxxQ3EUreaki8BgfUEYya3l1eS61C3itLK9eN2aCXeoAiZc7WYZzhscHHenZHPU5n70up0Onaha6hJMtvdQ3D2z+TP5RyFlABKn356VJJbRvOZ2K+YgIDH+Ed6ytKS7j0q9lh02C0v5JJJBAuMSPnhmPGSeM1DpkOs28lvFftHdxyqWuG3AeU+ScAdxjApnM47s6fT2R7KIxOHQjhh0NFSQKqRKqAKo4AAwBRUlLYyfGTainh25bRvI+3BoygmzsI8xdwOOfu7sY74rFW2vZ1sdQiiW3QSbp4pPmYxYIxwcZ+768ZrrL8M1o4RWZiQAB9RWVcCSG1NvKyxxOCocD7oPai9jaMvdshNR+w/2WeYljGNu0dD7Y/lXKWNvZ2drDp6vbFJw4S2uJAzzckv1+9z7VdvhFbst0tpNezQ4SPyVUvtJAyMlePXnOB36UW9ncSus6wWlxJBMxgaVQpiPTjqfbIxmnexvBcqepmNdCLUvssWnXcFtYLHJG8EqiNgVPyMuc7R15A56ZqSPUrfWJoDayQw7wZY42mwzgHaSUHVc8HNV9OudSY6zeab517eKzwRWcw8mMSp1IPUK2RzzxitKFrV0P8Aaenbb9hknaGKFsZXf2578A4BolotTbRPQfNpx+yyxpqV/HLt37YpEDAZxwCpIH+NZPih9Q0vTTNp8l3e3aLuWF5gTNgcLtwAc+/FSwWNzPqarZReY6wPHJO5wR2xnIPXpjgYNZuu6TczacLSdXdt0YIkcq3ysCMsDnAIH1/Opsa0oLms2aKX/kaT9qvBMrrjcIV+dMg8HHTGQO1aVvaG8jgeyiw4H7yXoTx0buTzn2rnNKl1uKWCCeK2mhErnz/N+8gGV4AHzH0weF5yTXUrcXUdzAjGQKIvmRVyHJP3snoBnnih6EVlyP3TNt7O7g1N/MvpyiK0bR5UfxZDDjO4DpzjjpzXLT6HI+rXFvc3lzLplvZLHPPcR7UuEyC/mucKXI6OuNo3A812epzo66jdNKoNrHlh5Z2qQCc+rY9vSsnSpINc8OFWki1DYxjlMassTsDwAG6jBwRkjqDzxTV0Qry95bl3R9OitbJo5oUaeBt6OWG58k7W4J+UnJweOtUtP1xbuzniutIaKSIxi/RZ1jWFi43HOQxUD584AZeRnNaVvIyzQbLcSgytGWR8GBdp/hPuMYGevp0rX7afY37G/t7RS5FxDKy4keRAc8Y52rkg5J68DFF9SHG+iJ7OCGNZbe2cRwpLIzRPLuIY88cnaO+3oAw6cVXSSSbUbq1k2LZGDa7r5kcyy5PQ4A24PUHqPxqizxDVHmlvpoktI2maRo1jiKucgZwM7QT6fe5pdFsxd3qTTyJOsMBEbC5Z2kViQTINoDAqq/Mc8/TJTZoo6M21cRNH5LxvgEHLZBI7euayL37RJLC1nHbu8kgMjMSCY+5Uj0P171uyuroFRcKuM9tv5Vz+v6VeIsNppMk1vaR3CSzOZim9dxJVGXJAz1XGMDqKzjK5pCeq8zG0/SbrU9e8i5gN7b6XctJFNMC8xLKrI4bhcrll5Gcbea6G0hu11Ke+vPtEOE8lIjPkrtZiCIwcbmGDn3APSrXh3VoYDL5aTGO3Z4HQptbKkZIz1HcEdam1nVkbUItkcn+lDYh2kjgE7iQDj2zim5XFPnc+W2hJdGWRiZZt7AZjc/xD0HvS2c7qJIliit1kUs8oQAs565/2uByfWore3nkbcqkqzZByAoPXPrn8KJVt9Isn86S7vCpBAjUyysWboe569PSouRJRS5WR2t1JDcPLLFMwR1UNuDeaOpYKOnJ6Hpik0S4GoGQ3FtLPbrJJHL51vsVxk84PBBz+OM4q1HEm7aZoxFkg72OQfTPX+VSJqKwW09rBbHy3L4fKhRx3557/AJUmKSurRV2WbkqNhsgsMap8sKMF3qB129uopksTX3hB0aLyTOw82JyDsyRuBI4PfpxVKIYbEkxYDhSY9rYwM4OOee9aa+ZdeErgTuhZidrRjAPPGME1VP4jmrwahoYFrqt1JqsP9mWzvoot3t22oFeKdWA346lSM4IzzS+HluLnxTeXNxdt9neNofsjyH5QCCpKnoTzyPWuc8JadrWgeJriORJ5raWVTcalLID9pYDiOJAfkUMTx7c1o6a+n3Wu6jqNpcTvK7iKSBuNjgjJ7eg61u2c8YrmfLvYyPF+o6vorTWllp1lqV5cmWFGsoyWt2bLBcdmMfJI64rY0PwfqFl4HXTr/U9R+038YOYZNklswG7aG64yOc/St6RAk4tbaOO3lkm8+eQgs2MYbYcfexwCe1Uf7H0+HUrSM6hqD7ZjNaQyTkeWcDIBPUcdKjk9/mOiNdOj7NJb3btr/wAAz9c07VntLS00y+sCxURzXEqqxbAAcEZz8wznvUojh8N6rLpFpp894uof6TCsBjb7O4ADbUYghRgH2zWYJdEt/FrXjaRqcM9/O1q13OAsUcgGAce5PXoc1PpfiO00Txpcxa5CkM0shgtpvLLSMchTz2U8HtzV3YoU1y8qV+p0Gs2OovfSanJapcQ29t5UNuJPmlcjq/YYJPTmuca/1nxBbabFY+fbC5gdluLQrJZ27BmwXOCGPGNvbFUr2fXbLUNVsLia9kudXYzW99bQ+baRxFsLGVPIGD8zdRkYqx4E1i8XRfsf9jW9jPaztby+WCsbEHlgDzyfz60r6nRGLUOn9L7jd1q8itNI03T728WXV7mFSJLGXyfOfAG4EnCqT796oXeqvpx1Ke9t9Vm1iNg0ekW83mGSI4VWwOAuTye2Ksa7Yxz/ANkxJoun3EKy4mWYkNGhOSUJPbBO3ntVTVr03+rLcaTp2pPfyu9g91E4xHEMEOMcdxj0GadiIxukrFvS9OM1nNY6VfyyXTKZ47y+lWeSzZuGRM/MBwfY1n+FtNtNU1a+u21q31C9TUPOWZEHnxxbcGI55VCc4xxVPxNp/h/QPElpqGoS6nHrKozpcKu6K4CIRsc/dHBJxx161d0zxBFD4W0vVL0adpd5ewytcFLQh32g4IHYbsH8eOtIpxfL7i32/r/IyIlk8Q6nY2wkS8trQSwXdt5jI4AY+XIP72SFyM8n17a8l9Le6XLZX93PaT3s6RrdaeyCVI/u91yQCD6kZzkVrWF5os+rrDbW1zaatGgMMojKpKhUkHP3eeeoyCa5TXBr+neJ9Agitop7p5ZbtpLiQBYVOAykrweM9e+MUG91K6aszR8c6lbP/wAUdf21yIpreN47+NQzM6sCflwADgZJHvTfHln4du/CmlNfXMlyqtHDDO2R5h2krHLJglASOT2OKyNWS81zxHK+m6w0uoxXbxxxNCxgTb8yrIxAIUYGSM559a73TdNtpdItEiTTgiMxvVDF0WbuV3c5DdNw4o3MpWpxjZ6nluia5rOi2Mml6Npl7aC3IuZIdQh3rbxnO/ZIg4DEYHGQa7WDQrVNGu5PE7lrq/O1b1WHm2MMhBWNphgkK3fOMe3FdMujwPMwkiuEGx40uEkHybwA2MdzgdRXPar4PurPT/EU73s19e3umtaRpISFOFwGOP4zj86diXOMnpozN8F6zawWtxa6ppUTQaMMC9Ku3mEvgON/HIwc5+lSR3VnpniDW5dS0zUJLSWETh5VUxNtO0Ig53FvmIbI4OMcV2nhDQbax8P2ixbmlktER45W+U/IBgr2HHT61g69pviDXNG0uygW1t5oL5E1C3gnwiwKcgDjPI28D1qWtAlVhzv+XqaXh620uXQLbUBFJpNjJCQloX8uNAxJGV/vZrqEjW2tbc20TTs21C5HzbcdT/nvVswQxwx5jDCPG0HnBqLUbow28km0NtUnAPt39BVJM4Jz5nYqWWuW15dvbILiKWNsETRMm4+xPWoIYBc6rfTRaxJMjwiA28LjbA2Tlhjo316VyC2c3jXUIdTF6YEs5AiRxSHaHwckEcEHj8iK65dKsdG02zjF39kihkV5JdwQzsOu89885oKqQUXa+p0FlCtvaxxK0jqowGkcsx+pPJoqSHBiUggjsR3opEoqa3dR2WmTXM8piij2ln/ujcOT7eprCkvftRhFzKqmRv3UII3PjOT7468dK0vGHkjw3etdPAkChXkafHlhQwJ3Z4xx3ribuW7s7p75L22OmfZgQywjzB3Z94OWDDpgdu9FjqoU+dablzV1Gm3QS0ubqQzStM6K+9yNv3E3cLkjgDGADWhZz2kVpeNaSKscD/MBghWIDc984IP41k6nbm4hsmtHJuAyzRxCUqXK9RjIYja3IGM8A8EitK432izPbqkCzMZGb5cA8Z3e/HX2oa6Ftc3ulGz1C407U9QkjaO7hmHmW6JJlmXHcbfl5Ddz1/AXm1Fr94j9kkCyhVkhDDdGD1Y5649BzWaltezy2l5AI0X7R++eFfkaMnAByCc85zxyOuCc6bzieZ45I5Y4rU43MmzcDjkEfn0oY5JX8+5R8OW8nhye4iN1d3kADuXuGDsRuyACAOAMgD0q2tu2p6mL2eEogXMcbsNrg8cj/Pao721sdasNVsEl2wGMQOWbhmYZ4z9eo7+4rK0jWLu8sJ7axmjNzF/qhcxvEwwcbWz1+oNIu7leS3Nq/TT7GISSwQ2/mnywrgEPngD8SRx3rK022vkMdzc3KhipjaJGYoFByPvHHoD1PvXTaZDbG136gUlus5ZZG3+WR/CueeP65rNiaxjtHt5lFvZqxaMkgB885BH45/woXYzjPpa5R1PVTBHdiSJEgTylgcS8zSOdoQqQSuWKjJ459qwIru1t/EKyS3l21reyy23ztiNJ1UfIAQMHCucnjIJ7iui0RBqJupGaGZlYrGI0YLJD1Qsc/O2Odw4BPFYGqW8T6/qKamt3BZbUl82SVliY4CEqwb5QMn5TySSw71S7GkL3cehpeDb2/wBRa7kvI4hMsmyOSOUGOVV4c4GduH3LjJORWb40uoLyYRS23zxJuXzETEpkJVoAWI5dc9O35Gxptlc2aXek25e1hXLW93vQ5Rv4dv8AsncMtnI7k9Ld1pjT26GK6nhCR+S8kewl8j75BBxg9CORS2dyvhlc5sNeaJbXWmvapfb2UK8t0yxTKxK7BvLEbVOMc5J4rptC02Kw1NJ0S3SMQCFF5ZgN2Spb8Rwec555qtp95bGKdh5zwRsG82eQFGVsHKEkfICfb7vAJFV722gtbi5ne9to4L3bEIQDHJJKFG3DqRngHk5OMDgDlPU0avpsbsskVxqULXJQXEW4oqOQpGSDle45A59atX9wfszJkKgTc5chVXnjJz39Bz71y6gW6wxyPax6zcRvIkDy72AyN6oeGKjjgcDNWIbLy/tDzRT3SzyIZoJJSYwvAwitwFGMkDuOOajlE6Sa06DRp8sk9vcXdxNNdIANkTFIywJzhSc4bIyGJGAKuxJdw311BexwfYUWNoHEjM+7ncpXGMdMEGrMZAQ7Rltp4X5So9Rnp1Gag0axhtLS3jluri5dJCG85tzlM5GSeWwMDPfr1oCUuha0/VLpftMH2GS0EUgVGlxmXjJYYJwOMc1WsTDb6zcXVjEv2m4kDTo7EAsFwWx0zjAJ6nA9q0mV41e/s1DpI/lpG53YJOM89O/enTW01usFrN9klQjdh4ixznkjnjgkfiPpUNGKlFdNzD1uK4vdSsNQs4raOeKUpN5yNIxhONwjIYAMdo6jH9bs7JBibeGQYO9gRj0yKbb+bb3n2WdlZ2lPkDOzjghBzzxnk/lUmsWmpQRN9nYWjZHlyj96qHvkEgnjjtSsacyT5RlrcyJJPE5VpomMpRIyMIxO0dT6HkccduldBpNtbw+HfJs4oreFXYiNUwvXJGB6881jabe6hPDHcX8cMNzHkbYm3gDJHJIBPY9BzV63aKw8K3U6cwRSPMIhx0OSvuCc/n6VpG1zmxGsdDEuPFMEJa3t1V7uIK83T/RoW3YkOfQqDg+tclPdTahfCGzgnjeyuP3ssKBZZ5lGd3Bxhgynp1zXQeD7C2N3caldWFpZnU98kux2dpgMYJDdhlvzqa5msr3Xbm0smWKSKIyGHa3zBTj7w4BOen+FbRV3qcjrOkrRjdrc29UvoYPC+pahOYgILV5ZVHVNiklTjt6jrWV4Wjins455FuH3Roy2sw4jIzymf72c+tUNX8PaqLBF8KX39neaWa6EqbxMHXAwT90j24yRmtTwdFJpvh6ztL66e51GCMG4llYsWOecN7ZxU6pinOKp37jbLydSudVcX1xLG5A8ptrrbOP4kUrgjvznnNc9awtdavcxalALu/0q4ENvqN6P9cz4KFVQY59Tx9K7rxAs1toV3qGk2q386xb1hUgNI/pu/GuA8HeJdU1jfaXDx2t4LrNzFMeEh4JRG7kcr9apyXU1oxnZzjsjMsdVuLzQ9fGki81aa3nQSZVrdGL8MIWPcHIx2z9K3PAuj6zPHL5etQT6dEjRbUkWSVpyefNbB+ZF+UfStaTWbaytbOPSZLJtOgP2a7swF2oxOAvX5ST61f0Kw0rw7LqMMAtra2uZRdMr/KdxwGye4HHuKRsptwulvqUI7IyrfLqN/BqECxyxgwjy2342lc9AQOCc9TnAxWB4MgsU1C3gup/sHiRLJIk0yJy6wQAnayt0LEYzye9dPf6TYak2rn7Yz6W0LQS2auBEvUyNgDJYjvz+tUNMl8LaFoGl3VktxDaXUyiIqjBpMcfNu528ZxxQHNKadty9qon1C/a0u/s12kbqJIZEIHbnGeD36kcDpWH4m0VYfFehWkSsunPFNBcXO/iGMqQIwf4cZ4PXpyava5pl5qGoW2p+HLtY7QyrPdLHKWmnK/di/wBlcc4/Sq/i7wsoa41G01e00trrm4GoASRKrH5gVJw30PH0pXNYyStZ2FudNt9MTTtIuLq6nltracW+q5JEWOSrAcEYHTtgU2+0q68VafZW/wDacb6DJbRhblFb99IrEOr4I+UjHHtVPxNo8jwTz2HiB5tKv7VIZ0gcOkcZYMbhE3dDgg455PNQfb9M0SW2i0iCfUrvyVFlcXO4W0xxkrGRwCfmx33Z60BT5mlFPU0iWfxTJo8mn2Nno81uLdrzBMs5IwAjg4GQO/pVjRdNvvDmu3JsbaGHSbwgTNdSMLiaQLjKEnYSdo7L171haLqkOpHTtM1fw5dQaZvL28kpbm4BJKhsDhuRtP0xXR6//aMmn3eqWTzpemLZFYXLMVEhIG5RnnGT074oRU1Z2fX+vvJ/DOsTTXV+t6l1arEwi+zXTK75PIkAUZ/z+NS3utavqXhi7lsBFpd/Dem2WS9YKkihgNw/3u1c/rAtrbVnuxol7deIBbx25YllSVNwJIPILDnGetb+o6XeweH7uD7FJrckzAiC5cFRx97H3VA6bV9O9PoZzjFSWn9f13N+8nvra3uWsLPzG+zfJKrAs74G0Y/E/lVHwzqf2aSHT9Vuln1h4/Nn2gHbgdGI71zdroXiLVLTTBc6rHp0FqWE9tBJtAUfd27eOBjgnirWn/D2fTPDuow2OqL/AGreEkX/AJQRypHAJXv3yPWi7IlTpxXK5anc38nnWR8mVAZl2oXBxzwOnNcixuVtrXw/PqNikVxujnkiTaSnOVUMxO49Mn374rkrOHxDolg+la94hMt1OWWCOVWkeRRx94H5R35P1rZ8GaFp17byvYXfnXsLBGuSBIgOQTsB4zgYz061LlK+xccPSp03Ocr+n/BOtsGt4o103RLCI6fb4jcg7VBBAwD3x61H8QV1I6GP7L0uLUi0ipPbyMQTHnkr79KsaV4g028v721hdomtLj7KwcbA8mMnZ/ex3qxd6/BBq1rp5VnmnYgheiKAclv0H409zkSfNexqaJ5o0m1FxD5EoQAxZzs9s0VYtJElt0eNg6How70UC3KXiaZoNCvJI4FuHCfLEzbQ5JAAJ7CuJsNIvtR0101CGI25cMIoVK7VXBVcHnII69OnHWu38RXH2TR55vIluApT93Eu5jlwMgZHTOfwrIiu57FmCReZbycozMAS3TH0x3p3sdFKTUfd3MESRRaurSSzBhE0YiLABckEnHTd24I49amuTFqlhPB526KWPcBE2GGRgH179vaqHirS7jxLrEFoySR2skW6SWMlcjdwgYYYNn5gR02c53Yq1d+G5bDT7g2YeOdzvMi7QygD7inByvHQ+p5pbbnTeOj6k+h6dLZ6NLapNfGC3QxiOZwZH/2s+/v7026LWguJdkk5Kqy24KnjoQoxx79fanXly0VtEZzsSRkQSAckngZxnOenftVRNSjtkMeob5GuZjFA0SMxcZwq4xwcZPoOckUiGpa+ZBaWEbajd3KATlkicWkoQmDrn5exG498fN1q8LRJ/Kc2oimQ73jLZEbnjjsO44q8fD4CPqEkcUV0Y187ksWVe2eg6c8c1XUTXUP2eIiJJCrLKyHITA+6R3x+Wc4pDhV5nzItx7pLNGgsZZNjAsqBcEgjoSRnpn8aoXt/o9xdxm5lQ3hDJHDI+xzxkgq2OgJz7HpW7YXyW1psuEfyk4WULkNxz0/n3xWFfW1tqGsG8Vdl5sKwsV4AHBJ7ZoW5FNc0nfRGVp13qenWX2Kzs43ZNsUUMU3+qXbxvGMquRgFQeMHHWn6jNNDY3P2qdru7RMslso3jn5Tg59vyzUNzqj211PHpdlJfaxFAsojUeXlSTwZCNvY8Z/pTNel1G2gtdW1OGztI1kj+3MHBKR85y+MkAlSB1yfypHQ/dky1b2+tDTbc3scEEz2yiR4DvPng4JwFAOfUkYI4HetSy1R4bO488RWyeZ5RM7D5icBWGD3BHGQc1PN5i2/mxxzSpv4SMjOPUgkdK5m7vIrXWLG1ee9MscvktHNErJeB13BlPcpxkjAHI9KN9DO3MuUnuo5VnnS4is7q3dPKMKY8ycBmzlW4K4I4z1z04rL0mC2u5Jo47aK2njd5oV2bTbBl2Elhld5+Y8HO1hx3rTkjMXii6ngubnz2dJbi2mgyixBMN5WRkEnacqTyoyOtS29n9kurjy44xDMxnlk2lSzDG0FcnnaBk9yD0zgLZG1OV1YdHaXgv7CTdb/ANnLG0U6yIWmLcbdrDjnofzpttBqJuYjbWttDdysqXCtIxVVGc4GT83049yRVQrBq0k0eoWd1HHaXKtCWZkyyEEOu08qc9D+Nb+nXLxC1u5YBE7OwMcZ35XkAjpziobshTck79SSfTZo5oWuNrMzjD5+X6Ee9NjRZtUkiDwiFw656qfYf59fw2by+s5rCQrMj5HygHnPbg9Oa5XTLSezHlLbW6Wkblo4o0OAWPUsSQck57AZxzUXMYSck2yMyX80ctpHdJY/v1ETSReYRtb5mxnBUjocjGa27j7RF4gtpJ7rdbpCd0ewBXJ6HJJ5BH61RfTtSgvIoGige3VDKzwEhg2eiqegxnuaZq7O99AYL/fD5Z3RToCQcHaytxhhyMc9fxp36DaUmmi1qMFnd6xbXqpGZoW3RP1CPjGfrjNbYIv7IyTSBQhPA4CkevrWD5bwWUEUvlmXGGlXjccdSo78VY0qAvJLDGQvOQZCWIUY4Oepzn06CsyZxVk+wahNODHcGNk3fKJDwMdP65q7J5MXhmWOcAwu+za567jwufXnA/CpNR8xrb7LOI8EAhg3XB+lZNzClx4DSG5gEUm6MNHHITskDLgBsdjj8qunuY1HzQ0CymMsZkWGeG3jwiO0QKOMA7lweBzg5xzWbHp19Y6veGxEUkVw3mPIwyxz0HXjntj3rR0LxDb2emrb3TRkRA/KTksCeBj8cc1jJZRw6hNrcMzRXLMMqp+Vx2zj2wMe1dFrnBTxDjZt62Hacl8viWW6uJZIEhbCkOXS6TGSMfwkNSafp3iqCDXLueG2ubiWRzp8e8BNpHyhv613WnaYisJ7j5pmXlf4R9BWmCqjaF4HFCsaczbvax53barN4Z8PWrX8Vxc3DlInhtotwEh459Fz3rPl1Tw5c+JNPS836b4neAM0Dg4ZW42lumcjIpPiNpT2j6nrUOslbRIhLdWM7MyPg4XYVIKdT09qhufEWmaj4y0rSZ9Kju7mSPzfOKjzLdAM/MeuPx/nRr0N48tkknd3NLxBYaI1sun3SR2qahMrEwqI3kcEkDdjnkHg9s0Xb6dqtjqMmmaktnrdvH9mSS5wvktkADHPDdM89auatLY6rFpVjfae1xZamX27uURwfunGdpxk5z2NY+gabo/iPT5ANHns7m2l8qSG63KGeM/Lls5YZxznHFN6k0HKN+Z6dP8Ag+Rb0zUrWxvhp2oNbpqc8S+Y4xGLpto3bR19h061rvc6X4X0CAasLa10OFEWFShcwt2yTn8/esTU/Dk+paMdT1hrS38R2Aka1n25ij6bQ68hsYBGelaGlie+8F27xtZ3c5TbMApWOWTqRz93kfrRcucVzXT9fU1NBh0KGxluvCaWipcpkeV8iOwHBOKxoLO91vTIE8XaZaLP5hMsKHcmAThgc8Z545/WuWGra1PeaRbaFPJbXMe8XEX2Ym1+R/mRm7MBjB4zxXXavq8aTawl0txcxSRpafZYCuAXzyD1VsH+RHpU3KcJxd7/AOZShHh7R/E32/TokmluYFtViRvkiC4BCjHA6cY/nW9rFrJeW0Kx/Y4bJCrmOVflVVPYdFb3rhvBMlvDfy6fa2dzF9l3rHdTEvKpPBbOMdhx7D1q9PNHYWtzoMcn9uTSKbqWDVJfMby2OAegG3I+7jjNO1lqOT5pqMdbbnR3WkXsd2lyl/ar4aii8+S3kh3MXX5t+76gHPWqNotj4z1Sw17Tri4WGz3QlCNqMeGyB3Hr9BURvE0/wo+nt9q02O5P2ITW0ZkW0dhwVDE/J244FdDZ2d3aDTksv7PezSPFzIoKvJwMFApwORzmktSedxvff9DjvEDajqmuz29jql62n3rxRw3NkOLZ1J3ISOoOQc1s2mua/plvp9n4itIpJZpZVm1C2yYIokAIeTONu4cema1NT0cbZRp7y2wlRonWFsBFPdVHfNcw+sTaNfWGkaqsJ068iEBiy5fc5KsWHOV5HfjNN6Gikq0Vy20+81tHvFt9AuTpQj1W6kmYTFZBhd3TJ7jAqtr88Wtac/h37XcW99bxJLcW9jKUkxwQocjp61sad/Zuj3cOhaNpv2QKAzpbRAIi8nJPfOP1p8MdqmoSm3hhkvyuyW5c7WOM4UnqQM/rRbqT8a2/rzK8Xhu1bCX01xMlztcW0suQpAJIz1Pv64q9qVncR6VdQ+G4rO2vAgjj3phBz0O32zXMaHqn/CReI4G8R2kumazpjzJbxxSnypgRgsO/StixtrLdc3lkstpdvdNN+9ckSt0PB6KSOM+lO9yHGaeoy08MypfaJeX1vBd3lqrGS480qEZgM7V/i57mp/EVlNpd8NbsrZ7ueZYrOeFeNkTSZdx6n5v0q/bajPHMDfx7XYhP3Z3Ad8+1XtRbUFuLb7IYGhLYn3g52+1Jibm53kT+GYJLbQrOKd/MkVTlvXJJorQtyGgQgYGOlFIzKevMyaVMyAbsr1Xd/EO1cTcy3SWTSwwW26R9/wC+lz8x4GMHrj0Ndp4ijaTSZVSV4TvjO5MZ4dTjkEYOMH2Jxg81ySsmoDZaQxSxJN5cwYbRHt/iCkHOMdKDqoWtdjNI1CWWxt79IYnZRwYZC6bgSrJnGeoIJHpW4+u2VxagRpLK8p8vyvLJ2nHRh2rHuZY7eKRclghMhCd8HqAO+T29a09MisLiwnurjZE5OZH3bSoA4yeO3+FJsdSCsptGNe2CtNaTz3txbrAxAijkOyQtwob1xjjsPes3y7W011JJWw6qdkO/hz1J9zxnJ9D6ZrRurTVPtVxcmezl0lWXy+T5rjPzA9iDjjBqTw/YmS+GsPYwJCVZYkjHzBc8ZU8ZAGOMd6NDeNVRTdyzbXc0tjLCtzcOuw/OU3sv1x+IqtNqZu7N0t41jlVSu51ykcgHGexA/wA96uanqq6bI8mnwO6S4Vlij3YbnBwPx/SpYHkDLJZR5EeBMrngt6j8/wBaleZkl5W7HOXevQxaPtkvVlWMAM9sodd20n5QDzxn5RV5r+bV4Y5IY5ImkjEgjc+VIqYyCU+8Dnscd6beW0d7fvdHeTgE2+AY+OjMpHJB5z9OuKla5jhubUzIr3s37oSRocjCliPYfX1qrpmtkraDNM1yVNEWSOxSW8ZgJ7cyDzIh3JUZ7YOPfrUj3sc+jMl1b+bYTREmN4j+8XByuD1z0xVTTrErrjX3m3DJKX3ZIChAFGAMc84P/wCrFb16YQALcvJGw+aTzBiIeuD1peREuVS16nJaXchZrWOa01K0QAeTFGHmjcMcKr8ErgIDyAAGPNb8is92G3K4QYKAZKt1HbjnuTVLw7odta6gb52uoLmSJbdz57FT0wxz3wABnoBV/XEi0wXM0arLKybpfJQedjpuxnHfOaHpoLmvKxD44u76106wdnt4Nt1GZJmlVQq5+YHcMHIyuB13dRis+9kZ7aRkMlspH3mH+rA5PUYx9R05qS+lk1LUpZN1vqGlQxqJI2UM4YkHO3pt464JyPSrcTW93DLHgHtJGwwwbA+XHY4x+Yo6mtG1Na7nMaNdi4g8/ThBJJNNumRrkP8AISV8xQCeG25CgjOfrW/ElwEljYI7sxaLyxn5c8Z9xjmse3sbWwuxcrAiXlwqx740P+rUnYCfYAc/StewnuNGuLu9uXmuYuXKGPmGMqCAu0Fm5XuM/N16ZmRrVbS5kQeHsRyG0aJbeZSSVaViilhnhjjI56EcfTFWhNJZs2nwxRCE5DPExIAzycde46ZxUdxcXP8AacM/lH7McySKAc5yCoII4zljnI9xWvpywXepbjHtiKllU4wXHBwPap6mEnpzS1M7wpq0upW9xPHc2H2xo9728V0J1XDMqlWGODjHTqCKRMGYSymJ5JEBJHQEkZIz/nirXiVLDS42k/c26IpZ9qj5Bkc8dATiqup6pbltPivEhVpCVjUj5pCB/hzSauOkm/eWzLU1vl4J2mVlblMYOOOgP+GKluSFV7lX/wBIjwPlbAwO2ffiqlo5QxyMhMathio/hwOMdz+tX79rSaNDZTBXIKhVOD68A9D07ZqbCldNJjNPvIr+OOaYzjfhlaRGUqvuG5B6ik8U2SXHhaWKGcxFbqOeKQqWG9XV13AEEqSMHpxVKGea4swbSAxXGxlVZjsCFQTliAQAfx/Pim6adWv/AAPejT7+GTUDdsrPLETEgDASIg25KjDYPP171dNanNXXu2RzuqaleaRpUU8GiwX+oyOsbwxMW2ISSWGF4HAOSO+a2571JbKK4MMdvGVRtrsMZyAQcfWs/Rdb0+9ga6it5rEQbo3a5O2RGBxjrnB7e1Jr91G9lM8N1A29FkzKSCoPQkAE4z0rdbnnyjemo217np8cizWatAyneuVbGRmuK0nwtrpTVU13VFl+3goHtyVaPkYIP58fSs/w1rZsdADvP512q5EVu25Zh22g4wT6Zpg8SX2vaRcLY3c1l5h2SNdRbHhU/wBzaDuI/n6VDSb1O2g60IOytf8ATzG674fjs9Mg0bQ7cXWf9eZsN5pGDlz6nFJreqWXhnw7p1/qmn20V64hhmdIhleCT82MgLycc1z3iuyEFta6fFdvFHpzLcySmUtPJEwGHxwWbcGGB/eWu38UuE8M2Nxdaa9zLJGsaWjJvbcwxhh06Ng+/wCdVdIfs3JLnd22/wCvQ5vWNIudU0f7Z4f1q90qIxNc24tpN0M5bGGbgkg5Ax0Gc1Z8MXKaJYPBqD3c1zBCbie6dN7RADO04OWwc478iumt0u4LWK2vrRrfam1TbACKNFAwoxj2HQYqdoLe3t/tGUjRcnKrg/MME8f54p26idVW9mzzbUPEM91Fp95oj6tdodRCMsMDkSqfvpIDgADJAyeOOetaV1r+oaLfyyx20cqRyLazQSy+XAqOflbJGN3GOM9cV0F5ZX0V9Z/2JqUWn6WhUSxeTvMhJ5BPqc/erFsP7Y0zxTeWmsP/AMSSCNZLe9vMESuT/qie4HzHJwQQKryJSSfMtu39bmtpsFsPHD3NvBIJntnVnVmCAZBzt6cknnqcZpml6JdjWdReG/trnT7u6aWS5jKiVcMMQEjqB0z2Aq5/wkVhHLqcl8n2SytIlMspjIQg8HaR1HI/wqpa3sOjW5vLCJB4btLVpFt7WNnkznhgP4i1TsyuZ1I8yXQ0L60t9R0m+sLxrmwilBj82KXZLkHIKsOucZrn9B8I3ujS3srzWmo2v2NRZ/a0BunkGCEkfqVB7Zx06YrpkvNN1XTINSnhD2gQXIMqFXAHXIPQip7u8F9p1zIWhksbiMsjNwUX1PsMdabd2Y4duELf1uYVrqOt6toUE12IrK5hmaOaOOHcpOflOT2wf89K2LTw3PKEkTWbyL5t5SN/x2/SqmiXf9keE5725nku2mnLp5eWLAkAKN2Pz4FV5p7rRLi91vVNRuzY3YRYoBFj7Nk5+bBIBBOCcYpI6Kk7NqJ3FtFsQpJIjzAYJXg/iK4DxxdapDdW1ppEsFvqQl8xGkVSJFwQoBPQk4zjmub1LUtTi8zTWvHvtWlnEunXZwjeU38JZDhsf56Vel1oatfGxv4Y59VsLZgA0bbJpkAZl5UDGM4I+vHFG+gRoezakzufCF7e3ukLLq1kbTVFBjmTHUjuD1x6Vza6Zdf8JLLq00rwQohATkgnuPQjitF/EVrotvBd3AnuV1O6SCGKJQxRivIY5+tbkt/Zghym6MsGfGGMWV4LDtRoVSlKDel7lKy+yywRyXCRNhvkuHAyxPPyn+tUvFek35kkn0sRtHgBkZsD6n2qPxrFqc1jb/2H5RMbAA52hQe/pxU3hy/Qi70+eZrq78kmXa2Vc45C5+v60XNUml7SP3DdLtYo5NMj1CRJr2QbshvlOFO4j1Ucc1pa/wCIrbRdS0q2uY5GOp3P2VHUjahI4z65PGBXG6TpGm6X4X06Ke9NrYSO6N9pk2yJvOfK3DhRkAV2mqajp+h6bHc6lNFDbAr80gBG5uBtPr/Sh7HNVvOR01qQbdCBgelFNsmje1iaEqYyMqV6YopGTVtBupBWspQ4JXg8fWuTieW0WcXDw3Bd2eMQpt2qTwp5OSMctxn0rq9SjaWykVCoOQcsMjgg9K5fU9a0m3ieC7gaGWNN5c25EcfX5vMxtA4Jzngcmg2pN7IdZaxpSJcWN5eWy3aDfNE0gyoYEg4POMA/lWXc2F/q1ukVg1ssSSoJRcoWDxfxKOfvYxg9M1z194m020nh1C0iimvXQBkDKI2Qn5S7jIBxhgOTtyQDg11Gk68+pSyJDb3VjdyRxkCWHEfzDPDdGI5Bx7UctjdxlDWPUm0lYdPRDfPcSupb5ZVBMXPACqMADoMD+tLF4jitbyeJLWV4DtZREB8oOeewwcH/ACarJfLaRJY6veWctykgWRmZVLsxyqkdM47d8VYbQ9Om36i8NuL102JKqDeEB4XPUjvjpmoegvcWs+pmWk6SyzSwXDfaFVCbcsD5ZO4rhff264PpxBqmo6ppyJNDbrNKUaSZRGT5iqCcLg8MeAM5FV/AujXa63qdzJJ5Lo7RpEw+VY9xKbcKpAA9zg5HPNdBq6Xc2m6lEHh+1MjxojScFivAyBlc5HPanc3lOMXy9EYeh6lqWp+Y1zFZWYRQNkTF+T0JbjII5I2jGSKypdWuNL8Wg3+o2VrbJCksaTFipXcfMO3HXAI3ZPTpitPUvDdl4esLfVdAsdk8ZUXNvGW3TRtwfl7sCQQTk8HpnNYc13barrbrhJzZxyK74MZgxt+UMcMMncSw45xniqXdGsHGom4bfkdxaTNcNE9yPs8k4ZiobIReSGB44NAl62q3Chj87pnJwDjIz2Jx+f41n6zrSx29pcyyfaoZQpBtxnylOPm7FgDjpycjANWN1vawPdxJFJbOgSKTJZiNuSGzz1H+TSsc8VZK5FottfRxas4SIWglDQlGO5xtBfcvQNu3dO2KfrZltdNleWN3jIAJVAxK988Djj1GBzWNp+rXOpyQW+ktdwQ3F3JFJIsXmqAnXcd3yZ7Z556Vspa3ckAsdSna5AQ75dwTdk9gOvHfPapaLvaWpoeGLHTV0KHyhAp8pVZkwBgDjp1Fc3ZXk8Wu3dmbq1dYY1lKKGEoLH72c428EDvwavSXK2csUVvJav8AZQHmjD/Mq45IUZPYEZ9alVWnRr+WIrJMoyBHjaOwPHoT+vFDdgglCTk9mV7lPOnDStIR5eIkIA45IzxnnkVW0aWfdciWUTxySMIpFb7y53JyMDI5H+TVzWp7eC/gSGZHjysQYAlckZw56Y44zxVe0mPmvDLtWeMbsEjdtPAbHocHn60jaKUoF3TtVj1C3l/s+UuwYoTJGcqwwCDnnOf056U6WAmWOO2ZEG4s685xg8g54OcdRVG11BLmCSVLSe1ExEZHlYljk5VnJGRjGwg9MVoLHClrDJJdZuFG1mJwxbGOQOpPcUrmTSWliD7NLPfytMkSJCciQNzLkDIOcnIOeM46fgroouxIUBwpkPmjc3HGV9eM9PX87wXDFYf3kZxls/dJ4+vaq014t/HFJZyCTyWZBIEZSMYBJPH6devNJyFza2RXijFzep5cTvC8ZwoJBZgejdMAZPX0piQxafPaWttbl987Kxkf/VEhySc5P3uMD+9U3hvyrdbgBbpQ0zjNwxbBJz8hPROcrjj0ojupWnvW+xNtgmEZfIIYkckDk45GM1m2Dk+Zp7FHWLGOXTZxqty1hHPiCZYT5kTAv02kEZI4z2z9K7fw80p0nE0YTy5DGpDA71GMN7Z9K4+xtrs3p/tBY5/JDvC4kaMBGP3CmSGIAU7j36YrsNGPl6IWYnBcnkEd/etIy1ObER93UwvGOgW11byXUUZEpGH2gkHjg4BHfHccGuP0Wwl162F54ksPs8yEQRMw8twgBzuCnoT0B6fhXomuSLLo93D5zQefE0SyggFSRjIz3rnbG1jtLSL7OfPnWMCSWYjLBeM4788k+9bJpq5505yguWK3OQt4NR02O5utLtZNZs7e73DdE6NGQeCp4LLjA7itmzgbUvF099dQRRRIpWLy2IIY7cq4/HkcdO+a2dD1W6ihnj1bW7G+ikOEfyhC0YP8OBw34Vz/APwitvpM+panoMV9Lqd0JHkaaUyCTJ3fd4AOQBn0FKx1SxNou+5sRQ3GtG3vby1ittWtnaK2MnTAPDH+97D1Ga6U6tPp1rp0OoiGbULiUR7I3AyN2Nwz6A5NcxpTfadJiR9kUvBlhVgrB+/bkZqfTZ7Z5ZJkMV28G5FfcHZTnlQe3biqcOqZyrGONo1Y/wBf5G/resRBra2VHZZ5fK3bCVbgn8Bx16Vh3GoQaudQ0xUlgmsplDBhjcCPlb1wc9enBFZWrwPqBbWtOe5t9Wjt/JSyuZMRxjcMkovXp1+lb+ikXdh9svLVU1HasEswjKGYKM/xAHGSfxzTTfU0UVFc6ev9dCzax/ZtExbxNeXHSYb8Ecn9KoeI1vdT8I38aaRFd3eRstp3O0nI5BGDx1qnDdl9XnhsJ7+1kiVTJKoHlS59N2Qcd8Y61k3PieTUNR1C00u/1NdQsiftFs0SEHHHAfGO2MHnPTmh6ajhNybTVmipNJqtz4qvdKvtPij0dYY0kXyyVdjywDHqOK0fBuo6hZCGz1nVNLkUERLFC4DqS2RuAxzgquMVX8QabrfiWPS7vTrVoDZzqTb31x5KzerP5eTgc4Gecn8dW+sbC18P3stusUUBaST7RA/mSCQAjOTyCD0OeCBVN33JpwdNyu/dl+BreKLrVY4bWfRorWWCORTeidyhMBzu2HpuHXn6VRjjs7+DZNbFYtsiRP0JjbIKsoOCOen0rmbS8utV8HXegXJluXa0Jgv7kn/S1zht47MuV7n3rX0XTjceFrE66jW11Zy7SbeTb5gUghhg8g45HU+1JFStTTbdpJr5pml4a1dGb+w4rCU21rGPIuHG5Wx0z6Nmte7abUJJQuGEtts+zyLxv55PqOn5Vg619o1WTTbzw+9rBa+aRJKzeWxHcbSM5H5810E+pafpKRLd3cEbPtjRpm28t0GfU4NOySM5SqOpzR/z6nJ6BDPq0kFreaO+lXtjnE38LKG6gHnnP6V1dndNb3y2F2kpmVS4nKZRlLHAz2IAGRTF8QRyag9m1rdW0nASaSImJifRxS6fb3EdxcXt/f7/ADQQEU/u4/X2P1/OlY6Z1XNPoTXmlrDpZhtYojNC73ERkXcBKckN69z0rkfDllbWNo4TxBdPrN0AZbqQoS5Uk7RHj7oyRgjOK6eTW44be4mKsVtlyxJHzKP4ueP16VyZ0nTvtsGtwLLe2s2J0w5AV25DbT6ccfz6VLRthVzpqZt311Lp6vfpJJIiKSUCHbx64BxmovD+tabrEyakbEwXrIQVUnPHcdOD9KzhfT2F6r3l9FDDOD80/wB0r3yP61t6rZJLpYh8OX9paanNHmGVVWU4OMlV7/0zSOmpyqNnu10/UZqWitftpSrC66bdtIb+1ZeJA68b/TBHbvWH4iMHinxE/hjUbJ3i0xluxIr7UYHhVI6nANd5aT/2bp8EV9dGeZIlEj7Rl2xy2BwM1z11PIPEbOLW3XTruDcLwYD5A+6wPb0pvXQ56Lk581u52Ph0qdEtNmdgTAyMcA+lFSaMix6XbJGwZAvBHQiikc0t2S37mO1dgm8gj5c4zyK5vUpRq/8AoiwqVwTIkmMMMEY+hrotUSN7CZZnMceMlwcEYOc1xNiZfsSS7Iy+TlySHIzxuGOvTp/9ak3Zm1GN9epk33hHw7NpsyTaHZ/KQsQ++HCqAAQemMdB6HFattaysEmvZLZ7plK7oYym2LOVGCTzz1/QViyy7NWu21WC7FnKiKPNaPyVwpB2lfmGTgktgccYrchgbUFFtb3I8toiyTqAcZ7qf60m2dai1rcTVfDtpcRv9mlNvLOyyyypjeWXkHJB+nPrUvhuEaHYkNN57BTkOQNnJ4B6BR0wAKz7ex1iC7niubyK5skQKJJFxNxwSxGAc8HpnJqjb6JdyTr9r1Ka4gRpGWMqispZuPmAzhRwPXJJz0palOHNHlbNwOJrkz27eXcvy5U5Hso9+lQyWElheG6vrxyAxkHmsCMMcFM9l6cdSQPoY7TS7YSvf28BjvEVV85Rjcg568Z6nj1qzN50k4uJZt0Lp5ZjkUFV984z+FK+pm49Fscn4t8Qp4vsLqx8PG2luIJlSUySuiIFbJYMg3EZBHHcY9atadBeWd2slxDPdo4LOsEe1MdS24chhgDGefSpPDek2EOvavf2drGktyBFJJGnlhtpPUZxuznJwPfNbF1awNbwLIrypBMtwjLKykODxnaeRyT6Vd0mdHPyU/ZRRHp0FlfSw3mom5itposQrOxQAueN6/3sYwT6+tYS2z6dqlxDpNghmmkDMSzIJI2f5nB6bsAnj1A71sSed4g0S6tpxNZxRzlWBChpAp6jIPyngjofpxXPxyX0Hio2TtEbmKN57OZgyxnI24cgn+JsleOqkdKa1ZMIv3m3fyL3g+yurdpp3eaOS6dYw3lqsjbcljIMDJJ3AHAOAtdZqkTJE7xzETEFA2BlQRy3T17kVmaHYyNBdS6nebNTciQpCw8tG2j/AFYxuwSN3OTz+FLqMkN3ZNb7pN0i/vPKbBX3LemR9ah3uZW5p3WxylypfUobkW10b/ySUuDEgiuhjAjbnqCMjOBlhjIBrcv9clkgs4Egmh1C6w6WkWxy+wAuFJYAjnBI6VRuLNtS0q2tNcidJvtKyR+QfMMYDZUFjnGcEZAGATjGM10+nymDUYPtkkUrqXwUQKI16Af/AKqbaWppVkmr2ONs78JOzzxjT7u+keNg6urh1HCsSuOMYU9CAcE450fDUE+k2d5DeSz6nO0aCJz8uUBbbySeSMknOD6DpXTeIYV1UQm3MojgdWeWE4O0EMVJP8JwMgda5q6vrySOe3tfIj1HypZLYMfMVkU7VJbGMnKHHUZ61N7ijJ1YagJoHjW7tY0uTlYxsI3J1B6njg5IPpVq3nS8hllthcSAShVhnjKLGUOGZcgZ7kHvjilghinle4iMBMqhZfmAL8ZB47/M1WNOM8+l7nmjLJcyqixgjdFk4yD/ABcqc+pOOCBSZc5LSwlta3kbyC+lW4kL5Tau1lX0OOpHrSzztb3NvBHbXU7zjd5qIDGoz/Ec8H/PWmzXSx2vmrnIJAXOCxx90Z7kil0aW4vLESTK9tJLh2glwSmTyuR6DHfFLoKaa1ZZQuZ5ITEEPO192MDPbuOn5dKz8y6dIWvE+0GRyUaBWwFJyMgnng/4VeijljlWGdZFQMv7wYPf9Dz3GPrUHiGSayniNjbPeW54kSLmQknBwMjoOfb6Vna7JUtbXJBAi3P2lIUaJm+bd/F257Vuwv5Hh+dpJNyrKWGOy5ztH096wr+PUlt4prUxG0LjzS3DBP72MHLZx6Drx0pnixb9Ph3cDTI4Tey3ESosk3lg7pFzhj3549TV09znxPvU7oy/EHiARahZuF8y3jnFuEVDIxmZcqT2VQAc5rY8+O2s4bzmKK2jO+SZCQc9eBkkc1w2izW3hPS7yXULgylXM11KGyduecA8nJ43dO1a0njXTH03TbuyXUrmyuX8uLyrdnZX5xuA6DjGea1emhw2jKzXQzQbPW9StTbzG2S0uvMVEAVHyMqOnU/XHPrXQeHNY1S7kulurixjvmkCtCkisVXHQDnJ+uOD+Fc54+0W+8Tarp8OkyS2szQtBdTq2FSPcpB6YLgg4A5q54V8NQ+H/EF3rAa5F5dS5njZwytjcFbHuBmhXudNSVNU0dNp9vEt1fiwt9jLIvmtACMyckgnp0x06VnW9nqWl3eo3sLQ3dtNKW+zsgjdGbvuJ5xit60v4IN72lxE4mcl13BssOD0PXHUVlX+nXU2t6VrEV5IrW25pIQMpOjA8Hnjnniq2OZTvp0MTWbux8E36azqpnmXUQY55s5eIgBlCqONvXj6V12ja5p2s6al7Z3UcsEqgLv+TJ9MHvS3ctl9ldNQjjaCNWkCGPKk8YA61y1zFb6pf2OoSx3Uc9ur7DYHaAp48twfvcnPTtUp2Zv7GVeClFarcsXX/CN+Gft8T+G7qOxu4mNzc2kWUAAO7cQflOCfTisPWrK1n8ER6n4Uv49HglkSKa41FtzSQgkffOTuBww+nWtR9MTV7+7gudUuraa5jVQYjwyLkYlRshsg4zxkGm6vo15J4Ul0m6ggvRbD/RVVDFHMOgBBJIIycEEVTv0JhDlkoyKPh/T9X0bWXvdO1eG50+/RJpY2IdHl4wUB6ZAPQ+nWtySxnPiI3Ti3stOdzJKJJARMQpJTYPu88kk9qwh4ec+ALW30a3mtrpriK5WxvLgsItr/ADRqT0UgHjP8VdQulpeS39vfNPd2sj5WKRVXZlfuoVHIGSMmqiiKlaNN8t7q50loFuggYwwovzxNDjDg9eB2Nc/oOrQanFeyadDe2cUE2yW1u4PLZGzyV6hgRWXbafp2mXk2l6Jdvpl9Miyxxs+77p+ZVVsjB749K6a/XVrXSnkghtptRMR8tJchGbHcjnH0pwb6nPiqUdJx+T/q+hw2uG61TxFp9rd3CWGqyWcxitYiXtp4w+chs8NgHjB49OldfqXhWDW/DFhaawGe7t0DJJvIBYL90n0qtPL9kewW88pNRMSu8cfzIjMAG2k8kZ4/nnrXSWzy3Vg1w0m5kyFRVPOPX8quS0Ip4iUanLazt8vMyPCc11YwnTdVngludx8rYuAoCjCDOCxzznHeptAili0hLfU1aeWeWQOVGFCsT1yfSoYNV0nU9Ue2u0kj1OwUuIQMORgcgfxdqd4cm1uS/wBTk1dYPsTXObBlTa5iI6MPUZ785zUXuzqqe7T2MfVdMukku9CsLxIxcW222imQ7AAc7Q3JGVyM8/hWbod9f6HZXdjq9pLb2dparsjt4w7xsOGA6BlxtYH6jtWnpupf8JDq08FxLdLaS3Amsrq3OPKxwY2I6HI6Hiuh8U6Te3VuEtLvggRt5ihuvcn6UkzobtZSOB1Swl0+xm/tXxAdRhd1lQCNd6QkZ24xwc+4rubR9E8O6NBdSyQ28VwyRiWRv3kjNjAH19BxxXG682neE9XXVb6Z4JpNqTrHiSOUHjJBGQRjNUviRp8kmn+HtSsNTmurKeXyiTF5oCysDvHIAxjHrjp3pSdlob/xXGMpaPqdn42ivprOOfT2XyFX/WI3JFZ+n6dZ3P2C51iS4huYI8xOW2xgk43fn6nnNY/grxC1x4UudO1e2t4VtbqSO2jhdkKiM9JM989++at+JLCz8XaSkWpzPa2cTruZXCbSO5J4Oc/y71PmbxjJQ5Hsup6xpieXYQoNuFGPl6daKg8OwxQaHZRQOrwpEAjKcgjsc96KZ5ct2M8TXENrolzNdMVhXaCQM9WAH6kVwniCO5S2f+yb2G1u4rhTEJSFSVh0icnkZJA45r0+ilY1hV5Fax535UdzdW8d06iSQ4AU5UuVyyr7Y7n+daUmkJpxiaBzDGzbVC4wM9sY6V2VFFhvESv5Hm9/eTQXNuV8vyScSyvLtO/oPlOARz0pEuW820F0jS20/wC6Z4I3OXP8R/uqMEc9SfQV6TRS5SvrGlkjgtWmmtIpoLUm43JmNFdVdxnleePfNVtUjhn0eWBp47aedHijcuUdnx0GCCTgZ4PavRqKFEPrFkrI8T8NpcQapJZXd5awTLIlxNE0nnMwK8k5AAJPAIzjH4V2/wBoRIJIcROSSFbOBjpx/nvXa0U2rlTxXO7tHjT2VxcatffYtSMKlfIj2lZMNt+9hujKSeO4xnnmpluLyfxHLbi1u7a0t2ibMoUB9yszquV5GRgkE9eMHNev0UWKeMu72/E8vknke6uoJIpY4hFvFyJVxvYkGMY+YOMDnGORio4LK1S+abn7TMoVmDMGY9sjoRgfjXqlFCQlirdPx/4B5LoDpdSazBZQz2khlcyTMMMxYAiQA528k/KQOhOOa1dIijsLNII0ZiPvO6BWkPcnHBzXotFJxuL6yv5fxOD+0SLbXZsplZuY5UlyFVsE9cZ6nGRnr7ViWulpcKwvIkT7UoDxyhHVHQAbQccjgnnv0r1eijlJjieXoeQ3Ultbagmnm3uJRPGozHbl44yQwALDoOMc47VNcyvDaG7nVri6toHP2mG2ywU/N8ijPzYVQR3KivWKKXIW8Um03H8TyrRrCW2ee9tjDPHe5uBFeRBXRyvyqSBkEEnrkgHFadnKwnFvPHbpd+WHaLoI85HA64yDgkDpXoVFHKQ8Re+h57d2sN0S95tdoMSQKSCNwJBIPUdcfjXOyT39zdifQ761ntrJ2t72C4JCLjljvxkFQAOODnJ6V7JRS5OoLEW0scC9xLfaeBbyBUbhFUhgRjqD0xzTmsHj8FW9rqmbmT7RFufYFLNvXDAZ45rvKKI07dSKlXnjyJWPnO7TQ5/iTfpJaO13p9osUlpJGdvlM4IboQwyw+gz6VSntY9JvxqshW5mdvM8i0DQJnI2DanLsMfxcADpX0zRVu7RnBqLV9Uuh4JpHiK+iu2hFoxilUsrMpb5hwCG9eRntUdrZ63omrXN0+pzaml0ybLOSQEQgk5ZfQjjjjjNe/0VKjY3nWg/hhY+VtatLLTPs/iDw3JeSK7yGaCBjIEuG4JIJ4xkYGOwq54T1TXdB8Q6fDcG6v8AStSVWnN9IwnhcjlgrcBfoMV9O0U3G5LrRcOVxPNbvUre2CeZNCkMknlI27qxGf6GuP1fyb/WlisopIQmGLzv5YJ3HJUg+te9UU7BRqxpa2/E8ut9HGj28V5AFSeRSZ5XbeQBzjJ655707X/EFva3cC31tcSW1xIFZ2b9zHkcKWz8pz0zge9en0UEynGW61PB9WOp6D4nGqaXbeIdVsbgtbvY3BfZA/GGAYEbcdCDiuo1DW7nS0gtbrSJri5uQwSaytjOir2ZwMAEZ5HftXqFFVcyst2rnj95YTz6tp8HiE6NdXTsz2ZjEsUgAHzbTk/XbkdD6Vr+IJ9U060Z9LWS5kXYqxsDINpPzHjk44/CvSaKalYylSvyq+x5P4Y8SWWs6P8A2vqcVpbxx7kmYsHWIr3z2Pp9R61Uu77U31yK60vVba40+4DCOLIjkDgbhkHBJ2gn6CvY6KcZ2ZFTDqpFxvv+B4xjULYLrmpWdnqd+lwFSa2ZkeNCDkP9O3au30/U7e6dIY5MXBjWVVx8w4z/AFrsKKHJdinCcrKUr2XY81u/B+hPqjeIoC+m6mPvCKcxRTOem8Dg5PX61Z8HaXrWhaN5OsXwuiG3jBJZST9wk8EDjn3r0Gipuayc5Q5JM84k0C71PxBfXN/dM2lXFr5MNm8CFYpehcEg59RnvWR4UV7PVtRtLzUba600Lie1ByInGAGRB91SByvQHp2r16ii5pCbimjyXxBDpsevWNu7LEmov+6lWI7JnHUFhwG+pycd6d4g0fw9qca6DfRCQMokRVk2EsvYEd8HOPevWKKRoq8kkuiM/wAPwi30WzhUYCRhQMAdPpRWhRQYt3dz/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Portal inflammation and lymphoid aggregate (*), and surrounding macro- and micro-steatosis. B) High-power view showing portal inflammation with lymphocyte-mediated bile duct damage (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Badizadegan, K, Jonas, MM, Ott, MJ, et al. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998; 28:1416. Copyright &copy;1998 Wiley-Blackwell.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12279=[""].join("\n");
var outline_f11_63_12279=null;
var title_f11_63_12280="Gastrointestinal amyloidosis";
var content_f11_63_12280=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gastrointestinal amyloidosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/63/12280/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12280/contributors\">",
"     Michael Camilleri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/63/12280/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12280/contributors\">",
"     Lawrence S Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/63/12280/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12280/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/63/12280/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amyloidosis is a generic term that refers to the extracellular tissue deposition of fibrils composed of low molecular weight subunits (5 to 25 kD) of a variety of normal serum proteins which are misfolded [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/1\">",
"     1",
"    </a>",
"    ]. These fibrils have a predominantly antiparallel &szlig;-pleated sheet configuration (noted on x-ray diffraction), and can be identified on biopsy specimens both by their characteristic appearance on electron microscopy, and by their ability to bind Congo red (leading to green birefringence under polarized light) and thioflavine T (producing an intense yellow-green fluorescence).",
"   </p>",
"   <p>",
"    The precursor proteins involved in the formation of &szlig;-pleated fibrils undergo transformation to a fibrillar configuration. A number of distinct low molecular weight proteins are now recognized to form amyloid fibrils [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/2\">",
"     2",
"    </a>",
"    ]. The three most common causes of systemic amyloid deposition are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary or AL amyloidosis in which the fibrils are composed of fragments of monoclonal light chains. Affected patients may have amyloidosis alone or in association with other plasma cell dyscrasias (multiple myeloma, Waldenstr&ouml;m's macroglobulinemia). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35815?source=see_link\">",
"       \"Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Reactive (secondary) or AA amyloidosis in which the fibrils are composed of fragments of the acute phase reactant serum amyloid A. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/24/30086?source=see_link\">",
"       \"Pathogenesis of secondary (AA) amyloidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dialysis-related amyloidosis in which the fibrils are composed of &szlig;2-microglobulin that is retained because of the marked decrease in renal excretory function. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5609?source=see_link\">",
"       \"Dialysis-related amyloidosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A fourth type of systemic amyloidosis, senile systemic amyloidosis (SSA), remains to be completely understood. SSA is a prevalent disease affecting the elderly and results from the pathologic deposition, predominantly in the heart, of unmutated (wild-type) transthyretin (TTR) molecules [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1467472912\">",
"    <span class=\"h1\">",
"     PREVALENCE OF GASTROINTESTINAL AMYLOIDOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of clinically apparent gastrointestinal involvement varies with the type of amyloidosis. Gastrointestinal disease is present in as many as 60 percent of patients with reactive amyloidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/4\">",
"     4",
"    </a>",
"    ]. Among patients with amyloidosis and autonomic symptoms, the two most common presentations are orthostatic symptoms (approximately 75 percent) and gastrointestinal symptoms (approximately 70 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/5\">",
"     5",
"    </a>",
"    ]. The most common disease causes of reactive amyloidosis are chronic degenerative arthropathies, particularly rheumatoid arthritis (which accounts for approximately one-half of cases) and less often ankylosing spondylitis and psoriatic arthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33000?source=see_link\">",
"     \"Causes and diagnosis of secondary (AA) amyloidosis and relation to rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gastrointestinal involvement appears to be less common in AL amyloidosis, with biopsy diagnosed disease and clinically apparent disease occurring in only 8 and 1 percent of 769 patients in a retrospective review [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/6\">",
"     6",
"    </a>",
"    ]. Hepatic involvement is much more common, being seen in as many as 70 percent of patients. The incidence of dialysis-related amyloidosis has not been well studied but clinically apparent disease does not appear to be common.",
"   </p>",
"   <p>",
"    In one case series from Japan, biopsies from senile systemic amyloidosis patients showed transthyretin amyloid deposits in 44 percent (4 of 9) of samples obtained from the gastrointestinal tract and subcutaneous tissue combined [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/7\">",
"     7",
"    </a>",
"    ]. Given increased life expectancy, clinicians should be aware of the possible gastrointestinal involvement by senile systemic amyloidosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal disease in amyloidosis results from either mucosal infiltration or neuromuscular infiltration. In addition, an extrinsic autonomic neuropathy may also affect gut function.",
"   </p>",
"   <p>",
"    In general, histopathological patterns of amyloid deposition are associated with clinical and endoscopic features. Amyloid deposition in the muscularis mucosae, submucosa, and muscularis propria are the dominant patterns in AL amyloidosis, leading to polypoid protrusions and thickening of the valvulae conniventes, whereas granular amyloid deposition mainly in the mucosa occurs in AA amyloidosis, resulting in the fine granular appearance, mucosal friability, and erosions. As a result, AL amyloidosis usually presents with constipation, mechanical obstruction, or chronic intestinal pseudo-obstruction, while AA amyloidosis presents with diarrhea and malabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Mucosal infiltration",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the gastrointestinal tract is affected, the most common sites of infiltration are the descending duodenum (100 percent), the stomach and colorectum (more than 90 percent), and the esophagus (about 70 percent) (",
"    <a class=\"graphic graphic_picture graphicRef81395 graphicRef73928 graphicRef58003 \" href=\"UTD.htm?33/16/34058\">",
"     picture 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/9\">",
"     9",
"    </a>",
"    ]. Affected patients may present with nausea, vomiting, gastrointestinal bleeding, malabsorption, or, rarely, obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/6,10,11\">",
"     6,10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The endoscopic appearances of amyloidosis include a fine granular appearance, polypoid protrusions, erosions, ulcerations and mucosal friability, and thickening of the wall [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. Occasional patients have nodular or polypoid lesions, which may demonstrate mucosal bridging [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/13\">",
"     13",
"    </a>",
"    ]. Rare patients have tumor-forming deposits of amyloid, called amyloidomas, which can be found in any portion of the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/14\">",
"     14",
"    </a>",
"    ]. There have been several reports of localized amyloidomas of the small intestine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Differentiation of such amyloid masses from malignancy may be facilitated by narrow band imaging during endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Neuromuscular infiltration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuromuscular infiltration initially affects the intrinsic nervous system and results in a neuropathic process [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/18\">",
"     18",
"    </a>",
"    ] that is characterized by normal amplitude but uncoordinated contractions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/19\">",
"     19",
"    </a>",
"    ]. At a later stage, tissue wall infiltration results in a myopathic process with low amplitude contractions (",
"    <a class=\"graphic graphic_waveform graphicRef62577 \" href=\"UTD.htm?38/37/39505\">",
"     waveform 1",
"    </a>",
"    ) that are typically associated with significantly prolonged transit as in certain other systemic disorders such as scleroderma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuropathic and myopathic variants have been demonstrated pathologically and may be related in part to the type of amyloid fibrils [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. One report, for example, evaluated 16 patients with amyloidosis and intestinal pseudo-obstruction (13 with AA, 2 with AL, and one with dialysis-related amyloidosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/21\">",
"     21",
"    </a>",
"    ]. The patients with AA tended to have amyloid deposits in the myenteric plexus without appreciable muscle infiltration; the other patients had diffuse and extensive infiltration and replacement of the muscularis propria throughout the gastrointestinal tract. Why this might occur is not known.",
"   </p>",
"   <p>",
"    Although there have not yet been systematic studies of gastrointestinal motility in patients with amyloidosis, neuromuscular infiltration usually induces stasis syndromes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Gastrointestinal amyloidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with symptomatic gastrointestinal amyloidosis usually present with one of four syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastrointestinal bleeding due to vascular friability or mucosal lesions (ulcers, nodularity or polypoid lesions, shallow ulcers, erosions, submucosal hematomas, and small mucosal hemorrhages) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]. A series of 19 patients with AL amyloidosis and involvement of the gastrointestinal tract suggested that amyloidosis should be suspected in patients with plasma cell dyscrasias who have gastrointestinal bleeding and submucosal hematomas (ranging in size from 5 mm to 3 cm) seen on endoscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic intestinal dysmotility resulting in dilatation of the intestine is more likely in the myopathic, infiltrative stage of the disease. These patients have stasis syndromes such as dysphagia, gastroparesis, constipation, or chronic intestinal pseudo-obstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/18,21\">",
"       18,21",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=see_link\">",
"       \"Etiology and diagnosis of delayed gastric emptying\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/26/2474?source=see_link\">",
"       \"Chronic intestinal pseudo-obstruction\"",
"      </a>",
"      .) Dysmotility leading to rapid intestinal transit may also cause diarrhea [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Malabsorption due to mucosal infiltration or bacterial overgrowth. In one of the largest series that included 19 such patients, the most common clinical features were weight loss (100 percent, median 30 pounds [range 2 to 134 pounds]) and diarrhea and steatorrhea (95 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/29\">",
"       29",
"      </a>",
"      ]. Less common features included anorexia (42 percent), dizziness (32 percent), hypotension or orthostatic changes (53 percent). The median time from symptom onset to diagnosis was seven months; only three patients were diagnosed correctly upon initial presentation. Most patients had evidence of amyloid involvement in other organs. Serum or protein electrophoresis was positive in 95 percent. Median survival was 11 months after histologic diagnosis. Similarly, in a series from Denmark, most patients with gastrointestinal AL amyloidosis experienced weight loss and all had signs of malabsorption. [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Protein-losing gastroenteropathy should be suspected in patients with hypoalbuminemia and edema even in the presence of proteinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/31\">",
"       31",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3881?source=see_link\">",
"       \"Protein-losing gastroenteropathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rarely, amyloid deposition results in obstructing masses or globular deposits [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Deposition at the ampulla of Vater has been reported to result in obstructive suppurative cholangitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A rare form of encapsulating peritonitis causing small bowel obstruction has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/35\">",
"     35",
"    </a>",
"    ]. Extraluminal amyloidoma may result in bowel obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Deposition of &szlig;2-microglobulin (&szlig;2-M) amyloid protein in the blood vessels and interstitium of the gastrointestinal tract has been associated with abdominal pain, visceral perforation, pseudoobstruction, gastric and colonic dilatation, intestinal necrosis, malabsorption, and chronic diarrhea in patients on long-term hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Hepatic amyloidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver involvement can be seen in both AL (primary) and AA (secondary) amyloidosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     AL amyloidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The liver was involved in 70 percent of cases with AL amyloidosis in an autopsy series [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/38\">",
"     38",
"    </a>",
"    ]. Liver involvement is uncommonly associated with significant clinical manifestations. Nevertheless, such patients generally have a poor prognosis, which probably reflects relatively severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Median survival was only nine months (five-year survival of 17 percent) in one of the largest published series of 98 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/41\">",
"     41",
"    </a>",
"    ]. Independent predictors of shortened survival included heart failure, a total bilirubin &gt;2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (34",
"    <span class=\"nowrap\">",
"     micromol/L),",
"    </span>",
"    and a platelet count",
"    <span class=\"nowrap\">",
"     &gt;500,000/microL.",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    following features of primary hepatic amyloidosis were described in that series [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Median age at diagnosis was 59, and 69 percent were men.",
"     </li>",
"     <li>",
"      The most common symptom was involuntary weight loss (72 percent), averaging 10.4 kg. Other symptoms included fatigue (60 percent), abdominal pain (53 percent), anorexia (26 percent), early satiety (19 percent), nausea (15 percent), and dysgeusia (10 percent).",
"     </li>",
"     <li>",
"      The most common physical finding was hepatomegaly (81 percent). Other findings included ascites (42 percent), edema (26 percent), purpura (15 percent), splenomegaly (10 percent) and spider angiomata (7 percent).",
"     </li>",
"     <li>",
"      The most frequently abnormal test of hepatic function was an abnormal serum alkaline phosphatase level (86 percent of patients). Of those with an abnormal level, 61 percent had values of 500",
"      <span class=\"nowrap\">",
"       U/L",
"      </span>",
"      or more. The serum AST was more than twice the upper limit of normal in 37 percent of patients.",
"     </li>",
"     <li>",
"      Many patients had extrahepatic manifestations of amyloidosis (including nephrotic syndrome, heart failure, peripheral neuropathy, orthostatic hypotension, and carpal tunnel syndrome), and the majority (82 percent) had amyloid detected in biopsies of nonhepatic tissue.",
"     </li>",
"     <li>",
"      A liver biopsy was performed in all patients. A concern related to liver biopsy in hepatic amyloidosis is the suggestion from case reports of an increased risk of bleeding",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hepatic rupture following the biopsy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29608?source=see_link\">",
"       \"Percutaneous, fine-needle aspiration, and laparoscopic liver biopsy\"",
"      </a>",
"      .) Four patients developed bleeding two of whom required blood transfusions. No cases of hepatic rupture were observed. Amyloid deposition was solely sinusoidal in 66 percent, solely vascular in 13 percent, and both sinusoidal and vascular in 21 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     AA amyloidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical features of hepatic involvement in secondary amyloidosis are similar to those seen in primary amyloidosis. Although histologic differences between AL and AA amyloidosis have been described, there is considerable overlap making the clinical significance of these observations unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. It is important to appreciate that patients with AA amyloidosis may have liver disease related to factors other than amyloid deposition (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    therapy for rheumatoid arthritis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical diagnosis of gastrointestinal amyloidosis can be difficult in patients in whom the presence of amyloidosis has not yet been established. There should clearly be a high index of suspicion in patients with disorders known to be associated with amyloidosis. These include multiple myeloma, a chronic inflammatory disease such as rheumatoid arthritis, and chronic renal failure treated with maintenance dialysis. Amyloidosis should also be suspected when there is involvement of other organs characteristic of systemic amyloid deposition such as the nephrotic syndrome, otherwise unexplained heart failure, or, in dialysis patients, the carpal tunnel syndrome or swollen painful joints, especially in the form of scapulohumeral periarthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/29/13784?source=see_link\">",
"     \"Renal amyloidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/10/23722?source=see_link\">",
"     \"Clinical manifestations and diagnosis of amyloid cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients in whom AL amyloidosis is suspected should be tested for the presence of a monoclonal protein in the serum or urine (Bence Jones proteins). However, even if this is found, the diagnosis should be confirmed by tissue biopsy of duodenal or colorectal mucosa, which is more sensitive than a fat biopsy (",
"    <a class=\"graphic graphic_picture graphicRef81395 graphicRef73928 graphicRef58003 \" href=\"UTD.htm?33/16/34058\">",
"     picture 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. The biopsy should be deep enough to include lamina propria since amyloid birefringence is best identified in the wall of blood vessels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=see_link\">",
"     \"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Radiologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    radiography is of limited diagnostic utility, since the changes that may be seen, such as dilatation of the small bowel or colon, are not specific for amyloidosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77965 \" href=\"UTD.htm?43/11/44223\">",
"     image 1",
"    </a>",
"    ). Nevertheless, in one report the following radiological features were described [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/46\">",
"     46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AA amyloid was associated with a coarse mucosal pattern with innumerable fine granular elevations due to expansion of the lamina propria by amyloid deposits.",
"     </li>",
"     <li>",
"      AL amyloid was associated with polypoid protrusions and thickening of the folds which reflected massive amyloid deposits in the muscularis mucosae and submucosa.",
"     </li>",
"     <li>",
"      Dialysis-related amyloidosis produced a marked delay in transit time and dilatation of the small intestine and colon due to extensive amyloid deposits in the muscularis propria.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A non-neuropathic form of hereditary amyloidosis (Ostertag type amyloidosis) that involves lysozyme can also present with gastrointestinal manifestations or bleeding without evidence of AL or AA (secondary) amyloidoses [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abdominal CT imaging may show wall thickening or bowel dilatation, and rarely mesenteric thickening or adenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/46\">",
"     46",
"    </a>",
"    ]. Radiologic findings of hepatic involvement are non-specific [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/48\">",
"     48",
"    </a>",
"    ]. Ultrasonographic findings include heterogeneous echogenicity, while CT findings include diffuse or focal regions of decreased parenchymal attenuation with or without extensive calcification. MRI findings include significantly increased signal intensity on T1-weighted images without a significantly altered signal intensity on T2-weighted images; the reason for high signal intensity on T1 is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the gastrointestinal complications can result in significant morbidity, they are not usually the cause of death, which is most often due to renal failure, restrictive cardiomyopathy, or ischemic heart disease. Therapy is directed at symptomatic control of the gastrointestinal manifestations and at the underlying cause of amyloidosis.",
"   </p>",
"   <p>",
"    With respect to symptom control, anecdotal reports suggest that the neuropathic form is more likely to respond to prokinetic agents, while those who are malnourished or unable to tolerate feeding due to dysmotility may benefit from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no reports specific to treatment of neuropathic dysmotility due to amyloidosis, and recommendations for this problem are based upon extrapolations from patients with chronic idiopathic or secondary pseudo-obstruction. The principles of treatment are: restoration of hydration and nutrition (enteral or parenteral), suppression of bacterial overgrowth, use of prokinetic agents, and antiemetic agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/28/22984?source=see_link\">",
"     prochlorperazine",
"    </a>",
"    5 to 25 mg PO or by suppository).",
"   </p>",
"   <p>",
"    Severe diarrhea and protein loss due to gastrointestinal amyloidosis may respond to glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Diarrhea may at least in part reflect the rapid intestinal transit that has been documented in patients with amyloidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact on gastrointestinal involvement of novel pharmacological approaches to treatment of systemic amyloidosis is unclear. However, there are case reports suggesting benefit of a humanized anti-IL6 receptor antibody [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, treatment of the underlying chronic inflammatory condition has been associated with regression of gastrointestinal amyloid (",
"    <a class=\"graphic graphic_table graphicRef87769 \" href=\"UTD.htm?2/62/3052\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/52\">",
"     52",
"    </a>",
"    ]. With respect to the underlying disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with reactive AA amyloidosis may show stabilization or even improvement if their underlying disease (eg, rheumatoid arthritis, Crohn's disease) can be controlled; this will reduce the production of the amyloid precursor, serum amyloid A. One report documented the successful treatment of small bowel infiltration by amyloidosis in a patient treated with the anti-TNF-alpha agent,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23383?source=see_link\">",
"       \"Treatment of secondary (AA) amyloidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with primary AL amyloidosis may show increased survival by treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/54/22376?source=see_link\">",
"       melphalan",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      . One report documented improved liver and gastrointestinal amyloidosis on treatment with corticosteroids and interferon [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/54\">",
"       54",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35994?source=see_link\">",
"       \"Prognosis and treatment of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Case series have suggested higher response rates and increased survival with autologous stem cell transplantation compared with conventional chemotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/55\">",
"       55",
"      </a>",
"      ]. However, substantial treatment-related toxicity has been observed, including toxic megacolon and other gastrointestinal toxicities. High-dose chemotherapy and stem cell transplantation increase partial response rates and complete response rates predict survival in patients with amyloidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The overall management of gastrointestinal and hepatic amyloidosis should be conducted in collaboration with specialists in hematology and oncology since autologous or allogeneic stem cell transplantation in combination with cytotoxic therapy such as risk-adapted",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/54/22376?source=see_link\">",
"       melphalan",
"      </a>",
"      , steroids, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/63/11257?source=see_link\">",
"       bortezomib",
"      </a>",
"      (a proteasome inhibitor) have the potential to induce responses and, in early cases, to induce complete hematological response and organ improvement [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/55-59\">",
"       55-59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Liver transplantation offers an effective way to treat the rare familial amyloidotic polyneuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12280/abstract/57\">",
"       57",
"      </a>",
"      ]. The amyloid deposits in this disorder are due to a mutant form of transthyretin (prealbumin) that is produced by the liver. Thus, liver transplantation results in the production of normal transthyretin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Amyloidosis is a generic term that refers to the extracellular tissue deposition of fibrils composed of low molecular weight subunits (5 to 25 kD) of a variety of normal serum proteins which are misfolded. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastrointestinal disease in amyloidosis results from either mucosal infiltration or neuromuscular infiltration. In addition, an extrinsic autonomic neuropathy may also affect gut function (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathology'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      Patients with symptomatic gastrointestinal amyloidosis usually present with one of four syndromes: gastrointestinal bleeding, dysmotility, malabsorption, or protein-losing gastroenteropathy. Rare presentations include an obstructing mass and encapsulating peritonitis causing small bowel obstruction. &szlig;2-microglobulin (&szlig;2-M) amyloidosis can cause abdominal pain, visceral perforation, pseudoobstruction, gastric and colonic dilation, intestinal necrosis, malabsorption, and chronic diarrhea in patients on long-term hemodialysis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Gastrointestinal amyloidosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Liver involvement can be seen in both AL (primary) and AA (secondary) amyloidosis. Patients with hepatic AL amyloidosis are typically older than 50 and more commonly male. The most common symptoms are weight loss, fatigue, and abdominal pain. Most patients have hepatomegaly. The most frequent abnormal liver biochemical test is an elevation in the serum alkaline phosphatase level. Many patients have concurrent extrahepatic manifestations of amyloidosis (such as nephrotic syndrome). Clinical features of AA amyloidosis are similar. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Hepatic amyloidosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical diagnosis of gastrointestinal amyloidosis may be difficult in patients in whom the presence of amyloidosis has not yet been established. There should clearly be a high index of suspicion in patients with disorders known to be associated with amyloidosis. These include multiple myeloma, a chronic inflammatory disease such as rheumatoid arthritis, and chronic renal failure treated with maintenance dialysis. Patients in whom AL amyloidosis is suspected should be tested for the presence of a monoclonal protein in the serum or urine (Bence Jones proteins). However, even if this is found, the diagnosis should be confirmed by tissue biopsy of duodenal or colorectal mucosa, which is more sensitive than a fat biopsy. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the gastrointestinal complications can result in significant morbidity, they are not usually the cause of death, which is most often due to renal failure, restrictive cardiomyopathy, or ischemic heart disease. Therapy is directed at symptomatic control of the gastrointestinal manifestations and at the underlying cause of amyloidosis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/1\">",
"      Nordling E, Abraham-Nordling M. Colonic amyloidosis, computational analysis of the major amyloidogenic species, Serum Amyloid A. Comput Biol Chem 2012; 39:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/2\">",
"      Glenner GG. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med 1980; 302:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/3\">",
"      Westermark P, Bergstr&ouml;m J, Solomon A, et al. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003; 10 Suppl 1:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/4\">",
"      Okuda Y, Takasugi K, Oyama T, et al. [Amyloidosis in rheumatoid arthritis--clinical study of 124 histologically proven cases]. Ryumachi 1994; 34:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/5\">",
"      Wang AK, Fealey RD, Gehrking TL, Low PA. Patterns of neuropathy and autonomic failure in patients with amyloidosis. Mayo Clin Proc 2008; 83:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/6\">",
"      Menke DM, Kyle RA, Fleming CR, et al. Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc 1993; 68:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/7\">",
"      Ueda M, Horibata Y, Shono M, et al. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study. Mod Pathol 2011; 24:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/8\">",
"      Tada S, Iida M, Yao T, et al. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest Endosc 1994; 40:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/9\">",
"      Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc 1990; 36:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/10\">",
"      Reddy MB, Poppers DM, Uram-Tuculescu C. Recurrent obscure gastrointestinal bleeding in a patient with gastric amyloid. Clin Gastroenterol Hepatol 2009; 7:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/11\">",
"      Kim SH, Kang EJ, Park JW, et al. Gastrointestinal amyloidosis presenting with multiple episodes of gastrointestinal bleeding. Cardiovasc Intervent Radiol 2009; 32:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/12\">",
"      Bighi S, Trevisani L, Lupi L, et al. Amyloidosis of the gastric stump: radiographic and CT findings. Gastrointest Radiol 1990; 15:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/13\">",
"      Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008; 135:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/14\">",
"      Kahi CJ, Vakili S, Liepnieks JJ, Benson M. Amyloidoma of the esophagus. Am J Gastroenterol 2007; 102:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/15\">",
"      Saindane AM, Losada M, Macari M. Focal amyloidoma of the small bowel mimicking adenocarcinoma on CT. AJR Am J Roentgenol 2005; 185:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/16\">",
"      Peny MO, Debongnie JC, Haot J, Van Gossum A. Localized amyloid tumor in small bowel. Dig Dis Sci 2000; 45:1850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/17\">",
"      Hui YT, Lam TW, Yee Lam PW, et al. Narrow-band imaging system with magnifying endoscopy for rectal amyloidosis. Gastrointest Endosc 2008; 68:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/18\">",
"      Battle WM, Rubin MR, Cohen S, Snape WJ Jr. Gastrointestinal-motility dysfunction in amyloidosis. N Engl J Med 1979; 301:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/19\">",
"      Camilleri M, Malagelada JR, Stanghellini V, et al. Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology 1985; 88:1852.",
"     </a>",
"    </li>",
"    <li>",
"     Malagelada JR, Camilleri M, Stanghellini V. Manometric Diagnosis of Gastrointestinal Motility Disorders, Thieme Medical Publishers, New York 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/21\">",
"      Tada S, Iida M, Yao T, et al. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut 1993; 34:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/22\">",
"      Tada S, Iida M, Yao T, et al. Gastrointestinal amyloidosis: radiologic features by chemical types. Radiology 1994; 190:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/23\">",
"      Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 2008; 103:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/24\">",
"      Petre S, Shah IA, Gilani N. Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy. Aliment Pharmacol Ther 2008; 27:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/25\">",
"      Chang HS, Myung SJ, Yang SK, et al. Massive small bowel bleeding in a patient with amyloidosis. Gastrointest Endosc 2004; 59:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/26\">",
"      James DG, Zuckerman GR, Sayuk GS, et al. Clinical recognition of Al type amyloidosis of the luminal gastrointestinal tract. Clin Gastroenterol Hepatol 2007; 5:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/27\">",
"      Cowan AJ, Skinner M, Seldin DC, et al. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica 2013; 98:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/28\">",
"      Guirl MJ, H&ouml;genauer C, Santa Ana CA, et al. Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am J Gastroenterol 2003; 98:2219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/29\">",
"      Hayman SR, Lacy MQ, Kyle RA, Gertz MA. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med 2001; 111:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/30\">",
"      Madsen LG, Gimsing P, Schi&oslash;dt FV. Primary (AL) amyloidosis with gastrointestinal involvement. Scand J Gastroenterol 2009; 44:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/31\">",
"      Suzuki C, Higaki S, Nishiaki M, et al. 99mTc-HSA-D scintigraphy in the diagnosis of protein-losing gastroenteropathy due to secondary amyloidosis. J Gastroenterol 1997; 32:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/32\">",
"      Baldewijns M, Ectors N, Verbeeck G, et al. Intermittent subobstruction and cholestasis as complications of duodenal amyloid tumours. Gastroenterol Clin Biol 1995; 19:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/33\">",
"      Hemmer PR, Topazian MD, Gertz MA, Abraham SC. Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis. Am J Surg Pathol 2007; 31:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/34\">",
"      Yoshiki Y, Yamamoto G, Takazawa Y, et al. AL amyloidosis with severe gastrointestinal invasion and acute obstructive suppurative cholangitis. Ann Hematol 2012; 91:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/35\">",
"      Jones J, VanRosendaal G, Cleary C, et al. Primary amyloidosis presenting as small bowel encapsulation. Can J Gastroenterol 2004; 18:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/36\">",
"      Willson TD, Bird J, Azizi R, et al. Extraluminal amyloidoma of the pelvic cavity causing large bowel obstruction. Case Rep Gastroenterol 2011; 5:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/37\">",
"      Dulgheru EC, Balos LL, Baer AN. Gastrointestinal complications of beta2-microglobulin amyloidosis: a case report and review of the literature. Arthritis Rheum 2005; 53:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/38\">",
"      Buck FS, Koss MN. Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol 1991; 22:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/39\">",
"      Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 1988; 85:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/40\">",
"      Levy M, Fryd CH, Eliakim M. Intrahepatic obstructive jaundice due to amyloidosis of the liver. A case report and review of the literature. Gastroenterology 1971; 61:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/41\">",
"      Park MA, Mueller PS, Kyle RA, et al. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 2003; 82:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/42\">",
"      Chopra S, Rubinow A, Koff RS, Cohen AS. Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 1984; 115:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/43\">",
"      Looi LM, Sumithran E. Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis. Hum Pathol 1988; 19:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/44\">",
"      Yamada M, Hatakeyama S, Tsukagoshi H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum Pathol 1985; 16:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/45\">",
"      Breedveld FC, Markusse HM, MacFarlane JD. Subcutaneous fat biopsy in the diagnosis of amyloidosis secondary to chronic arthritis. Clin Exp Rheumatol 1989; 7:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/46\">",
"      Araoz PA, Batts KP, MacCarty RL. Amyloidosis of the alimentary canal: radiologic-pathologic correlation of CT findings. Abdom Imaging 2000; 25:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/47\">",
"      Granel B, Valleix S, Serratrice J, et al. Lysozyme amyloidosis: report of 4 cases and a review of the literature. Medicine (Baltimore) 2006; 85:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/48\">",
"      Kim SH, Han JK, Lee KH, et al. Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol 2003; 58:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/49\">",
"      Fushimi T, Takahashi Y, Kashima Y, et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid 2005; 12:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/50\">",
"      Shin JK, Jung YH, Bae MN, et al. Successful treatment of protein-losing enteropathy due to AA amyloidosis with octreotide in a patient with rheumatoid arthritis. Mod Rheumatol 2013; 23:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/51\">",
"      Okuda Y, Takasugi K. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum 2006; 54:2997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/52\">",
"      Kuroda T, Otaki Y, Sato H, et al. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab. Rheumatol Int 2008; 28:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/53\">",
"      Lee CK, Park JY, Shim JJ, Jang JY. Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis. Endoscopy 2011; 43 Suppl 2 UCTN:E326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/54\">",
"      Dhodapkar MV, Jagannath S, Vesole D, et al. Treatment of AL-amyloidosis with dexamethasone plus alpha interferon. Leuk Lymphoma 1997; 27:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/55\">",
"      Gertz MA, Lacy MQ, Dispenzieri A. Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report. Bone Marrow Transplant 2000; 25:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/56\">",
"      Gertz MA, Lacy MQ, Dispenzieri A, et al. Transplantation for amyloidosis. Curr Opin Oncol 2007; 19:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/57\">",
"      Suhr OB, Holmgren G, Steen L, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/58\">",
"      Mejhert M, Hast R, Sandstedt B, Janczewska I. Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract. BMJ Case Rep 2011; 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12280/abstract/59\">",
"      Landau H, Hassoun H, Rosenzweig MA, et al. Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis. Leukemia 2012.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2642 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-2F5800EE8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12280=[""].join("\n");
var outline_f11_63_12280=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1467472912\">",
"      PREVALENCE OF GASTROINTESTINAL AMYLOIDOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Mucosal infiltration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Neuromuscular infiltration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Gastrointestinal amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hepatic amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - AL amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - AA amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Radiologic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2642\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2642|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/11/44223\" title=\"diagnostic image 1\">",
"      Amyloidosis of small bowel UGI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2642|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/31/41462\" title=\"picture 1A\">",
"      Duodenal amyloid HandE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/18/5410\" title=\"picture 1B\">",
"      Duodenal amyloid Congo red",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/58/34725\" title=\"picture 1C\">",
"      Amyloid high power HandE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2642|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/62/3052\" title=\"table 1\">",
"      Reducing the supply of fibril precursors in systemic amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2642|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/37/39505\" title=\"waveform 1\">",
"      Gastrointestinal manometry in amyloidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33000?source=related_link\">",
"      Causes and diagnosis of secondary (AA) amyloidosis and relation to rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/26/2474?source=related_link\">",
"      Chronic intestinal pseudo-obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/10/23722?source=related_link\">",
"      Clinical manifestations and diagnosis of amyloid cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=related_link\">",
"      Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5609?source=related_link\">",
"      Dialysis-related amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=related_link\">",
"      Etiology and diagnosis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35815?source=related_link\">",
"      Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/24/30086?source=related_link\">",
"      Pathogenesis of secondary (AA) amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29608?source=related_link\">",
"      Percutaneous, fine-needle aspiration, and laparoscopic liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35994?source=related_link\">",
"      Prognosis and treatment of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3881?source=related_link\">",
"      Protein-losing gastroenteropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/29/13784?source=related_link\">",
"      Renal amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23383?source=related_link\">",
"      Treatment of secondary (AA) amyloidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_63_12281="Acute tinea pedis";
var content_f11_63_12281=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54214%7EPC%2F62902%7EDERM%2F82787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54214%7EPC%2F62902%7EDERM%2F82787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute tinea pedis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The medial aspect of the left great toe demonstrates erythematous, papulo-vesicular lesions caused by Trichophyton mentagrophytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John T Crissey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute tinea pedis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 290px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vesicles and bullae are present on the plantar foot in this patient with acute tinea pedis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous tinea pedis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12281=[""].join("\n");
var outline_f11_63_12281=null;
var title_f11_63_12282="Management of pediatric dyslipidemia";
var content_f11_63_12282=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of pediatric dyslipidemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/63/12282/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12282/contributors\">",
"     Sarah D de Ferranti, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12282/contributors\">",
"     Jane W Newburger, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/63/12282/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12282/contributors\">",
"     David R Fulton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/63/12282/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/63/12282/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/63/12282/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 23, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H895972\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyslipidemias are disorders of lipoprotein metabolism that may result in the following abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High total cholesterol (TC)",
"     </li>",
"     <li>",
"      High low-density lipoprotein cholesterol (LDL-C)",
"     </li>",
"     <li>",
"      Low high-density lipoprotein cholesterol (HDL-C)",
"     </li>",
"     <li>",
"      High non-HDL-C",
"     </li>",
"     <li>",
"      High triglycerides (TG)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In adults, dyslipidemia, especially elevated LDL-C, is an established risk factor for cardiovascular disease (CVD) and correcting dyslipidemia reduces the risk of CVD. The effect of treatment rises as the risk of CVD increases, with the greatest benefit in adults with known coronary heart disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=see_link\">",
"     \"Lipoprotein classification; metabolism; and role in atherosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atherosclerosis begins in childhood and adolescence, and pediatric dyslipidemia contributes to early atherosclerosis and by extension to premature CVD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. Although there are limited pediatric outcome data, treatment of children with severe dyslipidemia due to homozygous hypercholesterolemia, who are at high risk for CVD during childhood, appears to reduce the risk of premature atherosclerosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link&amp;anchor=H4#H4\">",
"     \"Inherited disorders of LDL-cholesterol metabolism\", section on 'Familial hypercholesterolemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although long-term outcome data are not available for the general pediatric population, it is reasonable to assume based on evidence from adult studies and limited pediatric data that timely intervention to decrease and possibly eliminate dyslipidemia in children may decelerate the atherosclerotic process, which would prevent or delay the onset of CVD. As a result, identifying children with dyslipidemia and successfully improving their lipid profile may reduce their risk of accelerated atherosclerosis and premature CVD. In addition, population-based measures to promote healthy lifestyle, such as reducing dietary trans fat, may play an important role in reducing pediatric dyslipidemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/48/25352?source=see_link&amp;anchor=H1258262#H1258262\">",
"     \"Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children\", section on 'Promotion of healthy lifestyle'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of dyslipidemia in children will be reviewed here. The association between pediatric dyslipidemia and atherosclerosis, definition of pediatric dyslipidemia, and screening to identify children with lipid disorders is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=see_link\">",
"     \"Definition and screening for dyslipidemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894519\">",
"    <span class=\"h1\">",
"     RATIONALE FOR INTERVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rationale for initiating therapy to control lipid disorders in children and adolescents is based upon increasing evidence that pediatric dyslipidemia (particularly elevated LDL-C) contributes to premature atherosclerosis and the early development of cardiovascular disease (CVD) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=see_link&amp;anchor=H728055#H728055\">",
"     \"Definition and screening for dyslipidemia in children\", section on 'Association between pediatric dyslipidemia and atherosclerosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, there are data in a select population of children with severe dyslipidemia that suggest treatment decelerates the atherosclerosis process as assessed by indirect measures.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of pediatric patients with heterozygous familial hypercholesterolemia (FH), patients treated with a low saturated-fat diet and statin therapy had regression in carotid intima-mediated thickness (cIMT, an indirect measure of atherosclerosis), while control patients treated with a standard diet and placebo therapy demonstrated the expected progression of increased cIMT [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/2\">",
"       2",
"      </a>",
"      ]. In a follow-up report, earlier initiation of statin therapy correlated with smaller increases in cIMT suggesting that earlier intervention delayed progression of atherosclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study of children with FH, statin therapy was associated with improved endothelial function (assessed by flow-mediated dilation [FMD], another indirect measurement of atherosclerosis) compared with patients who received placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/4\">",
"       4",
"      </a>",
"      ]. FMD measurements in statin-treated patients approached the level of normal control children without FH.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In children with FH, evidence from a systematic review of nine randomized placebo controlled trials has shown that the use of statin therapy is effective in reducing low-density lipoprotein cholesterol (LDL-C) levels and was not associated with significant adverse effects (ie, hepatic and muscular toxicity and effects on sexual development) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/5\">",
"     5",
"    </a>",
"    ]. Of note, however, these trials were not designed to detect very rare or long-term adverse effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link&amp;anchor=H4#H4\">",
"     \"Inherited disorders of LDL-cholesterol metabolism\", section on 'Familial hypercholesterolemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No randomized clinical trials have demonstrated treating dyslipidemia in the general pediatric population reduces the risk of premature CVD. Several United States (US) major organizations (American Heart Association [AHA], American Academy of Pediatrics [AAP], and the National Cholesterol Education Program [NCEP]) and an expert panel sponsored by the US National Heart, Lung, and Blood Institute (NHLBI) concluded that intervention in children with significant dyslipidemia is warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1,6-9\">",
"     1,6-9",
"    </a>",
"    ]. This approach is based on the premise that many of these children are likely to have FH, and the belief that the consequences of elevated LDL in non-FH patients are likely to contribute to accelerated atherosclerosis and CVD.",
"   </p>",
"   <p>",
"    <br/>",
"    Because there is a lack of direct evidence linking drug treatment with a reduction in CVD, some question the risk-benefit of pharmacologic therapy in children with dyslipidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H894554\">",
"     'Rationale and criteria for pharmacologic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86020196\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for dyslipidemia includes both nonpharmacologic and pharmacologic interventions. Management decisions are dependent upon the severity of dyslipidemia, and the presence of other cardiovascular disease (CVD) risk factors; lifestyle modification is nearly always the primary approach of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894526\">",
"    <span class=\"h1\">",
"     NONPHARMACOLOGIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonpharmacologic therapy, also referred to as lifestyle modification, includes dietary interventions, elimination of smoke exposure, and increased activity, which can improve lipid profiles. In most pediatric patients with dyslipidemia, a trial of lifestyle modification is implemented before pharmacologic therapy is considered.",
"   </p>",
"   <p>",
"    An observational study that tracked blood lipid levels of children starting at age 9, 12, and 15 years through young adulthood demonstrated adult lipid levels were influenced by lifestyle choices [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/11\">",
"     11",
"    </a>",
"    ]. As an example, weight control and exercise were associated with improved lipid levels in individuals with pediatric dyslipidemia. In contrast, increase in adiposity, and continuation or commencement of smoking from childhood to adulthood were associated with adult dyslipidemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894533\">",
"    <span class=\"h2\">",
"     Dietary modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary interventions can modestly improve abnormal lipid levels in healthy children and those with dyslipidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/48/25352?source=see_link&amp;anchor=H1258283#H1258283\">",
"     \"Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children\", section on 'Nutrition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diet modifications are dependent on the underlying lipid disorder.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reduction of low-density lipoprotein cholesterol (LDL-C) &ndash; Low saturated-fat diet has been shown to modestly reduce LDL-C and total cholesterol. In addition, plant sterol or stanol esters may enhance LDL-C lowering effects in children with familial hypercholesterolemia.",
"     </li>",
"     <li>",
"      Reduction of triglycerides (TG) &ndash; Reduced intake of simple carbohydrate intake and weight loss can reduce TG levels. Omega-3 fatty acids supplementation or an increase in fish intake may also reduce TG levels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Dietary counseling should be tailored to the patient and",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    family. Behavior modification and motivational interviewing techniques may be helpful. Support and lifestyle modification for the whole family is usually necessary for successful change in the child.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86011050\">",
"    <span class=\"h3\">",
"     Hypercholesteremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary dietary modification for children with elevated total cholesterol (TC) and LDL-C is reduced intake of total and saturated fat, and cholesterol. In addition, dietary supplements (eg, plant sterols and stanol esters) may also be effective.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86011086\">",
"    <span class=\"h4\">",
"     Low saturated-fat diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several American societies (ie, AHA, NCEP, and AAP), and the NHLBI sponsored expert panel recommend that children with elevated LDL-C levels be placed on a diet that limits total and saturated fat, and cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1,7-9,12\">",
"     1,7-9,12",
"    </a>",
"    ]. There is good evidence that a diet that limits the total fat intake to 30 percent of total calories, saturated fat to 7 to 10 percent of total calories, and dietary cholesterol to less than 300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    reduces the levels of TC and LDL-C in healthy children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/48/25352?source=see_link&amp;anchor=H1258283#H1258283\">",
"     \"Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children\", section on 'Nutrition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A more restricted diet has been shown to effectively reduce LDL-C in children with dyslipidemia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In prepubertal children with familial hypercholesterolemia (FH), a restricted diet for one year of total fat (23 &plusmn; 5 percent of total calories) and saturated fat (8 &plusmn; 2 percent of total calories), and cholesterol (67 &plusmn; 28",
"      <span class=\"nowrap\">",
"       mg/1000",
"      </span>",
"      kcal) lowered TC, and LDL-C levels by 4 and 5.5 percent; there was no statistically significant difference in HDL or TG levels [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of prepubertal children (age range 8 to 10 years) with LDL-C levels between the 80",
"      <sup>",
"       th",
"      </sup>",
"      and 98",
"      <sup>",
"       th",
"      </sup>",
"      percentile for age and sex, children who were assigned a restricted diet, (total fat intake to 28 percent of total calories, saturated fat &lt;8 percent of total calories, and total cholesterol to 75",
"      <span class=\"nowrap\">",
"       mg/1000",
"      </span>",
"      kcal per day) had a larger reduction of LDL-C levels than standard care controls (15.4 versus 11.9",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [0.40 versus 0.31",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      over a three-year period [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/14\">",
"       14",
"      </a>",
"      ]. There were no statistically significant differences in TC, HDL-C, and TG levels between the two groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In 2011, an expert panel sponsored by the United States NHLBI reviewed the available data regarding the status of cardiovascular health and risk reduction in children and adolescents. Based on their review of the literature, the following staged dietary recommendations for pediatric patients with hypercholesteremia defined as a LDL-C &gt;130",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.4",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    were published: [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the child has not been on a low saturated-fat diet designed for healthy children, the patient is placed on an initial diet that limits total fat intake to 30 percent of total calories, saturated fat between 7 and 10 percent, and total cholesterol to 300 mg per day (",
"      <a class=\"graphic graphic_table graphicRef78256 \" href=\"UTD.htm?3/49/3870\">",
"       table 1",
"      </a>",
"      ). Implementation should be guided by a registered dietician.",
"     </li>",
"     <li>",
"      If fasting lipid levels continue to exceed the therapeutic target after a three month trial of the above initial diet, a more restricted diet that limits total fat to 25 to 30 percent of total calories, saturated fat &le;7 percent of total calories, and cholesterol &lt;200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      is recommended (",
"      <a class=\"graphic graphic_table graphicRef53962 \" href=\"UTD.htm?32/37/33371\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In our practice, we generally place children on the less restrictive diet that limits total intake to 30 percent of total calories because adherence to the more restrictive diet is difficult and may foster noncompliance and stress between the child and parents. We emphasize the intake of &ldquo;good&rdquo; fats (mono and poly unsaturated fats) as a substitute for saturated and trans fats because of their beneficial effects on cardiovascular health.",
"   </p>",
"   <p>",
"    In children with severe dyslipidemia (LDL-C &gt;190",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.9",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    diet modification alone is rarely sufficient to reach target levels for LDL-C. (See",
"    <a class=\"local\" href=\"#H894554\">",
"     'Rationale and criteria for pharmacologic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894540\">",
"    <span class=\"h4\">",
"     Dietary supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary supplementation with plant stanols and sterols appears to enhance a reduction in LDL-C in conjunction with a low saturated-fat diet [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. The benefit of other supplements (eg, fiber) to reduce LDL-C is less clear. The following is a summary of these supplements, which are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H14#H14\">",
"     \"Lipid lowering with diet or dietary supplements\", section on 'Fiber'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H8#H8\">",
"     \"Lipid lowering with diet or dietary supplements\", section on 'Plant sterols'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plant stanols and sterols &ndash; In adults, placement of these compounds in margarine, orange juice, yogurt drinks, cereal bars, and dietary supplements, have been shown to reduce dietary cholesterol by 5 to 10 percent. One study in healthy children showed that a mean intake 1.8",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      of plant sterol contained in a margarine product reduced serum LDL-C by 8 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/15\">",
"       15",
"      </a>",
"      ]. In children with familial hypercholesterolemia, clinical trials have shown that both stanols and sterol esters decrease TC and LDL-C levels [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/16-18\">",
"       16-18",
"      </a>",
"      ]. Although stanols and sterols reduce serum LDL levels, there are no data demonstrating they reduce the risk of atherosclerosis or early cardiovascular disease (CVD) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. Stanols and sterols decrease absorption of fat-soluble vitamins and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"       beta-carotene",
"      </a>",
"      . Children taking these supplements should take a daily multivitamin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H8#H8\">",
"       \"Lipid lowering with diet or dietary supplements\", section on 'Plant sterols'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fiber &ndash; Data vary on whether increased fiber intake can reduce serum LDL-C [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1,7\">",
"       1,7",
"      </a>",
"      ]. Fiber is thought to bind with cholesterol within bile acids, thus removing it from the enterohepatic circulation. Supplemental fiber is usually required as a daily dose of 6 grams for children ages 2 to 12 years and 12 grams for children ages 12 years and older. In our practice, we prefer that children consume fiber from dietary sources (eg, fruit, vegetables, and whole grains) and generally do not recommend fiber supplements. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H14#H14\">",
"       \"Lipid lowering with diet or dietary supplements\", section on 'Fiber'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other supplements &ndash; Other supplements, such as garlic, are not effective. Red Yeast rice extract, as it contains monacolins that have statin-like activity, has been shown to lower cholesterol in adults. However, we do not recommend its use because the amount of monacolins a child would be exposed to is unknown and unregulated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H4#H4\">",
"       \"Lipid lowering with diet or dietary supplements\", section on 'Red yeast rice'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86011519\">",
"    <span class=\"h3\">",
"     Hypertriglyceridemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most patients, significant decreases in elevated TG will occur with weight loss, diet modification, and fish oil (omega-3 fatty acid) supplementation. However, a high TG by itself is not a major CVD risk factor.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Significant decreases in TG and increases LDL-C levels were observed with small amounts of weight loss in",
"      <span class=\"nowrap\">",
"       overweight/obese",
"      </span>",
"      children and adolescents [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/21-24\">",
"       21-24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Data in adults and several pediatric studies have shown that a reduction of simple carbohydrates, particularly in conjunction with weight loss, results in reduced TG levels [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=see_link&amp;anchor=H723637349#H723637349\">",
"       \"Approach to the patient with hypertriglyceridemia\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Data in adults have demonstrated dietary and supplemental fish oil containing omega-3 fatty acids lower serum TG levels (in particular, eicosapentaenoic acid and docosahexaenoic acid). Similar data are lacking in children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H2#H2\">",
"       \"Lipid lowering with diet or dietary supplements\", section on 'Fish oil and omega-3 fatty acids'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36330?source=see_link&amp;anchor=H3#H3\">",
"       \"Fish oil and marine omega-3 fatty acids\", section on 'Effects on cardiovascular risk factors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based on the above data, the NHLBI sponsored panel recommended nonpharmacologic interventions for children with elevated TG include weight loss, and a reduction of simple carbohydrate intake (",
"    <a class=\"graphic graphic_table graphicRef61553 \" href=\"UTD.htm?24/20/24907\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. If the child is obese, weight reduction is particularly important so that interventions should focus on decreased caloric intake and increased daily activity. In addition, an increase in dietary fish is recommended, thereby increasing the intake of omega-3 fatty acids.",
"   </p>",
"   <p>",
"    In our practice, we recommend a trial of omega-3 fatty acid supplementation (dose of 2 to 4 g per day) for patients with extremely elevated serum TG (600 to 1000",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    Omega-3 fatty acid is given in conjunction with fibrate therapy or as a substitute if fibrates are not tolerated. (See",
"    <a class=\"local\" href=\"#H86017603\">",
"     'Fibric acid derivatives'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894547\">",
"    <span class=\"h2\">",
"     Activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence in both adults and children demonstrate that daily vigorous activity and reduction in sedentary behavior are associated with lower risk of CVD and better fasting lipid profiles. It is unclear whether this is an independent association or whether it&rsquo;s mediated by weight loss. Children with dyslipidemia should participate in at least as much daily physical activity as recommended for the general pediatric population (",
"    <a class=\"graphic graphic_table graphicRef75748 \" href=\"UTD.htm?20/10/20653\">",
"     table 4",
"    </a>",
"    ). Physical activity and cardiovascular health in children and adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/48/25352?source=see_link&amp;anchor=H5129625#H5129625\">",
"     \"Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children\", section on 'Physical activity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894554\">",
"    <span class=\"h1\">",
"     RATIONALE AND CRITERIA FOR PHARMACOLOGIC THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86012511\">",
"    <span class=\"h2\">",
"     Background",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical trials in adults with hypercholesterolemia demonstrate statin therapy lowers low-density lipoprotein cholesterol (LDL-C) and reduces coronary artery disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/50/19240?source=see_link\">",
"     \"Clinical trials of cholesterol lowering for primary prevention of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several clinical trials in children with familial hypercholesterolemia (FH) show that statin therapy, compared with placebo, decreases serum low-density lipoprotein cholesterol (LDL-C) without significant adverse side effects over several years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/2-5,27-32\">",
"     2-5,27-32",
"    </a>",
"    ]. Specifically, there was no adverse effect on growth, neurodevelopment, and sexual maturation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/5\">",
"     5",
"    </a>",
"    ]. Duration of follow-up has been insufficient to prove statin therapy during childhood lowers the risk of future cardiovascular disease (CVD). However, measures of preclinical atherosclerosis (eg, carotid intima-media thickness, flow mediated dilation) suggest statin therapy slows the progression of subclinical atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies of patients who have undergone cardiac transplantation also demonstrated that statin therapy was an effective and safe intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In two studies, the use of statin therapy compared with no statin therapy reduced total cholesterol (TC) and decreased the incidences of cardiac transplant vasculopathy and mortality. In one study, no significant side effects of statin therapy were noted during the eight-year observation period [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon the above findings, the use of statin therapy to treat children with significant dyslipidemia has been advocated by the AHA, AAP, and the NHLBI expert panel [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Others point to the lack of evidence that long-term, perhaps life-long drug treatment in young children reduces premature CVD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/10\">",
"     10",
"    </a>",
"    ]. In one commentary, the authors point to the potential pitfalls of using lipid levels as a surrogate marker for CVD, since not all individuals with dyslipidemia go on to develop CVD events. In addition, given the known, albeit uncommon, adverse effects of statin, the primary drug class used to treat pediatric dyslipidemia, they suggest the short-term risk-benefit ratio is not favorable for the initiation of therapy, and the long-term risk-benefit ratio is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894561\">",
"    <span class=\"h2\">",
"     NHLBI expert panel criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the 2011 NHLBI expert panel report, the following age-based recommendations for pharmacotherapy in children with dyslipidemia were based on review of the available literature [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. These recommendations caution that when medication is prescribed, it needs to occur in the context of a complete assessment of the cardiovascular risk profile of the patient and in consultation with the patient and the family.",
"   </p>",
"   <p>",
"    The decision to begin pharmacotherapy is based on the average results of two fasting lipid profiles that are obtained between two weeks and three months apart. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=see_link&amp;anchor=H86015453#H86015453\">",
"     \"Definition and screening for dyslipidemia in children\", section on 'Confirmation testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86015013\">",
"    <span class=\"h3\">",
"     Children below 10 years of age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy should",
"    <strong>",
"     not",
"    </strong>",
"    be used in children less than 10 years of age unless they have a severe primary hyperlipidemia or a high-risk CVD condition [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. These rare conditions are associated with serious morbidity and include homozygous FH (LDL-C levels &gt;400",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [10.4",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    severe heterozygous FH, and primary hypertriglyceridemia (triglycerides [TG] &gt;500",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [5.6",
"    <span class=\"nowrap\">",
"     mmol/L]).",
"    </span>",
"    These patients should be referred to a pediatric lipid specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86015141\">",
"    <span class=\"h3\">",
"     Children &ge;10 years of age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy of older children with significantly elevated LDL-C or TG is generally initiated when dietary measures fail to achieve target levels and additional CVD risk factors are present [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86016429\">",
"    <span class=\"h4\">",
"     CVD risk factors and conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The age-based NHLBI recommendations are dependent on the presence and severity of CVD risks and conditions defined as follows (",
"    <a class=\"graphic graphic_algorithm graphicRef54963 \" href=\"UTD.htm?0/45/726\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CVD risk factors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      High level factors include hypertension requiring drug therapy (ie, blood pressure &ge;99",
"      <sup>",
"       th",
"      </sup>",
"      percentile + 5 mmHg), current cigarette smoker, and body mass index (BMI) &ge;97",
"      <sup>",
"       th",
"      </sup>",
"      percentile.",
"     </li>",
"     <li>",
"      Moderate level factors include hypertension not requiring drug therapy, BMI &ge;95",
"      <sup>",
"       th",
"      </sup>",
"      and &lt;97",
"      <sup>",
"       th",
"      </sup>",
"      percentile, and high-density lipoprotein cholesterol (HDL-C) &lt;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conditions with an increased risk of CVD",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      High-risk conditions include type 1 and 2 diabetes mellitus, chronic kidney disease, heart transplant recipients, and Kawasaki disease with current coronary aneurysms.",
"     </li>",
"     <li>",
"      Moderate-risk conditions include Kawasaki disease with regressed coronary aneurysms, chronic inflammatory diseases (eg, systemic lupus erythematosus, juvenile rheumatoid arthritis), human immunodeficiency virus (HIV) infection, and nephrotic syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86015195\">",
"    <span class=\"h4\">",
"     Hypercholesteremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management decisions for hypercholesteremia are dependent on the level of LDL-C and the presence and severity of additional CVD risk factors. [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H86016429\">",
"     'CVD risk factors and conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with LDL-C &gt;250",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (6.5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      should be referred to a pediatric lipid specialist as it is likely that they have a severe primary hyperlipidemia condition (eg, familial hypercholesteremia) or a high-risk CVD condition.",
"     </li>",
"     <li>",
"      Children with LDL-C between 130 and 250",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.4 and 6.5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      are initially treated with a low-saturated fat diet and increased daily activity (see",
"      <a class=\"local\" href=\"#H894526\">",
"       'Nonpharmacologic therapy'",
"      </a>",
"      above). After a six-month trial of",
"      <span class=\"nowrap\">",
"       lifestyle/diet",
"      </span>",
"      management, pharmacotherapy is considered based on the persistently elevated LDL-C and the presence of CVD risk factors or condition as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      LDL-C &ge;190",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.9",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      without additional CVD risk factors.",
"     </li>",
"     <li>",
"      LDL-C &ge;160",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.1",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and &lt;190",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.9",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and",
"      <strong>",
"       one",
"      </strong>",
"      of the following conditions: (1) a family history of premature CVD (defined as a heart attack, treated angina, interventions for coronary artery disease, stroke, or sudden cardiac disease in a male parent, grandparent, uncle, or sibling before 55 years of age, or a female parent, grandparent, aunt, or sibling before 65 years of age), (2) one high-level CVD risk factor or condition,",
"      <strong>",
"       or",
"      </strong>",
"      (3) two moderate-level risk factors or conditions. If there are no risk factors, patients are maintained on a low-saturated fat diet, and continued monitoring of lipid levels and onset of other CVD risk factors.",
"     </li>",
"     <li>",
"      LDL-C is &ge;130",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.4",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and &lt;160",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.1",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and two high-risk CVD factors or conditions, or one high-risk and two moderate-risk CVD factors or conditions.",
"      <br/>",
"      <br/>",
"      If there are no additional risk factors, patients are maintained on a low-saturated fat diet, and continued monitoring of lipid levels and onset of other CVD risk factors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based on the above criteria for treatment, less than one percent of adolescents in the United States would qualify for pharmacological treatment. Specifically National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2000 showed only 0.8 percent of the 7180 adolescents between 12 and 17 years of age met the AAP criteria for pharmacologic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/35\">",
"     35",
"    </a>",
"    ]. Of these 26 patients, 11 had LDL-C greater than 190",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and the remaining 15 had LDL-C greater than 160",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    and at least one risk factor (obesity, diabetes, hypertension, cigarette smoking, and a positive family history). Overall, 6.6 percent of the group had elevated LDL-C levels (defined as &gt;130",
"    <span class=\"nowrap\">",
"     mg/dL),",
"    </span>",
"    and 9.6 had elevated total cholesterol (defined as &gt;200",
"    <span class=\"nowrap\">",
"     mg/dL).",
"    </span>",
"    The low number of children eligible for treatment based on the AAP guidelines is intentional, and is related to the lack of long-term efficacy and safety data. Nevertheless, it is estimated that 100,000 children in the United States would qualify for statin therapy based on these criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86016612\">",
"    <span class=\"h4\">",
"     Hypertriglyceridemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapeutic options for children with elevated triglycerides are limited, and the main intervention remains diet modification including increased intake of fish or the use of fish oil, and weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H86011519\">",
"     'Hypertriglyceridemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <br/>",
"    Drug therapy includes fibrate or niacin. However, these agents are primarily used in children with primary hypertriglyceridemia who typically have an average TG &gt;500",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (5.6",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    or a single TG level &gt;1000",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11.3",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    These patients should be referred to a pediatric lipid specialist. (See",
"    <a class=\"local\" href=\"#H86017603\">",
"     'Fibric acid derivatives'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H894582\">",
"     'Other agents'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In addition, in consultation with a pediatric lipid specialist, drug therapy may be considered in children with TG between 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and 499",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (5.6",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    and a non-HDL C &ge;145",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    after a trial of nonpharmacologic intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86016686\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid-altering agents encompass several classes of drugs that include statins, fibric acid derivatives, bile acid sequestrants, nicotinic acid, and cholesterol absorption inhibitors (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17844?source=see_link\">",
"     ezetimibe",
"    </a>",
"    ). These drugs differ with respect to mechanism of action and to the degree and type of lipid lowering.",
"   </p>",
"   <p>",
"    The following sections review the use of these drugs in children with dyslipidemia (",
"    <a class=\"graphic graphic_table graphicRef69650 \" href=\"UTD.htm?36/53/37725\">",
"     table 5",
"    </a>",
"    ). Discussions of these drugs in the management of adults with hypercholesterolemia are found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26122?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in secondary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/23/10613?source=see_link\">",
"     \"ATP III guidelines for treatment of high blood cholesterol\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894568\">",
"    <span class=\"h2\">",
"     Statins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statins are the most common cardiovascular disease (CVD) drugs used in the treatment of hypercholesterolemia in adults and are the only class of drugs to demonstrate improvements in CVD morbidity and mortality. As noted above, clinical trials in children with familial hypercholesterolemia have shown a consistent significant reduction of serum low-density lipoprotein cholesterol (LDL-C) with the use of statins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several different formulations of statin therapy are available. Currently",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/47/42743?source=see_link\">",
"     lovastatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/12/44231?source=see_link\">",
"     simvastatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/2/17447?source=see_link\">",
"     pravastatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/54/42854?source=see_link\">",
"     rosuvastatin",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/59/21432?source=see_link\">",
"     atorvastatin",
"    </a>",
"    are approved by the United States Food and Drug Administration for use in children (",
"    <a class=\"graphic graphic_table graphicRef69650 \" href=\"UTD.htm?36/53/37725\">",
"     table 5",
"    </a>",
"    ). Pravastatin, atorvastatin, simvastatin, and lovastatin are available in generic forms.",
"   </p>",
"   <p>",
"    When considering initiation of statin therapy, one needs to balance the extent of risk reduction of CVD against the risk of potential adverse effects from the drug itself [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/10,36,37\">",
"     10,36,37",
"    </a>",
"    ]. In adults between 45 and 60 years of life, six-year clinical outcome data showed statin therapy to be effective in reducing the absolute risk reduction of nonfatal CHD events and CVD death by 3 percent (from 9.4 to 6.4 percent). Data from adult studies also demonstrate a low risk of adverse side effects that include myopathy, new-onset type 2 diabetes mellitus, and perhaps hepatic dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/50/19240?source=see_link\">",
"     \"Clinical trials of cholesterol lowering for primary prevention of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=see_link\">",
"     \"Overview of primary prevention of coronary heart disease and stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32314?source=see_link&amp;anchor=H11#H11\">",
"     \"Statins: Actions, side effects, and administration\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similar long-term data regarding outcome are not available in children, who are at a much lower short-term risk for cardiovascular events and may require therapy for several decades to achieve an absolute reduction in cardiovascular mortality and morbidity. In addition, although long-term data have suggested a safe profile for statins, the long-term safety of statin therapy initiated in childhood is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/10\">",
"     10",
"    </a>",
"    ]. Bile acid sequestrants may be considered an alternate option for patients in whom there is a preference for avoiding a statin. Ultimately, management decisions must be individualized to the patient's specific circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H86017804\">",
"     'Management approach'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/50/19240?source=see_link\">",
"     \"Clinical trials of cholesterol lowering for primary prevention of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=see_link\">",
"     \"Overview of primary prevention of coronary heart disease and stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H177720975\">",
"    <span class=\"h3\">",
"     Statin therapy regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, when statin therapy is initiated, we follow the regimen outlined by the AHA and the NHLBI expert panel [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1,9\">",
"     1,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment is initiated at the lowest dose, which is given once a day, usually at bedtime, because most LDL-C synthesis occurs during nighttime hours.",
"     </li>",
"     <li>",
"      Adolescent females should be counseled about the possibility of drug teratogenicity and appropriate contraceptive methods while receiving statin therapy. Providers should be aware that oral contraceptive pills can increase lipid levels. In addition, use of statins by breastfeeding mothers is discouraged. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32314?source=see_link&amp;anchor=H19#H19\">",
"       \"Statins: Actions, side effects, and administration\", section on 'Risks in pregnancy and breastfeeding'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H894582\">",
"       'Other agents'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Initial choice of agent is generally based on price, the renal function of the child, potential drug interactions, and patient preference. In children, the lowest dose is initially used and, if needed, increased to meet the goals of therapy. In contrast, in adults a moderate dose is typically recommended based on targeting a LDL-C goal. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment of lipids (including hypercholesterolemia) in primary prevention\", section on 'Use of statins'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Baseline laboratory evaluations include lipid profile, and measurements of serum creatinine kinase (CK), alanine aminotransferase, and aspartate aminotransferase, these tests are repeated four and eight weeks after the initiation of statin therapy to determine the efficacy of the treatment and whether there are any adverse effects. They are repeated every six months in patients on stable therapy. The testing of liver function tests and CK in asymptomatic patients is controversial; and many clinicians (particularly those who care for adult patients) believe this is unnecessary.",
"     </li>",
"     <li>",
"      Our targeted treatment values of LDL-C depend on the presence of associated risk factors and are generally as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Minimal value, less than 130",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.35",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Optimal value, less than 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2.85",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Some providers target values of less than 100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2.59",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      for extremely high-risk patients, such as those with diabetes mellitus or chronic renal insufficiency.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the targeted value is met and there are no laboratory abnormalities, therapy is continued at the same dose. Reassessment is performed after four and eight weeks of therapy to confirm dosing, every three to four months during the first year, and then every six months thereafter.",
"      <br/>",
"      <br/>",
"      Once a dosing regimen has been established, ongoing monitoring of growth, fasting lipoprotein profile, and laboratory evaluation for toxicity should be performed at each visit.",
"     </li>",
"     <li>",
"      If the targeted value is not met, the dose (usually by an increment of 10 to 20 mg) is increased. Reassessment is performed in four weeks including repeat laboratory evaluation. If treatment is well tolerated but goals are not yet met, one of the following options are followed:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dose of statin may be increased until the target or the maximum dose is reached or there is evidence of toxicity. Laboratory testing is reassessed again four and eight weeks after each dose change.",
"      <br/>",
"      <br/>",
"      The US Food and Drug Administration have placed a black box label on",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/12/44231?source=see_link\">",
"       simvastatin",
"      </a>",
"      at a dose of 80 mg per day because it is associated with muscle toxicity in adults. If a daily dose of 40 mg of simvastatin is insufficient to achieve LDL-C control, a change to a more potent statin (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/59/21432?source=see_link\">",
"       atorvastatin",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/54/42854?source=see_link\">",
"       rosuvastatin",
"      </a>",
"      ) is suggested. Doses of simvastatin that exceed 40 mg per day should be given under the supervision of a pediatric lipid specialist. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33802?source=see_link&amp;anchor=H107312612#H107312612\">",
"       \"Statin myopathy\", section on 'Statin characteristics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Another drug (eg, bile acid sequestrant or cholesterol absorption inhibitor) may be added to statin therapy under the direction of a pediatric lipid specialist. (See",
"      <a class=\"local\" href=\"#H894582\">",
"       'Other agents'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If there are laboratory abnormalities, the drug may be stopped and the laboratory testing repeated in two weeks. When the abnormalities resolve, the drug may be restarted with close monitoring. For patients with adverse symptoms possibly related to the drug, it is most helpful to obtain laboratory testing while the symptoms are ongoing. This can help the practitioner to decipher if they are in fact drug-related.",
"     </li>",
"     <li>",
"      Children and adolescents generally are not treated with more than one class of lipid-lowering agents, because of the increased risk of side effects, particularly muscle toxicity. Side effects of statins are also more commonly seen in patients on additional medications, such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/24/34176?source=see_link\">",
"       cyclosporine",
"      </a>",
"      , and drug interactions should be reviewed. Statins should be used with caution in patients with renal insufficiency, and doses should be lower when used in these circumstances.",
"     </li>",
"     <li>",
"      Patients who fail to achieve targeted values of LDL-C despite pharmacologic therapy are likely to have familial hypercholesterolemias (FH). These &nbsp;patients should be referred to a specialist with expertise in managing pediatric dyslipidemia, especially patients with FH, as other interventions may be warranted. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link&amp;anchor=H4#H4\">",
"       \"Inherited disorders of LDL-cholesterol metabolism\", section on 'Familial hypercholesterolemia'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/5/10329?source=see_link&amp;anchor=H1557919#H1557919\">",
"       \"Treatment of drug-resistant hypercholesterolemia\", section on 'Referral to a specialist'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86017603\">",
"    <span class=\"h2\">",
"     Fibric acid derivatives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibric acid derivatives raise high-density lipoprotein cholesterol (HDL-C) and lower triglycerides (TG). Although data are limited on the use of fibric acid derivatives in children [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/38\">",
"     38",
"    </a>",
"    ], they may be useful in children with significantly elevated TG at risk for pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"     1",
"    </a>",
"    ]. In one report from a tertiary center that reviewed its management of 76 children with hypertriglyceridemia (53 patients with primary and 13 with adiposity-related hypertriglyceridemia), triglyceride levels decreased with the use of fibrates, did not change with the use of statins, and increased with the use of bile acid-binding resins [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our experience fibric acid derivatives have been well tolerated if given as monotherapy (eg, not combined with a statin). Generally, fibric acid medications are reserved for the rare child with severe triglyceride elevations (considered at levels &gt;600 to 1000",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    usually prescribed for levels &gt;1000",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    and are most often used in older adolescents. The risk of myopathy and rhabdomyolysis is increased when they are used in conjunction with statins or in patients with renal insufficiency. The simultaneous use of both statin and fibrate is rare in childhood, and they should be administered under the supervision of a pediatric lipid specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894582\">",
"    <span class=\"h2\">",
"     Other agents",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bile acid sequestrants are not as effective as statins and have adverse side effects that result in poor compliance (eg, constipation and bloating). For these reasons, bile acid sequestrants are used relatively infrequently. However, they may be useful in combination with a statin for patients who fail to meet target LDL-C levels [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/40\">",
"       40",
"      </a>",
"      ]. The sequestrants are extremely safe, as they are not absorbed systemically but remain in the gut and are excreted along with the bile containing cholesterol. For prepubertal patients with severe LDL-C elevations (heterozygous familial hypercholesterolemia) who are able to be very compliant and do not experience bloating or constipation, the sequestrants can effectively lower LDL-C as much as 10 to 20 percent. They can be used until puberty, at which time statin therapy can be initiated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=see_link&amp;anchor=H2#H2\">",
"       \"Lipid lowering with drugs other than statins and fibrates\", section on 'Bile acid sequestrants'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cholesterol absorption inhibitors (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17844?source=see_link\">",
"       ezetimibe",
"      </a>",
"      ) are lipid-lowering agents that prevent intestinal absorption of cholesterol and plant sterols. In adults, in combination with statins, ezetimibe further lowers serum LDL but may not further lower CVD risk. Data are limited on the use of these agents in children. In one observational study, ezetimibe therapy (10 mg per day) was associated with a decrease in total cholesterol (TC) and LDL-C in children suspected of having familial hypercholesterolemia or familial combined hyperlipidemia, who failed to adequately respond to diet therapy or developed adverse effects with statin therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/41\">",
"       41",
"      </a>",
"      ]. In a small clinical trial of adolescent patients with familial hypercholesterolemia (FH), the combination administration of ezetimibe and a statin resulted in greater reductions of LDL-C levels than did treatment with a statin alone [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/42\">",
"       42",
"      </a>",
"      ]. However, it remains unclear whether the addition of ezetimibe is warranted as there are concerns about its efficacy and safety. As a result, this agent should only be used under the direction of pediatric lipid specialist. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=see_link&amp;anchor=H9#H9\">",
"       \"Lipid lowering with drugs other than statins and fibrates\", section on 'Ezetimibe'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Niacin is particularly effective in raising HDL cholesterol, increasing levels by 20 to 30 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/43\">",
"       43",
"      </a>",
"      ]. However, compliance is difficult due to frequent side effects (eg, rash, flushing, and headaches). As a result, niacin is rarely used. Niacin comes in several different formulations, including various over the counter preparations, so care should be taken with dosing. The prescription formulation is the most convenient for use. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=see_link&amp;anchor=H5#H5\">",
"       \"Lipid lowering with drugs other than statins and fibrates\", section on 'Nicotinic acid (Niacin)'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86017804\">",
"    <span class=\"h1\">",
"     MANAGEMENT APPROACH",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H894596\">",
"    <span class=\"h2\">",
"     Pediatric versus adult management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision of when to initiate lipid lowering pharmacotherapy in pediatric and adolescent patients is based on global cardiovascular disease (CVD) risk assessment. This approach differs from the adult primary prevention approach that calculates the individual patient risk reduction with pharmacotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\", section on 'Deciding whom to treat'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adult primary prevention treatment recommendations are based on calculating the effect of statin on a patient&rsquo;s baseline risk for CVD by using either the validated Framingham or the Reynolds risk scores, which were developed from robust outcome data. In contrast, an outcomes-based scoring system is not currently feasible in children because of the lack of available pertinent data. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39048?source=see_link&amp;anchor=H9#H9\">",
"       \"Estimation of cardiovascular risk in an individual patient without known cardiovascular disease\", section on 'Framingham risk scores'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39048?source=see_link&amp;anchor=H12#H12\">",
"       \"Estimation of cardiovascular risk in an individual patient without known cardiovascular disease\", section on 'Reynolds risk score'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Because of the lack of data to determine an individual child&rsquo;s risk for CVD, a global CVD risk approach for children is recommended by the AHA, APA, and the NHLBI expert panel because of the lack of data to determine an individual child&rsquo;s . This approach is based on low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) levels, and incorporates other CVD risk factors and conditions that are associated with a high and moderate-risk for CVD [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/7,44\">",
"       7,44",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H894561\">",
"       'NHLBI expert panel criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Another key difference between the pediatric and adult primary prevention approach is that the adult assessment is based on a 10 year risk, while pediatric guidelines consider an individual&rsquo;s lifetime risk [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/45\">",
"       45",
"      </a>",
"      ]. This point was underscored in the Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, which stated &ldquo;Most young adults with very high LDL-cholesterol levels (&ge;190",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      are candidates for cholesterol-lowering drugs, even when they are otherwise at low risk with 0-1 risk factor and 10-year risk &lt;10 percent. Although their 10-year risk may not be high, long-term risk will be high enough to justify a more aggressive approach to LDL lowering&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/46\">",
"       46",
"      </a>",
"      ]. This is because these individuals likely have familial hypercholesterolemia, and therefore are not appropriate candidates for the Framingham risk score.",
"     </li>",
"     <li>",
"      Finally, it should be noted that the primary care adult approach for treatment should not be used for patients who have familial hypercholesterolemias (FH) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/46,47\">",
"       46,47",
"      </a>",
"      ], which is the most common cause of elevated LDL-C in childhood and adolescence. Patients with FH are at high risk for early atherosclerosis. Statin therapy should be initiated in all patients with homozygous FH because they are at high-risk for CVD events in the first and second decades of life. Adjunct therapy (eg, LDL-C apheresis) is also generally necessary in the management of these patients. Adult risk assessment scores, which were developed based on the CVD risk in a general population should not be used in individuals with heterozygous FH who have a lifetime risk for CVD events that is not adequately captured by these scores. In contrast, the pediatric approach identifies and appropriately begins pharmacotherapy in children and young adolescents with FH. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link&amp;anchor=H4#H4\">",
"       \"Inherited disorders of LDL-cholesterol metabolism\", section on 'Familial hypercholesterolemia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The differences in these two approaches may result in a discrepancy of recommendations regarding statin therapy as older adolescents transition their care from pediatric to adult primary care clinicians. As an example, statin therapy may be initiated in an adolescent without any other risk factors based on a LDL-C level greater than 190",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    whereas such treatment would not be recommended based on a risk reduction assessment when the same patient reaches young adulthood. This inconsistency is due to differences in expert opinions of panel members for pediatric and adult consensus statements and guidelines, and possibly because FH is less clearly identified in young adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\", section on 'Deciding whom to treat'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86020635\">",
"    <span class=\"h2\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the currently available evidence, we follow the approach outlined in the 2011 NHLBI expert panel guideline, the 2008 AAP guideline, and the 2006 AHA statement using global assessment of the child's risk for premature CVD and initiation of pharmacotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/63/12282/abstract/1,7,9\">",
"     1,7,9",
"    </a>",
"    ]. If and when there are more robust pediatric outcome data, pediatric individual risk assessment and treatment recommendations may become available, which would narrow some of the differences between the pediatric and adult approaches to primary CVD prevention.",
"   </p>",
"   <p>",
"    As is the case with all medications used in pediatric patients with no long-term safety data, we exercise caution and initiate statins only when the likelihood of benefit of treating outweighs (admittedly unknown) risks of long-term medication use.",
"   </p>",
"   <p>",
"    For the vast majority of children, the main focus of management to prevent or slow the progression of atherosclerosis is lifestyle modification. Non-pharmacologic therapy promoting healthy lifestyle changes is provided to all patients. This includes a diet high in fruits and vegetables, and an exercise regimen of daily vigorous activity (",
"    <a class=\"graphic graphic_table graphicRef78256 \" href=\"UTD.htm?3/49/3870\">",
"     table 1",
"    </a>",
"    ). For children with high LDL-C, we recommend a low-saturated-fat,",
"    <span class=\"nowrap\">",
"     low/no",
"    </span>",
"    trans fat, low-cholesterol diet. For children who are 12 months and older with high LDL or high risk family history, we also recommend low fat dairy products. (See",
"    <a class=\"local\" href=\"#H894533\">",
"     'Dietary modification'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H894547\">",
"     'Activity'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If lifestyle counseling fails to reach the targeted goal by six months in children who are 10 years or older, we consider statin therapy. The decision to start pharmacologic therapy is based upon the severity of the child's dyslipidemia, the presence of other co-morbid conditions (eg, diabetes or chronic kidney disease), the severity of family history of premature CVD (eg, homozygous FH), and the preferences of the child and family. The potential benefit of reduced CVD risk versus the unknown risk of long-term statin therapy is discussed with the family.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86017843\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evidence from pediatric autopsy studies and data using indirect measures of atherosclerosis demonstrate an association between lipid disorders in children and the early onset of atherosclerosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=see_link&amp;anchor=H728055#H728055\">",
"       \"Definition and screening for dyslipidemia in children\", section on 'Association between pediatric dyslipidemia and atherosclerosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management of pediatric dyslipidemia is based on the rationale that early identification and control of pediatric dyslipidemia will reduce the risk and severity of premature cardiovascular disease (CVD) in adulthood. (See",
"      <a class=\"local\" href=\"#H894519\">",
"       'Rationale for intervention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment for dyslipidemia includes both nonpharmacologic and pharmacologic interventions. Management decisions are dependent upon the severity of dyslipidemia and the presence of other CVD risk factors.",
"     </li>",
"     <li>",
"      Nonpharmacologic therapy, also referred to as lifestyle modification, includes dietary interventions, elimination of cigarette smoke exposure, and increased activity. (See",
"      <a class=\"local\" href=\"#H894526\">",
"       'Nonpharmacologic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dietary interventions can modestly improve abnormal lipid levels in children with dyslipidemia (",
"      <a class=\"graphic graphic_table graphicRef78256 \" href=\"UTD.htm?3/49/3870\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In children with hypercholesterolemia, diets that are more restrictive in the amount of total and saturated fat intake and cholesterol are recommended (",
"      <a class=\"graphic graphic_table graphicRef53962 \" href=\"UTD.htm?32/37/33371\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In children with elevated triglycerides (TG), reduced intake of simple carbohydrates, increased intake of healthy fats, and weight loss are generally effective in lowering TG levels (",
"      <a class=\"graphic graphic_table graphicRef61553 \" href=\"UTD.htm?24/20/24907\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H894533\">",
"       'Dietary modification'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Based on good evidence from adult studies and limited data from children at high-risk for atherosclerosis and premature CVD, several United States organizations (American Academy of Pediatrics, American Heart Association, and an expert panel sponsored by the National Heart, Lung, and Blood Institute [NHLBI]) have advocated the initiation of pharmacologic therapy for children &ge;10 years of age with significant dyslipidemia that is refractory to nonpharmacologic intervention. The decision to initiate drug therapy is based on the severity of dyslipidemia and the presence of other high- and moderate-risk cardiovascular disease factors or conditions. (See",
"      <a class=\"local\" href=\"#H894554\">",
"       'Rationale and criteria for pharmacologic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      However, an alternative perspective points to the lack of evidence that long-term (perhaps life-long) drug therapy reduces CVD, and suggests given the known adverse effects of statins, the drugs primarily used to treat pediatric dyslipidemia, short-term risk-benefit is not favorable for the initiation of therapy. (See",
"      <a class=\"local\" href=\"#H894554\">",
"       'Rationale and criteria for pharmacologic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest initiation of statin pharmacotherapy based on persistently elevated low-density lipoprotein cholesterol (LDL-C)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the presence of CVD risk factors or condition despite a trial of lifestyle modifications (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Our approach is consistent with the 2011 NHLBI guidelines and is as follows (see",
"      <a class=\"local\" href=\"#H894561\">",
"       'NHLBI expert panel criteria'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H86020635\">",
"       'Our approach'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      LDL-C &ge;190",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.9",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      without additional CVD risk factors.",
"     </li>",
"     <li>",
"      LDL-C &ge;160",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.1",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and &lt;190",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.9",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and",
"      <strong>",
"       one",
"      </strong>",
"      of the following conditions: (1) a family history of premature CVD (defined as a heart attack, treated angina, interventions for coronary artery disease, stroke, or sudden cardiac disease in a male parent, grandparent, uncle or sibling before 55 years of age, or a female parent, grandparent, aunt or sibling before 65 years of age), (2) one high-level CVD risk factor or condition,",
"      <strong>",
"       or",
"      </strong>",
"      (3) two moderate-level risk factors or conditions. (See",
"      <a class=\"local\" href=\"#H86016429\">",
"       'CVD risk factors and conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LDL-C is &ge;130",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.4",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and &lt;160",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.1",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      and two high-risk CVD factors or conditions, or one high-risk and two moderate-risk CVD factors or conditions.",
"     </li>",
"     <li>",
"      Children with extremely high LDL levels consistent with homozygous or compound heterozygous FH, or with multiple high risk conditions may be treated at early ages and to lower LDL levels, if possible, based on the judgment of pediatric lipid specialist.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In children treated with statin therapy, we suggest that laboratory tests are checked at baseline and then one and two months after dose changes. We recommend patients on stable statin doses obtain lipid values and laboratory monitoring for side effects every six months. (See",
"      <a class=\"local\" href=\"#H177720975\">",
"       'Statin therapy regimen'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/1\">",
"      Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5:S213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/2\">",
"      Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004; 292:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/3\">",
"      Rodenburg J, Vissers MN, Wiegman A, et al. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation 2007; 116:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/4\">",
"      de Jongh S, Lilien MR, op't Roodt J, et al. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 2002; 40:2117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/5\">",
"      Avis HJ, Vissers MN, Stein EA, et al. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2007; 27:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/6\">",
"      American Academy of Pediatrics Committee on Nutrition: Statement on cholesterol. Pediatrics 1992; 90:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/7\">",
"      Daniels SR, Greer FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/8\">",
"      National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/9\">",
"      McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115:1948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/10\">",
"      Psaty BM, Rivara FP. Universal screening and drug treatment of dyslipidemia in children and adolescents. JAMA 2012; 307:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/11\">",
"      Magnussen CG, Thomson R, Cleland VJ, et al. Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence from the Childhood Determinants of Adult Health Study. Arch Pediatr Adolesc Med 2011; 165:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/12\">",
"      Gidding SS, Dennison BA, Birch LL, et al. Dietary recommendations for children and adolescents: a guide for practitioners. Pediatrics 2006; 117:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/13\">",
"      Tonstad S, Knudtzon J, Sivertsen M, et al. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996; 129:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/14\">",
"      Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group. JAMA 1995; 273:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/15\">",
"      Tammi A, R&ouml;nnemaa T, Gylling H, et al. Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: the STRIP project. Special Turku Coronary Risk Factors Intervention Project. J Pediatr 2000; 136:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/16\">",
"      Ketom&auml;ki AM, Gylling H, Antikainen M, et al. Red cell and plasma plant sterols are related during consumption of plant stanol and sterol ester spreads in children with hypercholesterolemia. J Pediatr 2003; 142:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/17\">",
"      Amundsen AL, Ose L, Nenseter MS, Ntanios FY. Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr 2002; 76:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/18\">",
"      Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res 1995; 36:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/19\">",
"      Jakulj L, Vissers MN, Rodenburg J, et al. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels. J Pediatr 2006; 148:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/20\">",
"      de Jongh S, Vissers MN, Rol P, et al. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis 2003; 26:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/21\">",
"      Epstein LH, Kuller LH, Wing RR, et al. The effect of weight control on lipid changes in obese children. Am J Dis Child 1989; 143:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/22\">",
"      Nemet D, Barkan S, Epstein Y, et al. Short- and long-term beneficial effects of a combined dietary-behavioral-physical activity intervention for the treatment of childhood obesity. Pediatrics 2005; 115:e443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/23\">",
"      Becque MD, Katch VL, Rocchini AP, et al. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics 1988; 81:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/24\">",
"      Tripathy DN, Hanson LE, Mansfield ME. Evaluation of the immune response of cattle to leptospiral bacterins. Am J Vet Res 1976; 37:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/25\">",
"      Ohta T, Nakamura R, Ikeda Y, et al. Follow up study on children with dyslipidaemia detected by mass screening at 18 months of age: effect of 12 months dietary treatment. Eur J Pediatr 1993; 152:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/26\">",
"      Sondike SB, Copperman N, Jacobson MS. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr 2003; 142:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/27\">",
"      McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 2003; 143:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/28\">",
"      Stein EA, Illingworth DR, Kwiterovich PO Jr, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999; 281:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/29\">",
"      van der Graaf A, Nierman MC, Firth JC, et al. Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia. Acta Paediatr 2006; 95:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/30\">",
"      Clauss SB, Holmes KW, Hopkins P, et al. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics 2005; 116:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/31\">",
"      Knipscheer HC, Boelen CC, Kastelein JJ, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996; 39:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/32\">",
"      Lambert M, Lupien PJ, Gagn&eacute; C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics 1996; 97:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/33\">",
"      Mahle WT, Vincent RN, Berg AM, Kanter KR. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. J Heart Lung Transplant 2005; 24:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/34\">",
"      Wenke K, Meiser B, Thiery J, et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 2003; 107:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/35\">",
"      Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation 2009; 119:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/36\">",
"      Belay B, Belamarich PF, Tom-Revzon C. The use of statins in pediatrics: knowledge base, limitations, and future directions. Pediatrics 2007; 119:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/37\">",
"      Gillman MW, Daniels SR. Is universal pediatric lipid screening justified? JAMA 2012; 307:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/38\">",
"      Wheeler KA, West RJ, Lloyd JK, Barley J. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child 1985; 60:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/39\">",
"      Manlhiot C, Larsson P, Gurofsky RC, et al. Spectrum and management of hypertriglyceridemia among children in clinical practice. Pediatrics 2009; 123:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/40\">",
"      McCrindle BW, Helden E, Cullen-Dean G, Conner WT. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. Pediatr Res 2002; 51:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/41\">",
"      Clauss S, Wai KM, Kavey RE, Kuehl K. Ezetimibe treatment of pediatric patients with hypercholesterolemia. J Pediatr 2009; 154:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/42\">",
"      van der Graaf A, Cuffie-Jackson C, Vissers MN, et al. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia. J Am Coll Cardiol 2008; 52:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/43\">",
"      Colletti RB, Neufeld EJ, Roff NK, et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993; 92:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/44\">",
"      Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006; 114:2710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/45\">",
"      Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113:791.",
"     </a>",
"    </li>",
"    <li>",
"     Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) file://www.nhlbi.nih.gov/guidelines/cholesterol (Accessed on June 07, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/63/12282/abstract/47\">",
"      Robinson JG, Goldberg AC, National Lipid Association Expert Panel on Familial Hypercholesterolemia. Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 5:S18.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17048 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-190.92.87.104-9A95019A57-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12282=[""].join("\n");
var outline_f11_63_12282=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H86017843\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H895972\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H894519\">",
"      RATIONALE FOR INTERVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86020196\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H894526\">",
"      NONPHARMACOLOGIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H894533\">",
"      Dietary modification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H86011050\">",
"      - Hypercholesteremia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H86011086\">",
"      Low saturated-fat diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H894540\">",
"      Dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H86011519\">",
"      - Hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H894547\">",
"      Activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H894554\">",
"      RATIONALE AND CRITERIA FOR PHARMACOLOGIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86012511\">",
"      Background",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H894561\">",
"      NHLBI expert panel criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H86015013\">",
"      - Children below 10 years of age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H86015141\">",
"      - Children &ge;10 years of age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H86016429\">",
"      CVD risk factors and conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H86015195\">",
"      Hypercholesteremia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H86016612\">",
"      Hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86016686\">",
"      PHARMACOLOGIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H894568\">",
"      Statins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H177720975\">",
"      - Statin therapy regimen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86017603\">",
"      Fibric acid derivatives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H894582\">",
"      Other agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86017804\">",
"      MANAGEMENT APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H894596\">",
"      Pediatric versus adult management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86020635\">",
"      Our approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86017843\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/17048\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/17048|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?0/45/726\" title=\"algorithm 1\">",
"      NHLBI pediatric risk stratification associated with CVD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/17048|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/49/3870\" title=\"table 1\">",
"      Pediatric diet to prevent CVD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/37/33371\" title=\"table 2\">",
"      Further NHLBI dietary modifications for elevated LDL-C in childr",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/20/24907\" title=\"table 3\">",
"      Diet for pediatric hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/10/20653\" title=\"table 4\">",
"      Pediatric physical activity for CV health",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/53/37725\" title=\"table 5\">",
"      Lipid lowering drugs child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/23/10613?source=related_link\">",
"      ATP III guidelines for treatment of high blood cholesterol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=related_link\">",
"      Approach to the patient with hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/50/19240?source=related_link\">",
"      Clinical trials of cholesterol lowering for primary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/17/281?source=related_link\">",
"      Definition and screening for dyslipidemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39048?source=related_link\">",
"      Estimation of cardiovascular risk in an individual patient without known cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36330?source=related_link\">",
"      Fish oil and marine omega-3 fatty acids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=related_link\">",
"      Inherited disorders of LDL-cholesterol metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=related_link\">",
"      Lipid lowering with diet or dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=related_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=related_link\">",
"      Lipoprotein classification; metabolism; and role in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=related_link\">",
"      Overview of primary prevention of coronary heart disease and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/48/25352?source=related_link\">",
"      Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33802?source=related_link\">",
"      Statin myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32314?source=related_link\">",
"      Statins: Actions, side effects, and administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/5/10329?source=related_link\">",
"      Treatment of drug-resistant hypercholesterolemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in primary prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26122?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in secondary prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_63_12283="Baylor steroid protocol";
var content_f11_63_12283=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53128&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53128&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Steroid protocol, Baylor College of Medicine Liver Transplant Unit",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Induction (prior to transplant)",
"       </td>",
"       <td>",
"        Solu-Medrol&reg; (IV) 40 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anhepatic phase",
"       </td>",
"       <td>",
"        Solu-Cortef&reg; (IV) 1 g",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-op day 1",
"       </td>",
"       <td>",
"        Solu-Medrol&reg; (IV) 200 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-op day 2",
"       </td>",
"       <td>",
"        Solu-Medrol&reg; (IV) 160 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-op day 3",
"       </td>",
"       <td>",
"        Solu-Medrol&reg; (IV) 120 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-op day 4",
"       </td>",
"       <td>",
"        Solu-Medrol&reg; (IV) 80 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-op day 5",
"       </td>",
"       <td>",
"        Solu-Medrol&reg; (IV) 40 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-op day 6",
"       </td>",
"       <td>",
"        Prednisone (oral) 20 mg",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12283=[""].join("\n");
var outline_f11_63_12283=null;
var title_f11_63_12284="Prev umbilical cath infection";
var content_f11_63_12284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prevention of infection with umbilical catheters",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement and relocation of catheter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not replace umbilical catheter if any sign of catheter-associated infection, vascular insufficiency, or thrombosis occurs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Replace umbilical venous catheters only if mechanical malfunction of the catheter occurs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of catheter-site dressing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Replace dressing when the catheter is removed or replaced, or when the dressing becomes damp, loosened, or soiled. Replace dressings more frequently in diaphoretic patients.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        There is no need to remove a gauze or opaque dressing if the patient has no clinical signs of infection.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of administration sets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Replace administration sets, including secondary sets and add-on devices, no more frequently than at 72-hour intervals, unless clinically indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Replace tubing used to administer blood, blood products, or lipid emulsions within 24 hours of initiating the infusion.",
"        <strong>",
"         No recommendation*",
"        </strong>",
"        for replacement of tubing used for intermittent infusions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Replace tubing used to administer propofol infusions every 6 or 12 hours, depending on its use.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hang time for parenteral fluids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete infusion of lipids or lipid-containing parenteral nutrition fluids (eg, 3-in-1 solutions) within 24 hours of hanging the fluid. When lipid emulsions are given alone, complete the infusion within 12 hours of hanging the emulsion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete infusion of blood or blood products within four hours of hanging the blood.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         No recommendation*",
"        </strong>",
"        for the hang time of intravenous fluids, including nonlipid-containing parenteral nutrition fluids.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *&nbsp;No recommendation is made when there is insufficient data in the literature.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12284=[""].join("\n");
var outline_f11_63_12284=null;
var title_f11_63_12285="Long-term preventative tx of HAE";
var content_f11_63_12285=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F83115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F83115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Long-term prophylaxis to prevent angioedema in adults and children with hereditary angioedema (HAE)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary maintenance therapy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Advantages",
"       </td>",
"       <td class=\"subtitle1\">",
"        Disadvantages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Option 1",
"        </strong>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Androgen therapy:",
"         </strong>",
"         May be started at a relatively high dose and gradually lowered once disease is controlled OR started at low dose and gradually increased until disease is controlled. Over time, the lowest effective dose should be determined for each individual patient.",
"        </p>",
"        <p>",
"         See additional treatments for breakthrough symptoms below.",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Effective in most patients",
"         </li>",
"         <li>",
"          Well tolerated by many",
"         </li>",
"         <li>",
"          Inexpensive",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Side effects are prohibitive in some patients (elevated cholesterol, hypertension, mood effects, weight gain, others)",
"         </li>",
"         <li>",
"          Avoid in pre-pubertal children (premature closure of growth plate) and pregnant women (virilization of female fetus)",
"         </li>",
"         <li>",
"          Avoid in patients with liver disease or nephrotic syndrome",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Option 2",
"        </strong>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Tranexamic acid therapy:",
"         </strong>",
"         Less effective than androgens, but preferred for pre-pubertal children and some women.",
"        </p>",
"        <p>",
"         See additional treatments for breakthrough symptoms below.",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Safe in children",
"         </li>",
"         <li>",
"          Well tolerated by most patients",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Less effective compared&nbsp;with androgens",
"         </li>",
"         <li>",
"          Avoid in patients with history of thrombosis or thromboembolic disease or risk factor for thrombosis",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Option 3",
"        </strong>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Regular infusions of a C1 inhibitor product:",
"         </strong>",
"        </p>",
"        <p>",
"         See additional treatments for breakthrough symptoms below.",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Well tolerated",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Expensive",
"         </li>",
"         <li>",
"          Requires reliable venous access",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <p>",
"         <strong>",
"          Treatment for breakthrough symptoms",
"         </strong>",
"        </p>",
"        <p>",
"         <em>",
"          (Required in combination with any of the options above)",
"         </em>",
"        </p>",
"       </td>",
"       <td>",
"        A C1 inhibitor replacement product",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Requires venous access",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Ecallantide",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Subcutaneous injection",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Should be given with supervision due to possible hypersensitivity reactions usually within one hour",
"         </li>",
"         <li>",
"          Only available in the United States",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Icatibant",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Subcutaneous injection",
"         </li>",
"         <li>",
"          Approved for self-administration at home",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Plasma (solvent/detergent treated&nbsp;[preferred]&nbsp;or fresh frozen)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Efficacy not as well established",
"         </li>",
"         <li>",
"          Theoretical risk of transmission of blood borne agents",
"         </li>",
"         <li>",
"          Requires visit to hospital or clinic for administration",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12285=[""].join("\n");
var outline_f11_63_12285=null;
var title_f11_63_12286="Pregnancy rate singleton";
var content_f11_63_12286=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F66367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F66367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Cumulative singleton rate",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 318px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cumulative pregnancy rate resulting in singleton live birth of a consecutive series of 240 normogonadotrophic anovulatory infertile women undergoing classical ovulation induction (Clomiphene citrate as first therapy, followed by FSH as second-line therapy if required), calculated by the Kaplan-Meier method, with 95 percent confidence interval.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Eijkemans, MJ, Imani, B, Mulders, AG, et al. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 2003; 18:2357.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12286=[""].join("\n");
var outline_f11_63_12286=null;
var title_f11_63_12287="Dorsal ganglion";
var content_f11_63_12287=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dorsal ganglion of the wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 279px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEXAW8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD500+cw30Mv91ga9Ot5BMqOv8AEAa8mjJDDB+ten+FXFxp8R/u8VNVXRz0tNDo9Ph6GtuAYFU7RAAOK0I+BWaVjVsmXGOtSLgds1GppwNMRLkfSlz6VEDTg3tSAlzgdaM8etMB704H0phcfmlyBTN1A60gJAaXPamZ55oBoKJAeKXJxUec0ueetFguSbqXdUeefWlHWkBJkH1pQfrUe7HWgHPWmBJmlDYFR5pQaQD84pd1RlvTrQDxRcLEmcdqA1Mz3JoJ7UASZpMjtUeT3pC4xzkCgZN29aaxBGO9QMSDlW/CkabcARzjr6ilcLE6PuHFKHySO9UHnEUu4nCnrVoOGCuhyp7imncCYkUhNRg80pbigQ6jIpu7NBPPrQMdmk3elNJFGfQ0AOJ9aTPWm555pcnNADvpSZHb8aaT780meOKYDs8+lIT6U2jNFwFz6cUnFJSUkB8tRfer0n4eNvt5E7A/0rzVDjBr0P4ZSZluIz9f0rolsc8dz0aFasrUCDAqQfWskak6t+FOBqIH3p4NA0SA04VGCfWnA0gJAaPxplLTAkz6UuSaYppc0hDwaUdaZn2pc4oAfn3oB55qPNOz70rDJFPHFLmo/oaXnHFMB+eaXPrUYb8DTs80hocDgc80ing9aA3GMcVD8ytgnC0noPcsE9MUm/1ODURHOQT+dJ5hHQKT23c1LkBOWHrkUEj1qs9wVBLiIA+1U7jVYYPvspPoKmVSMdylBvZGl5gGQDk+lMMrE8Acetc5deIAxIhiAPqeaz5NSvLj5VbaueTWUsTFbG8cNN7nYNcIhO919eO1VJr22XJWQ7iO1c2fMkYEsd3p61Hj96fmya55YuXRG8cGurOgfUIZFAdhu78dabbXYhkxG+5G7elc7MwkOW4cH8DTSXHzKxDLyAKhYx9UN4Lszt4rlWmXaeCORVrcMVxMWqOmxnwjZ9OtdPaXy3EKvGy8jmuylXjU0Rx1KUqb1L6HI68UueKpRz7LnynwA3K1aPXJ6V0J3MhQfnxjg0uTntUakGRjnp0p+RTELk0uc0yjntTAdmkpM0hNACmkLenSkJNJkmgBxPbNJnimk9KM8UAfLSnB56V3Hwzn26wyE/eQ/wAq4Rfeup8ATeX4ihyfvArW72MVoz2gHB4FPBNRE/MQOOacp9etYWNCYHilBqIMOlPBoQEoNPBqIHHenAjjmmBJk0uTjmo+vekeSNPvuF+tJtLcdmybOadk9qotfQoOpP0qM6kMEhKxlXpx3ZtGhUlsjS9hSg4rHfU3x2HtXL+JfFl9Yyxw20TM79CKhYmEnoi/qtRLU9AyO5H50bwPvMBXkhv9c1K7t/MuJIY0bee34V00l7JJHtYtkDGc1FTFqHQ0p4GUzs2uoU4aVB+NM+323/PZCPrXGI37ovI5z2BPNPhUugyrYPeuZ4+XRHQsvXVnUyatar0Jf/dqA60h4ijJz3NU7WzQphs57ZqzFp+0EqwBHNQ8VVlsy1g6UdyU6nIE3MVHoBUD3s8iEsxA9qqtYyyzZyAo7npUxh8lPmbJNYutVluzVYelHZCfaLoKXEjbaqvdXAOWkbHU5NPllkdxEpAXuaZNaJt+9uI5xRzSe7K5ILoVZL2aRzgHb6Gqs0u9yzLj2FW5h8nzLtAqrKoMeNp570r3KUUJbshVzkZ96mt0Z+n3RVIf6gYABzWjZA7ASwJzVLXQJKxcW3YJuAOcU2SFljL4wx6VuWs0MlkzOANoxmszUpE8vP8ACat01bcxjJt2MmYBI+xbuB1FV4pN8nysMrSBsykhsgVKi4GVXO6ufRnUlYbOrStvZRwOlRWN7LYyYGShPKn+lXobR5FOGJ56elMmsfMY5x8lQm46xJlCMvdkbEdyLuEMj/OvPNW7O8YbVlfk9G7GufgRggB4Uc5FC3Dw9GJHoe9dkcU1Zs4p4L+U6y3ukJKOdr579KsrIM4JGa5aO8XpMNpPc1dtrzeNoYlezCu6liIy6nDUoShujbLEN7U/OfpWfFc7gFcgjoSO1WVkDJk84roTuY2JsjPvRkUxWzxwRQWx3qhDyeOelJmowcuST2pd2Dg0DHE4HWjPuKY33ck8Uu7vQB8rqT3ra8LzeTrdk3/TUCse2jknlWOBGkkbgKoyTXc6F8O/FE/kXkWmyLGrBvm4P8q6bNoxloeqZBJPqc04Engc097G6tY4xdxmM7RnNM89EX5PzrirVo03bqddHDyq6rYeflHzU0zKKqy3DE9M+lV2c5AYgVwyxk+mh2xwMOupe+1EfdGTTftUmeRj8Kpq5Dgrx71OTvG0An3rH6xUfU1+r019kZJdvyd2KpSXe485OOavtaN1OMHtimCJN2ET5h3POazbk9zWMYx2RT8x2ZcLwamQNuO081aMkWMGLLDuDioGIVWbGPbNJrUtW7FGeYxuWQfMOM1FMsk4R51UnoDtHFWDiZwGXatPmkCOEj+ZBUtuxokr7FJLfaTkcmpvspYKBk89qvWVv502XOF71tRW0UOPLwf1qIxctRyny6GPb6ekpzIDkVqwwqr4IBAHAxT9p3McYFOjk3NyvtmqSM73FjgZpCzYAqyWVQETBemx4KMWb5RUdqu5wwHPrVRi0yW7oR8rww6nHHao3KggcEfTpVqWDqQ2fUU0IP4VzxVqIroz5gu4NgflVK4DbiUFbbQptG7iqVyFjywFS4rqCZk3PMBBOGzUDKEhTJyD14q7MyPh5cbR2qpOqum7PHYelRr0LVnuMNp+7GzBJ7GpI7eSML8u1f60qMGwQSDjFXYpzhFI3DpWkIkydivKrqykk7fQdKz7t2kmkQkhOgzW3cW8jndAPwJrJvIg7NuBST0PStWnEiLTKFuhDMgJ+uK17WNDIIz0Azmqlosi5GAPcir0M4+0bRFn1Nc8om7lcuyW2ERkOJOeneo4Bv3LImG71Zf76FScYwR6VIkTRgv1FNxdyVLQqx27FXCYKjtioZ7MZBK4A9q0gDGpYMAfTFVEaQoyyHOTUtWtcd2QXVujxp/dHtVRYtoJjfaQelaskWYAVPK1G6x4DMoBPFDve4aNWZSS5lilAblCOT61divgHBjPB6g1BImYwrjgHrUXloAAAQT1rSGIqQ0uYTwlOfSxrm4fZuQdKmS6V4iyDnGSK515Li3O0Px70+DUTErCUBvcDFdkMbHaWhxzwU1rHU3Yr1GC7uCaleYFMj8DWDb3kMm2OQgLnPuM1YSQo0sW7dGTww7CuiFZT2ZzSpuOjRt7g69RyKYsgYCst5pIo9xIZHGVIp9jdYlZZenUVpz9DOx6F4D+F+geEUDxwLdXveaUZ/Ku4uJ0traSaQ7YolLEdOBU6x4rkviZffYtCFvG2HnPJH93vXbWquEHJ9DmhHnko9zzTxDrMuq38s0jfIThF9BWUuCRkk0LHgjccCp9hBwvAr5ucm9XufS04JRSWxG6ZxtBPFIlq5fkZJ4xVq3AhkDSkYp17dxh8QD5+xqbdWW9NEU57XyTiRsN1wKdDKCBsHTvTXVi/mSNuamtPs/hwKd1fsKzaLDynPJGPSqlxeLEDxgnioDO7OTnjsKbIpchpFPFNu+w1DuRNcOc7QcnpSQmYv8AODVxIABuIwKnEZdRtCqDWcpal2SKnkMVJY4z6VJHBz901cih5PNTomUxjB9ahXY20itBCxkAwdvoK2ooFSLcByB3qvA8cKnCgt6mpHdniPOM9a0i+UzfvEcqS7SegNRi4jRdmMN61Is4WLbu9qYI4x8zDLHpTu38I0u5FFK5BBzgnj3qysjqAqD5fWrFtCpj3YFLJgKVQD/CqSE35C+aqgLkZPc1NLNHFHhQCx71Re33qhJHBzT5VLDGRxTuyXFMrXF0xPPT2qrNIXUrxV6PlGDoOKzy4Vzxuzxila2o0UZYmGAwJGagaCRZgrA7T3rUuCBEdwAYjioYWDRZduegFJQRPMxIoo1XapyR3p0oVQFBweualjRfMyv3R1qWSJGYMHJYVsZtojjkMZXDFx0qrdZmfdIuRWn8gZVjX5sc1DFEsj4YgjvSm76CjvcodQoAwau2FoWYbiAT0NX47SMn7uFAqeOFFwU6fyqeXuaJ6FSQBWIdeR3pJH2xgRyEluxq1LGCwHf1plwACoIxilLzGlsVkRpSQwIOO9KIcoPY1d8lnbjOMcGoUXG7ccgdqLNblJleNflcZzUc6ogjJztBzVu3YGJw4xVCSQyF4zjYOh9Kh2sUtyVowzbtwMTc49Kglj2yRgc56GnRI7oVTOaUhzInGSKjVopaMzLxiXdSOV/WqQdSDlCQ3p2ranQNKW21D5CIzcYJGaiSdyk1YyGtyq72PT9ackzKcKx5/Wp7pjKdi/jTBbgJuXnbUpuOzE0pbkkd/ttkilGUU/eHUVLZXsLXbb3BUiqckBWMkctmqksRDZwRXRTxM46PU5qmDpz+HQ+r7iaO3ieWZgkajJJrybxtqa63fq0HEEXC5781b+IHiT7RdfYoXxbx/ex3NcNJqJLbU6Cu/GYvnfs47HDgcE9KjLJt8HcxFQSv/dIqF715iFxxmiWRchU6+9cbasety23HNjaDgsfSmjCvkrgVJGxHyr6dTTxC1woyOc9c1PK3qF0VZ5QjKex6Cq8kgdH39O1aVzAixg7eKoSxDZhRRJEpplS3lAkAOMDire/DA4qD7OEbcQMd+alwHQ5OPTFLdWBvW5OkxJbAyDxU/mbVUgVQidYm5xVtZSWBAFQk+o3qSGRguW6k1NHMykDIqB92C23dUsYRoeB8/c1ajrYljw55waJGdE5OM1AmA6rjGOc1LMBIdpPPpmhK6AdCuVBbvVracDcePaobVdrjcNw6VPOQH4zx2ppBe7JhINgVPlqRNksgTpnqe1Z6uVUk9z3qaCXYp28k+tOO4pLsX1iMcmCeD0pJEVclmBb0FRx3Abk8n0pt0wHOAWHPWrI1KlxKq5API7VlM7CXftzV+4QPh1GPWiGJX6rzWUtdDRaamZJL9p4IKkdqIYy0gBGR2FaT2u8ZQAH1pLSzdTsd+vRqFe5LaGRlkByuB0zT0zgsByTwRVyK3ZMxyEMKRo/LcBMAVstDBkUVrIwlc9duQRRbQbVJVvmPUVaLNHG+G5I6VTdtsRkBxj3qXZFJsn8wGPax59anJCRhl5Ydqz4j5ygN901NIxjj4PA9aSNdtB6yNPkt8uO1AniaTa3HHeqLynaZEOcDpTUk8yPcRyOgqGyrGzDMV7ioLhwNx6NWa5YIHJIGelDXLSdcUN6WDl1uXWfMOCQDis613mU7uRmpXk+URsOvQ1NGhjIbvS326DTsTIAzAYwe1NdCpJb5TR9oxKC64xTHkWV8k5zx9Kpq4tUQEiQEscN6+tVNRX51w2MjBNX38vzCpHSs6/jMpBUnC1k42RcdyoY0Q7s81GylpCVJwR0qYBRGSeaYzfKoAwPWs5WRZGynAJ6Hrmo5V3qD3HapZJc5QLjHeqVzKyS7c4GOlSPU2tRn82QvI2WJqi9yEPzdKjvpCxyvOPSoQu/72eldUlYUGlFI0La5RlJAwKlUBvmYkZPBzVG0i5PB2itGOMSMoU5AodxOyLESAOo3kg1rQFV+VBxjmsry5EBKnLenpVm1mkSMlzljVRbW5lL3uo6/Yuw2jiqvlgRnux60+WYNJnPFV7icJHjPJoeuokraFe4GM849qrBWZTsbFScyHduH0pWjKsoHTqaUVrct7FaKCSa4EeDgd63ILcLGD1x61FAMBWAwPWpTMc/KePStFC+plKbehYHyrtJGTRCgHCHr1qANucF+BTTc/vCijj1pSTBFmZVRtqkZ6ZxUKrncQQW/KkllUIADyaiZ1yN3BoXmO+hegIVQGO1qmyShY4J6VnMdgwDknnir1upaDA/WnsQ+4hBYEYH401WVJcHOMU+WMKowSW9qr+cRuDKD7UaFptkpIZSYyVx15qZGDAHOTj6VnxzpvwePpU0spwDGMn2pbDaZZ3AKVBp1tkEZ/OqTPsw2WyaljugF2nnNJaku5akZYgdrgk/w1HGwJPmZA7c1W4E/mA5z1pZWbG4HntTSfUl2Lsc4QnfnOeCaklkXOWACHvWYXJj+c/NUTzl0KscACqu0S0i5K7PkcbegPrVRwEHXI70kc42BW5qB3+R8HJ64qHqVG5ZR8R5Q9KQyNLHhhmqEbsqEVNHKNh5AIqOhrYtwRbIzwcUpddmNuCDTIWmYDH3aeqjdlzhSaLOwddRXO2Ilm+X09arDEhzHggdqsNHC2dzYI/KoY0QSMQceoptX0BMjdTKV2sTt6irCybn2EkH0qAsyT7Y14PenfNHNnAZx1PtUPQq5JckggN1UdahhdsjHPrUNzKSSc8txUUcjIoCnmlzDtZF2QB2JZsVUR5ADF19/WlQHLMPmJ7VWaRo2OMg0rJ6jQ/5MYY4cHkVHPIEjKEggnhqqI7Bi7E89qiuzuj2ZOc8CpaKa1LTR+YgKn8ailjLFT1qW1DrC3GMDOKgt0cKxduSahoETlSSfTtTlU8KFyamhjLOCaupHyMDj6V3TizmhK+hX2hVIx1HNPiyoG0HbVmKNCW3c0mAmeMj3qFFs0YiXKRfIQc9amkuEaPC4B9KzrnlwR96mOjsVIam5W0J5OtyySpzk1XmjMvKZwKeuPLweGpyPsjJxzULUqzQRW4IUjrTmUmTBztFSW53jK8CrZVFQADr1NaJXRnJtMq4JQcmgcHHepcIuSTxTYZFDHHPvT5tSbDg2PlPJqOPABO3PNO8zLsxUYp+6N8heFIpNjIol3TcsAlR3SjzzjGKVgB91ulLGkRPKlm96G7oHpqOhmjjKFV3H0rSNz5w+4qcfw1koGRuEHXrUn2hQ5zwfapTaDlTNKOQnIOB2PvUEqDzco3WqstydgI+9Vf7RIshYggelPnStcpRLBwWzt5HekR3ViVxtpguPN6ECpIyFGTxmpck9CtSRW80AucUyQjdyeB0pHyyEqPlHaq7tuXGMN2qbtaAolnzSG49Oand8xjcfl9az0Plvuk+hpbiQKAUbj0qeZrcHFFucqCuDnFQyAsrfNjFUvtWQfmpfPBTjkimpN6iasPSYBtrnBokBZsxnHFULkM7q4PIqwjEBRTT0sWo31RYX5I/m5NVUkZmOBgZqy6s0agHHvUJj2SAknJpa9Ski2rsWCknAqbzCuTgkVUzt+6efWk81vMUMcjNVfuJRuXHj80K27aR2qYIEbf8AnUcAVzy1TlkVcD8qtLqRLsRyId3nLzgdKqW8sk1wX6D0q2JCIdrdCc1Gw2Rny8AnkYrNpy1EtNCG9jLJlPvdTVS2jKAoCSfWrLzOdqyYB9qlhIxyKlrmY7tIrhTBuYnFZ0sklw2eQM4zV26O7qcpngVVmlKqPLGFPWoasaQdtSBz5QJc5xVL7QWmX5cHPWp5GG1st19agG1v9WOQeTT3Rpfqam9hb5JAJ4NQR7k3Ip98VFv3gqTgUilpJRg8qMZqLMk3ozsjB/iJwBV63iyQWPXrWdM2CoXkipEvNnynrXbUk1Kxy0o3WhtPHFGQBzVOfg9Mg1ALjzVGDgU7f2zke9Pmua8tiAR/vSzEbaVVHm5OAB0qSeSPyiV4I/WsR7iQybc96za1Glc05YVDBt3U0yUqh2DvWcbh2mXvir6RmX5m4qbMGrLVlq3KxKBninvIGBGelQRJuJTOaa6LCpUtljzVJt+hDSuK0quSjGljPlggcg1SZxuPOPeozMd+EzSs3qOxcZZkYlsYPbNSRISoDfLiq6BpDncQR61ZgLSDBYZ70+S+xLZFIxVgFXcO9JHMA5JDban24PNPaLEeQuR7U4xaYm9CjJclDlQTmomu8D5Bl/cVbnChPlU1VMQwDgg0NXHFoie7kL/PGfwqRrjdgk8DqDTcsJee/AJqR7YOhBAz3wKh32RpdEsDKGGeh9DVpZADg8jsDWfDiJSrAk9vanq4ycHNRZsOpcefbjA4PakLB0Jxg9jVGQtvyD+FTQly2Ogx901STG7JEsgaSE5wW/nVbazLjoRVplOMqce1QuS0eTgMKb2uyU7me6Zk4OD7VOuQuBjNEijJOcGq6yfviM8UtS0romBIIyO9XVGVB6GqiPuIIHSru4sgAHNRYb0JRHujBqvKr5yvP1qZZAicnNMMq55xzV9NRK9xEdVTEg+Y1GTmT5R8vrT5FDKT3PAqG3ypKsp69au19A8y3EojDHdyaghkkMm05xTpc+WQDnNV0meJh1IHrSloCLb3O4N2Ap0dwJISwPT1rMl3tISnQ0jnbCE6Hqaz1uFlYsSM7MZAeRTPtTHG3NVw++EbDnHWoBIYoi57nvUa7gXJmzJt7VFdMqxgKfm9KgilLFpDniofnLs5HWnq9hqIkgDRyMzD6VWt3aHLE/KBUUr43Bs5zUDT7yE796qxT7F6CZ5A5GPUVYgl2pk5B7jFULRj5noBWiFZT8oBzzRZvQm5u8bmB64qFVXfhjzTNziEvkkg4pJAXVXXjPWumsr6nLQbTNGNQpGB+FSSEMByBjtVRJSqDHUVJHtkRncdeaz30Oh6asZcgeW2KzJI3yT93NaDqZMjOBmneUHQK3SktAuUbdACFJ3NWgH+Ur0+tItukIDjk1JtBYHtTeom7jGkb5VXjPpUMg4+Y/jV0IoJY9cVXnKKoyCWo5erJT6FYooAB5zSqAiEj71PRd8nQqe1XAgztaPOe9XsJu5U/eSYC9auwW4Efz8MeppYbcBsL2qcjaeeR3oV0KyegLAABnBFSCPacxYyOcU+aLNuGXv+lQxKVXG/d70MLFe7Dytk8Y6imFXEe5enTFaKxhvmYZNWUjgij/eYYN+lHs29QuloYBOWXeuTUjrkLg4PathbWEv82Cp6UrWNukmd3GOlL2b6jconPOrdH6+tQSL5bYbp2IrUuIuW2425qnJGc8YOOx71nqtC1ZkRVXG8EhhViD5seZx/daogFwWTg/xLT1kCxkNgjsPSi9nqNq6JWQM24nBFV51GDng+o70+O4EilWAB7Gq0sjLkHke9EtVoTGLRTmLqcCmxISw45qfg/epEO1sDGaizWpsmOUGKTL/dParQk4yuMYqtI/mjacZFOR/3ZXvSv2E9RpbknJ+lIjFsjmk6nNOXAYnFJlotRq6hSDkGp2Qsg9aqCQ/Kq9PWtCLlBWsNrGU7rUgwFfaKScArjjFOeIpLv7elRTZMh2jPFaKyM9ygzMjHuBVdpvNDISATTr5nVGwcVjySuxGDz3qGjRal6N2ikUKeAealkZXf94eD0FVA3AH8WKkidQp3nJpON9BeZOXKxbcYFQyOwUdQO1Ne52kgrwfWnzOhiUr96ocbDiyrIueG69c1Xkiwdy8kcVPNNg8D5iMfSomEijzACR3popD7UsSxYYI61aSYjBzgdqpbyqbyM56ircYE8ajG004ky3OgK7bbGeppgbEAXuaWRsqqj0pyR4AY11SV0ccdGOiyflOMipVjcZyeKjyV5AzzS/vJG7gVjFHRdsnC7eSOakIXHynnrTQhyq55qZoNgweTRZC1II8OCOfSnyIFQYoPyDI7UwuT1+tCaW6G4tkEjMuMYH1ol3sAeCBzTGZHZvNJA7e9RGXdhQcUJg0WlcAAnr7VMhLLgHJ96pLGV5zwasQoRk5OKm93Yrl0Jll2Ejkn2pyXWMJt4Pc01WWNScZNIQH2lRRzNDSQt3PMNg5KMeAKVZGRQ2znvzSySYAXqR+lN3NIOnFUmmw6EyXbZI6LV07Sg2ndWPIpYgDjtVqH5AAW5FawlclxsXAGBxk1RvLySN2Tk+hp1xOcYXtWXLOQ2Wzx61nN9gjG7uyUahufB+R/Q96d5wYfvODVOVhIoaROvQjrVdvMizsJZfQ9azfmaWRclY79w4NQlt/IbDDtTUvIpl2sdrjsabJCT86dR6Umr9A2FabYQw6jqKtS7JIwQeorKuXZ24GG/nSWF3uZopOGHSi19RMuyDcBt6jtVWRm56g1YLlWyOaCPOUsOo61LHfqVVm2sM9asxNkg5qt5YYkOORUsbhZACODVJJjuW3GF4IzTV+7g9aAw25qOQHaSp5pNaj5iaEnbk8EVb80/KwHHesuCUtx3HWrccnzFWPFNIiRemnBi564qkzkjcDxUZlwSCevFRRzbiwXpVttslKyItTGVAVuvJrNt3S2mEjRhwOqnvWhcoZDnkEdaqmHsR71ce9hrVWZZmktL07rWMxnGSD61SZAoYntVuBRE49+KrTrvL/Si/cIxtoRPtYA5zQOF3A59vSqwRw5GeKmgX5DlsdqzlqOSsRytj3P8qeZCY1Q81C5Hllc5OaZFLtzjnPFLlAnPPysOO9An8rIzSH5wAOSaa8YVsOMGptYXqdPIwLJngGtBFBjArJuvmhJHDLzV2wn863QjrjBrvitGcMu5ZKhWwMYqSNgSBgc8VU/jJU5PpU0b8jiudtpnXCzRcK4Py80ZJHJ5qu05VvaohcqxbnmnzJmlrIfcMVPPSolcSggdKpXl0zEjpU1l/q8561i7yYPRajbmHHzZ4qmhdnIxgVqyYdcEVEVEa5YCnawk77iwozBcnIFWFbYxA/Kq8Y3R8NgZyKRdyZy2SelTcteZZJY/dxTzL5cXzYxUMb/AC/OcU2d0bG05FPVIlq7sSrIhUkKfrQs8bArkqfahX3IFCgCnLCm/lQDVWfQV0RtlQMfNmmtuHIP1qy6DPPGOlRBF2k5yaECZGCPXBqOf+65BFOcMDnjFRsNwBNO5SQ5AIwMcj0qN9jqzDIanIgPyng09xgYU8e9TuJmTLa+eDgc9iKrpdS2j7ZM7fet2NAPTNQXkSPlZEBHrRvqS3rYrKY7lM8A9c1nahbyRkSx/eFW1smiO6Ekqe1TeYjJskGD70JkN22ILGYXMOScSDqtTW4IlJzj1rOngktZhPbnI7gVq28kd5CHi4cdV9Kpjbt6Ek0O1ty8g1RkXawJ9avpcLEds3AHGaS8tw6KVOVb0qUrbEqXQgkJVRjoaRXwozTvLZowD1FM8nBOetaWXQtS7jJSYpdw6Gp0YZ3HoaidMwlW5PaoYpf3ZRuopcquO9yeZtzFRjOOlVlY5DKMetCTbyGPDA4ojZtjq3JByDQu4eRdRg3J61BJE244PBpkLE8Cn7xtIPanfmWgWsyOZlBXbndimrGTzTWO5uByO9LGxEo+tS1bUpMhljA7c1EIjnB+71q7O+xzkDFV3I3ZycHtTuuonexUARpWB4quyMrHYOKvzAZ3Ko+lMZAqGR8ZHIFKTtsC7ldFkJBC1IVMvzty3SpUkD4bOAO1EbBnYAcdqmQjbdSVJHSm6ZL5c0kJ7jIqV/lz6VnSy+VeRSL/AHsH6V2RdmctrqxqpId5PpUjS4GcjNLLFhWZeQeay7mQqe+amVO+44SLdxdnaRVH7WVyB1qpcTHIz1pY03KGFJU0jdSL0ZM+c1dgPlrtHaqlrhAKn385rKSVyr3LaSEnpSyssiYJxVJJPmzkgU75y3r3qCoxLMSYTGRT40+Y5qGDcasDcelSoqO42Dxg52mo44yMgirUa7Rhhk09Y9547VdieaxEuVIwOKlXJYE08oFBPeo2Y9hQ0Re4+WQAYqMn5TjAoI3EcYNKBhuaOoyA+uOfSmqMnvzVopznFIygHIotqPmKjIQeKY6nPBxV+RAecUwqMY9KLahzlbbkDJpjqTwM+lWJVwBikTAJLHAo5W9DNy6lMoynIJUikISb/WKM+1T3l5aQqTLKij3rltU8U6da5Ecu9/RRmtFRk9EiHVVrs3pYwi8EFT61z95cGwuDNC4XHUZrmLzxjcSZEKYHqTWBe6jc3jEyyHB/hFdMMJJ76HPLFRj5npLeI7K7tyZCA3tUGn+LLa2uBazyb4GOA392vMgG7A0bG/umt1g4Xu2Y/WpWske4G7hfDo64I4NRvcoRkEZFeR22oX8CbI3cp2BqddY1JTkFvyNY/VGnozeOKjbVHqqyBiDkfSq042SlwOK4C18UXcJHnJuHerq+LULgOjhT+lQ8NNdDVYiHc7GUBhvjGO9SIm5Q479aw9N1+0ntiPMAYdmq7Y3ivKVEgK4yMVjKDjujVTT1RaAdZCAOlO2sVIOOvFJ5h3A+vFAkAYg1Ni73IwcOc9DU+07N3U+tVyV3HBqXe4jwPumhx6hfsD/vOW/EU0ohXIU88CmK2MHPXrSjJyAeO1RZjZHsIbaRgDkVXnU7T1bJ6e1XiAQPm5phIw3SqUQuUVUAYHH1p6LsRSOp608KFcg459aY+Fcp1HWocWDOhckMQazL9VwpI5BzWvdxFXJ7isrUEJjPOeK6dmc0Xc245P3EeOflFZ92iyPleDU1ozfZo85+7SMhOSB1rRyVyErPQzpbXePYU+GJo8ccCr+3AGRTQOcEcVm3Y3T0G7SenSlCnvU4QbeM8VIqZ7Vm0r3GmVQnzYxT9rK3PSraxBmHBzUghBOCOazt1RrGdtyKMjb71ZjIHB60ghUGgLzTJlJMsDnipE461Eg5FLcyxxDLuoA96peRm5LYkYhhntTEVckk5qil+s7bLWKWZvRFNbeleHNf1Agw6c6KejOK0VNy0SM5VYxWrKbDnimvgGuwt/hr4ilIMjQxj3U1px/CnUGI828QDvgGtFhZvoYvF011POSd3FKWVBjNeqJ8J+AWvWGOvWrFv8JrIOGnuZmx2yapYKoQ8dTPHJLuJcgsoP1FU5NRiUnBLY/ujNe+w/Crw+sm+SKWQj1NbFl4F0CzGItPiOf7y/8A161jgZ9WZvHwWyPla81m4kOyzsp5XPAxGaqf2L421ljHY6ZLGp/ibj+lfZFvoGmW+PJsYEx6LV9LaNBhFC/St4YJLV6mE8e38KsfHNh8CvF2qMralOsKnrkk4rsNI/ZwtUwdSv5JT6Lkf0r6X8nnpSCPB6V0qkloc0q8pani1n8BvDNuBmFmI7kn/CtEfBrw4FG22xj3r1gxgHpxQqDPtR7GPYn2su55BN8F9DY5WMj8TVWX4I6V/ACPxNe17BinbB9aPYQ7D9tPueETfBGy6IT+ZrG1D4LFATCen1r6OaMc1E6Dae9J4aD6DWImup8j6v8AC28tc4h3CuK1bwdNbE+Zbke+K+3Lq1hkyGQEmuc1bwvZ3asGjU/hWTw9tmbRxL6o+IrvRGjztyKz45LnT7hXVm+U9M8V9T+JfhrDKHaBNp56ZrynxJ4Bu7UufKLL7A1D5o6SV0bKcZaxdmcxZ+I4p1Csdrnsa1lv0fABBbFcbqejS27kqhUjtg1UttQmtnxLk49etYPDxkrxOuGJa0mejI4YBgRjvUomG4JnmuT0vVRN8pY49M1tJKpIcHkVyThyuzOuM1JXRqIQ3A696WX5cY61Vjk7qOKcWLEZJJrGw76jkbDc9RU52bGZ+vUChDG7YIIY1HINvGSeaGO9yN0MkiuvUdKJ4jHhgM5pyuVccGnEebGMtg+lUlcTdj0nx/4dfSdVfaMRONyn8q4a5jO1s+lfRfxT0j+0NBFzChaa3O44HJSvCL+AhMoMiuutSdObijzsJW54K5BEnl28fpingqRgVLEmbZOOaQjjhcEVElY6E7shYYNRshxkdqnClwODTgny8DmspXRrAiG1lBHHrUkTdjVTPk3I3cIxx9K0PJA+ZelK1y2rE6JnBFOICcg5aiMErkU4BEGX/WrUTJjduQTUE15b2wzcOFrPvtUUzG3swXk9ugrb8KeBLzXrlZLzcY++egq4UnPYidRQV5MyIru91aXydGtZJXJxuxxXofhL4PXN4Uu/E12xzz5K9K9P8L+E9P0K3VYIU3gctgV0bSBBjv2xXfSwcY6yPNq4yUtIaGPonhTR9FhVbOziUgddvNbsSIOFVQPQAUyIbjlqsxrj6V2KKWiRxSk3q2Kq/TFPRacq8ZpwX8asm4m0e1GBxin7eKCMd6Qhm0HpSMgOacD6UcUBcZsHFNYFfWpc0h59KYXIscY60mfXrUpHNMKZGaAuRmmY9qeRtHPWmgc5NFtQG5pQ+Dx0pcDmmFTn1oQx+aQ8jgcUxhxwaZk59qLgNmiFUZkKNWluHrTXVXHalJDTMZlVzhlGKy9Q0W1ukIZFyfauhlt+ciqkiMvUVDRSZ5N4p+HFteK7JGAx6ECvDvGfw+vNPZnWIsg7qK+xZBngjNZOraNbXsLLJGMn1ArKVNbrQ2hWa0Z8Gyw3FhN8ysuO+K1bDVR91ya968c/C+K4V5baMKxz0Arw3xD4RvtKmf8AdMApNYzin8aOqlV5fgfyNa3vVZAA2M1ajn6lTzXD217LbNtlB49a2bDUVcnng1yTw7Wp3U6ymddbyLtJY5p/mZIOML61jW84cYBrQjJK461yyjY3TLrspVefxqG6KR4CnJqJHIYAilVjk9x71N+oz7QlYYIPIIwQehry7x74TP7y+0xAFIy8Q/pXosstUZ5sg56dMV71Wmqit1Pm6c3B3R8+REkGIrtKmonbazKTXoninw3CXa7sF2v1ZPWuCu4AWYgEHPIPavPnFx91nq06kZ6opLJsfk8GmyySRNuQ5HpSmLJxSqpGVbkVzS9Tqi0RpNb3KlJSEf3rTtCY0Eb8js1Yd9p6SqXyfwrGvZtRtIiIJvlHTdzTi+5bSa0Z3Mk0cI+chR1yaybmR9SkEFtnb3auB0eHU9b16OO4uJDEpBYKSBivf/BvhbzvLJjKxjBz610QoORyVa3s2UfAnggSyozR/L1LHvXuOmWMNhbrFAoAA5xVfTbSKygWOEYAFXdzEYXpXo04KCsjyqtR1HdkzS8YXrTooycE8mmxRc+tXYYjxWi1Mm7D4Yx1qdFxQFxTulXsQ2O4FISAOlJn0pCaQhdxIpCT3oJxSbqdgHbTg03GOTQX44pM0AOHNJkA0m49qPc0wFzk008/SjPPpSZ9KAEYDFQtU2AaayECiwXK7sRikWQg81KUBqIoc8VOqKJEcGjAOcVAVI7Um5gfSi4WJSOvSmZAJ4o3cc03jNADm54qB0BBB5qQH1NRE8nk0mNFWaH0qBlxwavMQSDUMq5qbFGbPEHUqRkVzOu+HLXUI3DxKSR6V10iYbIqGRQRyKlq5Sdj5t8d/DHl5bWPHsPr9K8X1HS7vS7hkdGGK+6ry0WZSrgEV5x408C22oK7JHhj3FYuDXwnRGrf4j5g0/VDEwEnFdFa6grqGDcjtWl4h+Hk1tIxiRsD0BrkpdF1CwkJVGIB7iuapTjLyZ2U6zW+p16Tgx56kUsThmJB49K5i11F0YRzDa2ehrVhm8xMqea5JUrHVGakfak+RxWbcnjrWtOOtZV2le2z59GNdykA1w3iW1UEzRp1+9iu2vEwDXN6lGWDBhkHtWNSPMjopy5Xc4uWDoU5FRFFySQa0J08iTbjKHt6VDNEpG5e9cUopbo9GE+bYpEg/KDx6VlanAnlsa0Z1MTZz1rPZTeXUVsgJeRgtRa+hulbU6/4T+EfPR76VMK7YGR2zXuOn2qW0SpGuABWf4W0pNN0i2tkXG1BnjvXQRx4+tenTp8iseLXq88mwVTViOM9ulCLVmJcda2S1MGyWGML1qyh4qNAAO9KT7VdjMlNIWGKiDGg59aLAO8welNLEnikxTwtADcnHNLyRkVIUo2kCi4XGqvqTQQc0/t7UuMUXEM2mm7WPAqTFLjA560XC5HtOTSY59qkxRRcLkfQ0DmnFRyaZ0PNMLiFcE8ZqIg1McmomBAoAaMZ96a0eevSlGc89aOeKVh3ImQg8dKQrxzVgH8qa4HWlYdyuQcetMI9utSsnORUb8Gk0NETjFQvyanfkVE4zipKTKrDI61BIMVakB5qtLSGV36Hpiq00YfqARVuQd6gYA5NSMxL/RIrkZ2A5rntQ8DwzhgYV/Ku/iAIArRghV15FLkT3K52tj5V+KPw6ls7BtQs0IMWSwAPTivJre+nsztkBxX3prujQX+nTwTxhkkQqcivlbxb8Op4mmWGM/LKcEDsSaznTSRvSqvvqfXE/Ss66Wiit2cqMW+XrmsC/jBzRRUNGsTmNSh5OMcVlwtlyjUUVhNI6KTaZBd2+cnP0rovhfoCXWrm6mVW8rpn1oorKlFc6OqtNqk7HuUEYAFWVX0oor0UeMyZBViMYHNFFWRcdu7CgHNFFAC9zilVuMUUUAOU+1PyKKKAHbjikzRRSFYNw4o7UUU7AJuxSbqKKdgAtgZpA+R70UUJALkGmtx0oooAbn0pOvHeiimIjIGTTGHeiikykIWPSkzniiikAdKhdc0UUARMMVC3oKKKloojfpVZ15ooqGUQsOaikXHSiikULFzjHBFatm3Aoopx3JZakVSmCODXJ3WjRXV3KrKpOc9KKKuaFFn/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The wrist is placed in a partially flexed position. The cyst is palpated for tension, fluctuance, and mobility. Passive movement of the fingers is performed to determine if the cyst is attached to the tenosynovial sheath.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_63_12287=[""].join("\n");
var outline_f11_63_12287=null;
